Use these links to rapidly review the document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________________________
FORM 10-K
(Mark One) | ||
ý | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the fiscal year ended March 31, 2014 | ||
Or | ||
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the transition period from to | ||
Commission File Number: 001-15491
____________________________________________________________________________
KEMET Corporation
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) | 57-0923789 (I.R.S. Employer Identification No.) | |
2835 Kemet Way, Simpsonville, South Carolina (Address of principal executive offices) | 29681 (Zip Code) | |
Registrant's telephone number, including area code: (864) 963-6300
Securities registered pursuant to Section 12(b) of the Act:
Common Stock, par value $0.01 New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None.
____________________________________________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No ý
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No ý
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ý
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act (Check one):
Large accelerated filer o | Accelerated filer ý | Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company o | |||
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No ý
Aggregate market value of voting common stock held by non-affiliates of the registrant as of September 30, 2013, computed by reference to the closing sale price of the registrant's common stock was approximately $182,411,910.
Number of shares of each class of common stock outstanding as of May 27, 2014: common stock, $0.01 par value, 45,362,350.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive proxy statement to be delivered to stockholders in connection with the Annual Meeting of Stockholders to be held July 24, 2014 are incorporated by reference in Part III of this report.
Index
3
PART I
ITEM 1. BUSINESS
Background of Company
KEMET is a leading global manufacturer of a wide variety of capacitors. As used in this report, the terms "we", "us", "our", "KEMET" and the "Company" refer to KEMET Corporation and its predecessors, subsidiaries and affiliates, unless the context indicates otherwise. KEMET's operations began in 1919 as a business of Union Carbide Corporation ("Union Carbide") to manufacture component parts for vacuum tubes. In the 1950s, Bell Laboratories invented solid-state transistors along with tantalum capacitors and other passive components necessary for their operation. As vacuum tubes were gradually replaced by transistors, we changed our manufacturing focus from vacuum tube parts to tantalum capacitors. We entered the market for tantalum capacitors in 1958 as one of approximately 25 United States manufacturers and by 1966; we were the United States' market leader in tantalum capacitors. In 1969, we began production of ceramic capacitors as one of approximately 35 United States manufacturers and opened our first manufacturing facility in Mexico. In 2003, we expanded operations into Asia, opening our first facility in Suzhou, China. In fiscal year 2007, we acquired the tantalum business unit of EPCOS AG ("EPCOS"). In fiscal year 2008, we acquired Evox Rifa Group Oyj ("Evox Rifa") and Arcotronics Italia S.p.A. ("Arcotronics") and, as a result, entered into markets for film, electrolytic and paper capacitors. In fiscal year 2012, we acquired Cornell Dubilier Foil, LLC (whose name was subsequently changed to KEMET Foil Manufacturing, LLC ("KEMET Foil")) and Niotan Incorporated (whose name was subsequently changed to KEMET Blue Powder Corporation ("Blue Powder")) which has allowed us to vertically integrate certain manufacturing processes within our two segments: our Film and Electrolytic Business Group ("Film and Electrolytic") and our Solid Capacitors Business Group ("Solid Capacitors"). In fiscal year 2013, KEMET Electronics Corporation ("KEC") acquired a 34% economic interest in NEC TOKIN Corporation ("NEC TOKIN") as calculated based on the number of common shares held by KEC, directly and indirectly, in proportion to the aggregate number of common and preferred shares of NEC TOKIN outstanding as of such date. The Company accounts for its investment in NEC TOKIN using the equity method for a non-consolidated variable interest entity since KEC does not have the power to direct significant activities of NEC TOKIN.
KEMET Corporation is a Delaware corporation that was formed in 1990 by certain members of the Company's management at the time, Citicorp Venture Capital, Ltd. and other investors that acquired the outstanding common stock of KEMET Electronics Corporation from Union Carbide. In 1992, we publicly issued shares of our common stock. Today, our common stock trades on the New York Stock Exchange ("NYSE") under the symbol "KEM".
General
Capacitors are electronic components that store, filter, and regulate electrical energy and current flow. As an essential passive component used in most circuit boards, capacitors are typically used for coupling, decoupling, filtering, oscillating and wave shaping and are used in communication systems, data processing equipment, personal computers, cellular phones, automotive electronic systems, defense and aerospace systems, consumer electronics, power management systems and many other electronic devices and systems (basically anything that plugs in or has a battery). Manufacturing a broad line of capacitors in many different sizes and configurations using a variety of raw materials, our product offerings include tantalum, multilayer ceramic, solid and electrolytic aluminum and film capacitors. Our product line consists of nearly 5 million distinct part configurations distinguished by various attributes, such as dielectric (or insulating) material, configuration, encapsulation, capacitance (at various tolerances), voltage, performance characteristics and packaging. Most of our customers have multiple capacitance requirements, often within each of their products and our broad product offering allows us to meet the majority of those needs independent of application and end use.
During fiscal years 2014, 2013 and 2012 we shipped 35 billion, 32 billion and 32 billion capacitors, respectively. We believe the long-term demand for the various types of capacitors we offer will grow on a regional and global basis due to a variety of factors, including increasing demand for and complexity of electronic products, growing demand for technology in emerging markets and the ongoing development of new solutions for energy generation and conservation. We operate 21 production facilities in Europe, North America and Asia and employ 9,600 employees worldwide. Our customer base includes most of the world's major electronics original equipment manufacturers ("OEMs") (including Alcatel-Lucent USA Inc., Bosch Group, Cisco Systems, Inc., Continental AG, Dell Inc., Hewlett-Packard Company, International Business Machines Corporation, Intel Corporation, Motorola, Inc., Nokia Corporation, and TRW Automotive), electronics manufacturing services providers ("EMSs") (including Celestica Inc., Flextronics International LTD, Jabil Circuit, Inc. and Sanmina-SCI Corporation) and distributors (including TTI, Inc., Arrow Electronics, Inc. and Avnet, Inc.).
4
Our Industry
We manufacture capacitors in many different sizes and configurations including surface-mount capacitors, which are attached directly to the circuit board without lead wires; leaded capacitors, which are attached to the circuit board using lead wires; and, chassis-mount and other pin-through-hole board-mount capacitors, which utilize attachment methods such as screw terminal and snap-in.
The choice of capacitor dielectric is driven by the engineering specifications and the application of the component product into which the capacitor is incorporated. Product design engineers in the electronics industry typically select capacitors on the basis of capacitance levels, voltage requirements, size and cost. We compete with others that manufacture and distribute capacitors both domestically and globally and our success in the market is influenced by many factors, including price, availability, engineering specifications, quality, breadth of offering, performance characteristics, customer service and geographic location of our manufacturing sites. As in all manufacturing industries, there is ongoing pressure on average unit selling prices for capacitors. To help mitigate this effect, KEMET as well as many of our larger competitors have relocated their manufacturing operations to low cost regions and locations in closer proximity to our respective customers.
Solid Capacitors products are commonly used in conjunction with integrated circuits, and the same circuit may, and frequently does, contain both ceramic and tantalum capacitors. Tantalum capacitors are a popular choice because of their ability for high capacitance in a small volume package. Generally, ceramic capacitors are more cost-effective at lower capacitance values, and tantalum capacitors are more cost-effective at higher capacitance values. Solid aluminum capacitors can be more effective in special applications. Film, paper and aluminum electrolytic capacitors can be used to support integrated circuits, but also are used in the field of power electronics to provide energy for applications such as motor starts, power conditioning, electromagnetic interference filtering safety and inverters. Capacitors account for the largest market within the passive component product grouping.
According to a March 2014 report entitled "Passive Electronic Components: World Market Outlook: 2014-2019" by Paumanok Publications, Inc. ("Paumanok"), a market research firm concentrating on the passive components industry, the global capacitor market in fiscal year 2014 (fiscal year ending March 2014) was estimated to be $18.3 billion in revenues and 1.59 trillion units. According to the Paumanok report, the global capacitor market is expected to improve substantially and achieve revenue and unit volume increases of 24% and 29%, respectively, by fiscal year 2019. According to Paumanok, the forecast of the capacitor industry for fiscal year 2014 and the expected growth to fiscal year 2019 are as follows (amounts in billions):
Fiscal Year 2014 | Fiscal Year 2019 | |||||||
Tantalum | $ | 1.9 | $ | 2.4 | ||||
Ceramic | 9.6 | 11.8 | ||||||
Aluminum | 4.1 | 5.0 | ||||||
Paper and plastic film | 2.0 | 2.6 | ||||||
Other | 0.7 | 0.9 | ||||||
$ | 18.3 | $ | 22.7 | |||||
Because capacitors are a fundamental component of electronic circuits, demand for capacitors tends to reflect the general demand for electronic products, as well as integrated circuits, which, though cyclical, continues to grow. We believe that growth in the electronics market and the resulting growth in demand for capacitors will be driven primarily by a number of recent trends which include:
• | the development of new products and applications, such as alternative and renewable energy systems, hybrid transportation systems, electronic controls for engines and industrial machinery, smart phones and mobile personal computing devices; |
• | the increase in the electronic content of existing products, such as home appliances, medical equipment and automobiles; |
• | consumer desire for mobility and connectivity; and |
• | the enhanced functionality, complexity and convergence of electronic devices that use state-of-the-art microprocessors. |
Markets and Customers
Our products are sold to a variety of OEMs in a broad range of industries including the computer, communications, automotive, military, consumer, industrial and aerospace industries. We also sell products to EMS providers, which also serve
5
OEMs in these industries. Electronics distributors are an important channel of distribution in the electronics industry and represent the largest channel through which we sell our capacitors. One electronics distributor, accounted for over 10% of our net sales in fiscal years 2014, 2013 and 2012. If our relationship with this customer were to terminate, we would need to determine alternative means of delivering our products to the end-customers served by them. Our top 50 customers accounted for 83.3% of our net sales during fiscal year 2014.
The following table presents an overview of the diverse industries that incorporate our capacitors into their products and the general nature of those products.
Industry | Products | |
Automotive | Adaptive cruise control, high intensity discharge lamp, light emitting diode electronic modules, lane departure warning, rearview camera systems, audio systems, tire pressure monitoring, power train electronics, instrumentation, airbag systems, anti-lock braking and stabilization systems, hybrid and electric drive vehicles, electronic engine control modules, driver comfort controls, and security systems | |
Communications | Smart phones, telephones, switching equipment, relays, base stations, and wireless infrastructure | |
Computer-related | Personal computers (laptops, tablets, netbooks), workstations, servers, mainframes, computer peripheral equipment, power supplies, disk drives, solid state drives, printers, and local area networks | |
Industrial | Electronic controls, measurement equipment, instrumentation, solar and wind energy generation, and medical electronics | |
Consumer | Digital media devices, game consoles, televisions and global positioning systems | |
Military/Aerospace | Avionics, radar, guidance systems, and satellite communications | |
Alternative Energy | Wind generation systems, solar generation systems, geothermal generation systems, tidal generation systems and electric drive vehicles | |
We produce a small percentage of capacitors under military specification standards sold for both military and commercial uses. We do not sell any capacitors directly to the United States government. Certain of our customers purchase capacitors for products in the military and aerospace industries.
It is impracticable to report revenues from external customers for each of the above noted products primarily because approximately 45% of our external sales were to electronics distributors for fiscal year 2014.
KEMET in the United States
Our corporate headquarters is located in Simpsonville, South Carolina, which is part of the greater Greenville, South Carolina metropolitan area. Individual functions continue to evolve to support global activities in Asia, Europe, and the Americas, either from Greenville or through other locations in appropriate parts of the world.
Commodity manufacturing previously located in the United States has been substantially relocated to our lower-cost manufacturing facilities in Mexico and China. Production that remains in the United States focuses primarily on early-stage manufacturing of new products and other specialty products for which customers are predominantly located in North America. In March 2012, we began the production of power film capacitors in the United States to support alternative energy products and emerging green technologies, such as hybrid electric drive vehicles.
On June 13, 2011, we completed the acquisition of KEMET Foil, a Tennessee based manufacturer of etched foils utilized as a core component in the manufacture of electrolytic capacitors. On February 21, 2012, we completed the acquisition of all of the outstanding shares of Blue Powder, a leading manufacturer of tantalum powders. Blue Powder had been a significant supplier of tantalum powder to KEMET for several years. Blue Powder's principal operating location is in Carson City, Nevada.
To accelerate the pace of innovations, the KEMET Innovation Center for Solid Capacitors was created in July 2003. The primary objectives of the KEMET Innovation Center are to ensure the flow of new product platforms, material sets, and processes that are expected to keep us at the forefront of our customers' product designs, while enabling these products to be transferred rapidly to the most appropriate KEMET manufacturing location in the world for low-cost, high-volume production. The main campus of the KEMET Innovation Center is located in Simpsonville, South Carolina.
6
KEMET in Mexico
We believe our operations in Mexico are among the most cost efficient in the world, and they will continue to be our primary production facilities supporting North American and European customers for Solid Capacitors. One of the strengths of KEMET Mexico is that it is a local operation, including local management and workers. These facilities are responsible for maintaining KEMET's tradition of excellence in quality, service, and delivery, while driving costs down. The facilities in Victoria and Matamoros are focused primarily on tantalum capacitors, while the facilities in Monterrey are focused on ceramic capacitors.
KEMET in Asia Pacific
Over the past several years, low production costs and proximity to large, growing markets have caused many of our key customers to relocate production facilities to Asia, particularly China. We have a well-established sales and logistics network in Asia to support our customers' Asian operations. In calendar year 2003, we commenced shipments from Suzhou, China. In connection with the Evox Rifa acquisition, which was completed in April 2007, we added another Chinese operation in Nantong, China, as well as a manufacturing operation in Batam, Indonesia. In fiscal year 2012, as part of our restructuring plan, we began to reduce the operations at the Nantong, China plant and relocate its operations to Suzhou, China. During fiscal year 2013 we closed operations in Nantong, China. With the Arcotronics acquisition, which was completed in October 2007, we further expanded our presence in China with a manufacturing operation in Anting, China. These operations will continue to support customers in Asia with top quality film and electrolytic capacitors. In the fourth quarter of fiscal year 2010, we began to manufacture aluminum polymer products in a second facility in Suzhou, China and during the second quarter of fiscal year 2012, we began production of Electrolytic products in a third facility in Suzhou, China. Manufacturing operations in China are expected to continue to grow and we anticipate that our production capacity in China may be equivalent to Mexico in the future. The vision for KEMET China is to be a local operation, with local management and workers, to help achieve our objective of being a global company. These facilities will be responsible for maintaining our tradition of excellence in quality, service, and delivery, while accelerating cost-reduction efforts and supporting efforts to grow our customer base in Asia.
KEMET in Europe
We acquired the tantalum business unit of EPCOS in April 2006, acquired Evox Rifa in April 2007, and acquired Arcotronics in October 2007. These acquisitions provided us with manufacturing operations in Europe. We currently have one or more manufacturing locations in each of the following countries: Bulgaria, Finland, Germany, Italy, Macedonia, Portugal, and Sweden. In addition, we operate product innovation centers in the United Kingdom, Italy, Germany and Sweden. We will maintain and enhance our strong European sales and customer service infrastructure, allowing us to continue to meet the local preferences of European customers who remain an important focus for KEMET.
Global Sales and Logistics
In recent years, it has become more complicated to do business in the electronics industry. Market leading electronics manufacturers have spread their facilities globally. The growth of the electronics manufacturing services industry has resulted in a more challenging supply chain. New Asian electronics manufacturers are emerging rapidly. In order to drive down costs, the most successful business models in the electronics industry are based on tightly integrated supply chain logistics. Our direct worldwide sales force and a well-developed global logistics infrastructure distinguish us in the marketplace and will remain a hallmark of KEMET in meeting the needs of our global customers. The North America and South America ("Americas") sales staff is organized into four areas supported by regional offices. The sales staff for Europe, the Middle East and Africa ("EMEA") is organized into three areas, also supported by regional offices. The APAC sales staff is organized into three areas, and is also supported by regional offices. We also have independent sales representatives located in seven countries worldwide including: Brazil, Israel, Canada, and the United States.
In our major markets, we market and sell our products primarily through a direct sales force. With a global sales organization that is customer-focused, our direct sales personnel from around the world serve on KEMET Global Account Teams committed to serving any customer location in the world with a dedicated KEMET representative.The traditional sales team is supported by regional Field Application Engineers who are experts in electronic engineering and market all of KEMET's products by assisting customers with the resolution of capacitor application issues. We believe our direct sales force creates a distinct advantage in the marketplace by enabling us to establish and maintain strong relationships with our customers to efficiently process simple repeat business as well as to consult with customers on new and technically complex custom applications. In addition, where appropriate, we use independent commissioned representatives. This approach requires a blend of accountability and responsibility for specific customer locations, guided by an overall account strategy for each customer.
Electronics distributors are an important distribution channel in the electronics industry and accounted for 45%, 46%, and 45% of our net sales in fiscal years 2014, 2013 and 2012, respectively. A portion of our net sales is made to distributors under
7
agreements allowing certain rights of return and price protection on unsold merchandise held by distributors. Our distributor policy includes inventory price protection and "ship-from-stock and debit" ("SFSD") programs common in the industry.
Sales by Geography
In fiscal years 2014 and 2013, net sales by region were as follows (dollars in millions):
Fiscal Year 2014 | Fiscal Year 2013 | |||||||||||||||
Net Sales | % of Total | Net Sales | % of Total | |||||||||||||
Americas | $ | 262.9 | 31 | % | Americas | $ | 244.9 | 30 | % | |||||||
APAC | 282.3 | 34 | % | APAC | 294.5 | 36 | % | |||||||||
EMEA | 288.5 | 35 | % | EMEA | 284.5 | 34 | % | |||||||||
Total | $ | 833.7 | Total | $ | 823.9 | |||||||||||
We believe our regional balance of revenues is a benefit to our business. The geographic diversity of our net sales diminishes the impact of regional sales decreases caused by various holiday seasons. While sales in the Americas are the lowest of the three regions, the Americas remains the leading region in the world for product design in activity where engagement with OEM design engineers determines product placement independent of the region of the world where the final product is manufactured.
Inventory and Backlog
Our customers often encounter uncertain or changing demand for their products. They historically order products from us based on their forecast and if demand does not meet their forecasts, they may cancel or reschedule the shipments included in our backlog, in many instances without penalty. Additionally, many of our customers have started to require shorter lead times and "just in time" delivery. As a result of these factors, the twelve month order backlog is not a meaningful trend indicator for us.
Although we manufacture and inventory standardized products, a portion of our products are produced to meet specific customer requirements. Cancellations by customers of orders already in production could have an impact on inventories. However, historically, cancellations have not been significant.
Competition
The market for capacitors is highly competitive. The capacitor industry is characterized by, among other factors, a long-term trend toward lower prices, low transportation costs, and few import barriers. Competitive factors that influence the market for our products include: product quality, customer service, technical innovation, pricing, and timely delivery. We believe that we compete favorably on the basis of each of these factors.
Our major global competitors include AVX Corporation, Matsushita Electric Industrial Company, Ltd. (Panasonic), Murata Manufacturing Co., Ltd., Sanyo Electric Co., Ltd., Samsung, Taiyo Yuden Co., Ltd., TDK-EPC Corporation, WIMA GmbH & Co., KG and Vishay Intertechnology, Inc. ("Vishay"). These competitors, among others, cover the breadth of our capacitor offerings.
Raw Materials
The principal raw materials used in the manufacture of our products are tantalum powder, tantalum ore, palladium, aluminum and silver. These materials are considered commodities and are subject to price volatility. Additionally, any delays in obtaining raw materials could hinder our ability to manufacture our products, negatively impacting our competitive position and our relationships with customers.
Tantalum is a metal found in minerals such as tantalite, columbite and coltan, and is mined principally in Central Africa, Australia, Brazil, Canada and Mozambique. As a result of our tantalum vertical integration program which began in fiscal year 2012, we have reduced our exposure to price volatility and supply uncertainty in the tantalum supply chain. A majority of our tantalum needs are now met through our direct sourcing of conflict free tantalum ore or tantalum scrap reclaim, which is then processed into the intermediate product potassium heptafluorotantalate (commonly known as K-salt) at our own facility in Mexico, before final processing into tantalum powder at Blue Powder. Price increases for tantalum ore, or for the remaining tantalum powder that we source from third parties, could impact our financial performance as we may be unable to pass all such price increases on to our customers.
8
Palladium is a precious metal used in the manufacture of multilayer ceramic capacitors ("MLCC") and is mined primarily in Russia and South Africa. We continue to pursue ways to reduce palladium usage in ceramic capacitors in order to minimize the price risk. The amount of palladium that we require has generally been available in sufficient quantities; however, the price of palladium is driven by the market which has shown significant price fluctuations. For instance, in fiscal year 2014 the price of palladium fluctuated between $640 to $792 per troy ounce. Price increases and the possibility of our inability to pass such increases on to our customers could have an adverse effect on profitability.
Silver and aluminum have generally been available in sufficient quantities, and we believe there are a sufficient number of suppliers from which we can purchase our requirements. An increase in the price of silver and aluminum that we are unable to pass on to our customers, could, however, have an adverse effect on our profitability.
Patents and Trademarks
At March 31, 2014, we held the following number of patents and trademarks:
Patents | Trademarks | |||||
United States | 113 | 7 | ||||
Foreign | 42 | 98 | ||||
We believe that the success of our business is not materially dependent on the existence or duration of any patent, license, or trademark other than the trademarks "KEMET" and "KEMET Charged". Our engineering and research and development staffs have developed and continue to develop proprietary manufacturing processes and equipment designed to enhance our manufacturing facilities and reduce costs.
Research and Development
Research and development expenses were $24.5 million, $26.9 million and $27.8 million for fiscal years 2014, 2013 and 2012, respectively. These amounts include expenditures for product development and the design and development of machinery and equipment for new processes and cost reduction efforts. Most of our products and manufacturing processes have been designed and developed by our engineers. We continue to invest in new technology to improve product performance and production efficiencies.
Segment Reporting
We are organized into two business groups: Solid Capacitors and Film and Electrolytic. Each business group is responsible for the operations of certain manufacturing sites as well as all related research and development efforts. The sales, marketing and corporate functions are shared by each of the business groups. See Note 9, "Segment and Geographic Information" to our consolidated financial statements.
Solid Capacitors Business Group
Solid Capacitors operates nine capacitor manufacturing sites in Portugal, Mexico, China and a product innovation center in the United States and primarily produces tantalum, aluminum, polymer and ceramic capacitors which are sold globally. Solid Capacitors also produces tantalum powder used in the production of tantalum capacitors. Solid Capacitors employs over 6,850 employees worldwide. For fiscal years 2014, 2013 and 2012, Solid Capacitors had consolidated net sales of $626.5 million, $622.3 million and $630.8 million, respectively.
We continue to make significant investments in tantalum production within Solid Capacitors and, based on net sales, we believe that we are the largest tantalum capacitor manufacturer in the world. We believe we have one of the broadest lines of tantalum product offerings and are one of the leaders in the growing market for high-frequency surface mount tantalum and aluminum polymer capacitors. On February 21, 2012, we acquired Blue Powder which we believe is the largest production facility for tantalum powder in the western hemisphere.
Our tantalum product line's broad product portfolio, industry leading process and materials technology, global manufacturing base and on-time delivery capabilities allow us to serve a wide range of customers in a diverse group of end markets, including computing, telecommunications, consumer, medical, military, automotive and general industries.
Our ceramic product line offers an extensive line of multilayer ceramic capacitors in a variety of sizes and configurations. We are one of the two leading ceramic capacitor manufacturers in the United States and among the ten largest manufacturers worldwide.
9
Our ceramic product line high temperature and capacitance stable product lines provide us with what we believe to be a significant advantage over many of our competitors, especially in high reliability markets, such as medical, industrial, defense and aerospace. Our other significant end markets include computing, telecommunications, automotive and general industries.
Film and Electrolytic Business Group
Our Film and Electrolytic Business Group produces film, paper and wet aluminum electrolytic capacitors. We entered this market through the acquisitions of Evox Rifa and Arcotronics in fiscal year 2008. Film capacitors are preferred where high reliability is a determining factor, while wet aluminum electrolytic capacitors are preferred when high capacitance at a reasonable cost is required. We are one of the world's largest suppliers of film and one of the leaders in wet aluminum electrolytic capacitors for high-value custom applications. On June 13, 2011, we completed the acquisition of KEMET Foil, which manufactures etched foils utilized as a core component in the manufacture of electrolytic capacitors. For fiscal years 2014, 2013 and 2012, our Film and Electrolytic Business Group had consolidated net sales of $207.2 million, $201.6 million and $293.3 million, respectively.
Our Film and Electrolytic Business Group primarily serves the industrial, automotive, consumer and telecom markets. We believe that our Film and Electrolytic Business Group's product portfolio, technology and experience position us to significantly benefit from the continued growth in alternative energy solutions. We operate twelve film and electrolytic manufacturing sites throughout Europe, Asia and the United States and product innovation centers in the United Kingdom, Italy, Germany and Sweden. In June 2011, we began the production of power film capacitors in the United States to support alternative energy products and emerging green technologies, such as hybrid electric drive vehicles. Our Film and Electrolytic Business Group employs approximately 2,350 employees worldwide.
In September 2009, we announced plans to reduce operating costs by consolidating the manufacturing of certain products and by implementing other Lean initiatives. Manufacturing consolidation plans include the movement of certain standard, high-volume products to lower cost manufacturing locations. We anticipate the plans will be completed in fiscal year 2016; however, the length of time required to complete the restructuring activities is dependent upon a number of factors, including the ability to continue to manufacture products required to meet customer demand while at the same time relocating certain production lines, and the progress of discussions with union and government representatives in certain European locations concerning the optimization of product mix and related headcount requirements in such manufacturing locations. In July 2010, we relocated our Netherlands distribution facility to the Czech Republic as part of our cost reduction measures. This relocation has allowed shipping lane optimization and customer consolidation (bi-weekly or weekly) for all import shipments. Our European manufacturing plants will continue to ship direct to 'local' customers (customers located in the same country as the plant). In November 2011, we reached an agreement with labor unions in Italy to continue the restructuring process in Italy by consolidating three existing plants into a single new facility in Pontecchio, Italy. We began manufacturing from Pontecchio, Italy in the fourth quarter of fiscal year 2014. Production within one other manufacturing facility in Italy is expected to move to Pontecchio in the first quarter of fiscal year 2015. During the remainder of the restructuring plan, we expect to incur charges of $10.7 million for relocation, severance and other restructuring related costs in Film and Electrolytic. The two legacy facilities in Italy are currently being marketed for sale but do not meet accounting guidelines to be classified as 'held for sale' as the facilities are not available for immediate sale. We expect the restructuring plan to result in a $5.3 million reduction in our operating cost structure in Europe in fiscal year 2015 compared to fiscal year 2014 and anticipate that benefits from the restructuring plan will continue to improve during fiscal year 2016.
Environmental and Regulatory Compliance
We are subject to various North American, European, and Asian federal, state, and local environmental laws and regulations relating to the protection of the environment, including those governing the handling and management of certain chemicals and materials used and generated in manufacturing electronic components. Based on the annual costs incurred over the past several years, we do not believe that compliance with these laws and regulations will have a material adverse effect on our capital expenditures, earnings, or competitive position. We believe, however, that it is reasonably likely that the trend in environmental litigation, laws, and regulations will continue to be toward stricter standards. Such changes in the laws and regulations may require us to make additional capital expenditures which, while not currently estimable with certainty, are not presently expected to have a material adverse effect on our financial condition.
Our Guiding Principles support a strong commitment to economic, environmental, and socially sustainable development. As a result of this commitment, we have adopted the Electronic Industry Citizen Coalition ("EICC") Code of Conduct. The EICC Code of Conduct is a comprehensive code of conduct that addresses all aspects of corporate responsibility including Labor, Health and Safety, the Environment, and Business Ethics. It outlines standards to ensure working conditions in the electronic industry supply chain are safe, that workers are treated with respect and dignity, that manufacturing processes are environmentally friendly and that materials are sourced responsibly.
10
Policies, programs, and procedures implemented throughout KEMET ensure compliance with legal and regulatory requirements, the content of the EICC Code of Conduct, and customer contractual requirements related to social and environmental responsibility.
We are committed to these business ethics, labor, health and safety, and environmental standards. We fully support the position of the EICC, the Global e-Sustainability Initiative ("GeSI"), the Electronic Components Industry Association ("ECIA") and the Tantalum-Niobium International Study Center ("TIC") in avoiding the use of conflict minerals which directly or indirectly finance or benefit armed groups in the Democratic Republic of Congo or adjoining countries, in line with full compliance to the EICC Code of Conduct. Our tantalum supply base has been and continues to be validated as being sourced conflict free. All of our tantalum raw material providers have been validated as compliant to the EICC/GeSI Conflict Free Smelter Program ("CFSP") program. This policy and validation requirement has been implemented for all conflict minerals. We will immediately discontinue doing business with any supplier found to be purchasing materials which directly or indirectly finance or benefit armed groups in the Democratic Republic of Congo or adjoining countries. We will continue to work through the EICC, GeSI, ECIA and TIC towards the goal of greater transparency in the supply chain.
Summary of Activities to Develop a Transparent Supply Chain
We have been involved in developing a transparent supply chain. We are a member of the EICC/GeSI working group that developed the CFSP assessment protocols and participated in the pilot implementation phase of the Organization for Economic Cooperation and Development Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas. We will rely on the EICC/GeSI Conflict-Free Smelter Program independent third party audits to supplement our internal due diligence of conflict mineral suppliers and are monitoring the progress of these audits to ensure our supply chain is conflict free. We fully support section 1502 "Conflict Minerals" of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and will comply with all reporting requirements.
Employees
We have approximately 9,625 employees as of March 31, 2014 in the following locations:
Mexico | 5,250 | |
Asia | 2,100 | |
Europe | 1,700 | |
United States | 575 | |
The number of employees represented by labor organizations at KEMET locations in each of the following countries is:
Mexico | 4,300 | |
Italy | 300 | |
Bulgaria | 100 | |
Indonesia | 200 | |
China | 100 | |
Finland | 200 | |
Portugal | 100 | |
In fiscal year 2014, we did not experience any major work stoppages. Our labor costs in Mexico, Asia and various locations in Europe are denominated in local currencies, and a significant depreciation or appreciation of the United States dollar against the local currencies would increase or decrease our labor costs.
Securities Exchange Act of 1934 Reports
We maintain an Internet website at the following address: http://www.kemet.com. KEMET makes available on or through our Internet website certain reports and amendments to those reports that are filed or furnished to the Securities and Exchange Commission ("SEC") pursuant to Section 13(a) or 15(d) of the Exchange Act. These include annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and beneficial ownership reports on Forms 3, 4 and 5. This information is available on our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC.
11
Global Code of Conduct and updated Mission, Vision and Values
To complement KEMET's Global Code of Conduct ("Code of Conduct"), which became effective August 1, 2010, KEMET introduced updated mission and vision statements along with a set of core values in June 2011. KEMET's Mission is to help make the world a better, safer, more connected place to live. KEMET's Vision is to be the world's most trusted partner for innovative component solutions. KEMET's updated Values embody the key expectations of how our employees should approach the work they do every day: One KEMET, Unparalleled Customer Experience, Ethics and Integrity, Talent Oriented, No Politics, The Math Must Work and Speed. The Global Code of Conduct and updated Mission, Vision and Values are applicable to all employees, officers, and directors of the Company. The Code of Conduct, Mission, Vision and Values and any amendments thereto are available at http://www.kemet.com.
ITEM 1A. RISK FACTORS.
This report contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may differ materially from those expressed in, or implied by, our forward-looking statements. Words such as "expects," "anticipates," "believes," "estimates" and other similar expressions or future or conditional verbs such as "will," "should," "would" and "could" are intended to identify such forward-looking statements. Readers of this report should not rely solely on the forward-looking statements and should consider all uncertainties and risks throughout this report. The statements are representative only as of the date they are made, and we undertake no obligation to update any forward-looking statement.
All forward-looking statements, by their nature, are subject to risks and uncertainties. Our actual future results may differ materially from those set forth in our forward-looking statements. We face risks that are inherent in the businesses and the market places in which we operate. While management believes these forward-looking statements are accurate and reasonable, uncertainties, risks and factors, including those described below, could cause actual results to differ materially from those reflected in our forward-looking statements.
Factors that may cause the actual outcome and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following: (i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate; (ii) continued net losses could impact our ability to realize current operating plans and could materially adversely affect our liquidity and our ability to continue to operate; (iii) adverse economic conditions could cause the write down of long-lived assets or goodwill; (iv) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased materials; (v) changes in the competitive environment; (vi) uncertainty of the timing of customer product qualifications in heavily regulated industries; (vii) economic, political, or regulatory changes in the countries in which we operate; (viii) difficulties, delays or unexpected costs in completing the restructuring plan; (ix) equity method investment in NEC TOKIN expose us to a variety of risks; (x) acquisitions and other strategic transactions expose us to a variety of risks; (xi) inability to attract, train and retain effective employees and management; (xii) inability to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xiii) exposure to claims alleging product defects; (xiv) the impact of laws and regulations that apply to our business, including those relating to environmental matters; (xv) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xvi) volatility of financial and credit markets affecting our access to capital; (xvii) the need to reduce the total costs of our products to remain competitive; (xviii) potential limitation on the use of net operating losses to offset possible future taxable income; (xix) restrictions in our debt agreements that limit our flexibility in operating our business; and (xx) additional exercise of the warrant by K Equity which could potentially result in the existence of a significant stockholder who could seek to influence our corporate decisions.
Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations and could cause actual results to differ materially from those included, contemplated or implied by forward-looking statements made in this report, and the reader should not consider the above list of factors to be a complete set of all potential risks or uncertainties.
Adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines; and such conditions could adversely affect our liquidity and ability to continue to operate.
While our operating plans provide for cash generated from operations to be sufficient to cover our future operating requirements, many factors, including reduced demand for our products, currency exchange rate fluctuations, increased raw material costs, and other adverse market conditions which we cannot predict could cause a shortfall in net cash generated from operations. As an example, the electronics industry is a highly cyclical industry with demand for capacitors reflecting the demand for products in the electronics market. Customers' requirements for our capacitors fluctuate as a result of changes in
12
general economic activity and other factors that affect the demand for their end-products. During periods of increasing demand for their products, they typically seek to increase their inventory of our products to avoid production bottlenecks. When demand for their products peaks and begins to decline, they may rapidly decrease orders for our products while they use accumulated inventory. Business cycles vary somewhat in different geographical regions, such as Asia, and within customer industries. We are also vulnerable to general economic events beyond our control and our sales and profits may suffer in periods of weak demand.
A single customer accounted for over 10% of our net sales in fiscal years 2014, 2013 and 2012. If our relationship with this customer were to terminate, we would need to determine alternative means of delivering our products to the end-customers served by them.
Our ability to realize operating plans is also dependent upon meeting our payment obligations and complying with any applicable financial covenants under our debt agreements. If cash generated from operating, investing and financing activities is insufficient to pay for operating requirements and to cover interest payment obligations under debt instruments, planned operating and capital expenditures may need to be reduced.
Continued net losses could impact our ability to realize current operating plans and could materially adversely affect our liquidity and our ability to continue to operate.
Our liquidity and ability to realize our current operating plans is dependent on an improvement in operating results. If cash generated from operating, investing and financing activities is insufficient to pay for operating requirements and to cover payment obligations under debt instruments, planned operating and capital expenditures may need to be reduced, or the debt instruments may need to be amended or refinanced. There can be no assurances that we would be able to secure such amendments or refinancing on satisfactory terms.
However, to provide financial flexibility, we could explore further extending our revolving line of credit and if necessary the sale of certain non-core assets. There can be no assurances that we would be successful in either of these strategic initiatives. Our ability to realize current operating plans is also dependent upon meeting our payment obligations and complying with any applicable financial covenants under our debt agreements.
Adverse economic conditions could cause the write down of long-lived assets or goodwill.
Long-lived assets and intangible assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset or group of assets may not be recoverable. In the event that the test shows that the carrying value of certain long-lived assets is impaired, we would be required to take an impairment charge to earnings under U.S. generally accepted accounting principles. However, such a charge would have no direct effect on our cash. In fiscal year 2014, we incurred charges totaling $4.5 million for the write down of long-lived assets. If the economic conditions decline we could incur additional charges in the future.
Goodwill is reviewed for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of goodwill may not be recoverable. In the event that the test shows that the carrying value of goodwill is impaired, we would be required to take an impairment charge to earnings under U.S. generally accepted accounting principles. However, such a charge would have no direct effect on our cash. If the economic conditions decline we could incur additional charges in the future.
An increase in the cost or decrease in the availability of our principal or single-sourced purchased materials could adversely affect profitability.
The principal raw materials used in the manufacture of our products are tantalum powder, tantalum ore, palladium, aluminum and silver. These materials are considered commodities and are subject to price volatility. Additionally, any delays in obtaining raw materials could hinder our ability to manufacture our products, negatively impacting our competitive position and our relationships with customers.
Tantalum is a metal found in minerals such as tantalite, columbite and coltan, and is mined principally in Central Africa, Australia, Brazil, Canada and Mozambique. As a result of our tantalum vertical integration program which began in fiscal year 2012, we have reduced our exposure to price volatility and supply uncertainty in the tantalum supply chain. A majority of our tantalum needs are now met through our direct sourcing of conflict free tantalum ore or tantalum scrap reclaim, which is then processed into the intermediate product potassium heptafluorotantalate (commonly known as K-salt) at our own facility in Mexico, before final processing into tantalum powder at Blue Powder. Price increases for tantalum ore, or for the remaining tantalum powder that we source from third parties, could impact our financial performance as we may be unable to pass all such price increases on to our customers.
13
Palladium is a precious metal used in the manufacture of multilayer ceramic capacitors and is mined primarily in Russia and South Africa. We continue to pursue ways to reduce palladium usage in ceramic capacitors in order to minimize the price risk. The amount of palladium that we require has generally been available in sufficient quantities; however the price of palladium is subject to significant price fluctuations driven by market demand For instance, in fiscal year 2014 the price of palladium fluctuated between $640 to $792 per troy ounce. Price increases and the possibility of our inability to pass such increases on to our customers could have an adverse effect on profitability.
Silver and aluminum have generally been available in sufficient quantities, and we believe there are a sufficient number of suppliers from which we can purchase our requirements. An increase in the price of silver and aluminum that we are unable to pass on to our customers, could, however, have an adverse effect on our profitability.
Changes in the competitive environment could harm our business.
The capacitor business is highly competitive worldwide, with low transportation costs and few import barriers. Competition is based on factors such as product quality and reliability, availability, customer service, timely delivery and price. The industry has become increasingly consolidated and globalized in recent years, and our primary U.S. and non-U.S. competitors, some of which are larger than us, have significant financial resources. The greater financial resources of such competitors may enable them to commit larger amounts of capital in response to changing market conditions. Some competitors may also have the ability to use profits from other operations to subsidize losses sustained in their businesses with which we compete. Certain competitors may also develop product or service innovations that could put us at a disadvantage.
Uncertainty of the timing of customer product qualifications in heavily regulated industries could affect the timing of product revenues and profitability arising from these industries.
Our capacitors are incorporated into products used in diverse industries. Certain of these industries, such as military, aerospace and medical, are heavily regulated, with long and sometimes unpredictable product approval and qualification processes. Due to such regulatory compliance issues, there can be no assurances as to the timing of product revenues and profitability arising from our product development and sales efforts in these industries.
We manufacture many capacitors in Europe, Mexico and Asia and economic, political or regulatory changes in any of these regions could adversely affect our profitability.
Our international operations are subject to a number of special risks, in addition to the same risks as our domestic business. These risks include currency exchange rate fluctuations, differing protections of intellectual property, trade barriers, labor unrest, exchange controls, regional economic uncertainty, differing (and possibly more stringent) labor regulation, risk of governmental expropriation, domestic and foreign customs and tariffs, current and changing regulatory regimes, differences in the availability and terms of financing, political instability and potential increases in taxes. These factors could impact our production capability or adversely affect our results of operations or financial condition.
We may experience difficulties, delays or unexpected costs in completing our restructuring plan.
In the second quarter of fiscal year 2010, we initiated a restructuring plan designed to improve the operating performance of Film and Electrolytic. However, any anticipated benefits of this restructuring activity will not be fully realized until fiscal year 2016. Since its initiation, the restructuring plan has been expanded to all business groups and includes implementing programs to make the Company more competitive by removing excess capacity, moving production to lower cost locations and eliminating unnecessary costs throughout the Company.
We may not realize, in full or in part, the anticipated benefits of the restructuring plan without encountering difficulties, which may include complications in the transfer of production knowledge, loss of key employees and/or customers, the disruption of ongoing business, possible inconsistencies in standards, controls and procedures and potential difficulty in meeting customer demand in the event the market dramatically improves. We are party to collective bargaining agreements in certain jurisdictions in which we operate which could potentially prevent or delay execution of parts of our restructuring plan.
The financial performance of our equity method investment in NEC TOKIN could adversely impact our results of operations.
On February 1, 2013, we closed on KEC's investment in a 34% economic interest in NEC TOKIN with the purchase of 51% of the common stock in NEC TOKIN. The 34% economic interest is calculated based on the number of common shares held by KEC, directly and indirectly, in proportion to the aggregate number of common and preferred shares of NEC TOKIN outstanding as of such date. These businesses are subject to laws, regulations or market conditions, or have risks inherent in their operations, that could adversely affect their performance. We do not have the power to direct significant activities of our equity method investments and therefore the performance of the investment may be negatively impacted. The interests of our partners may differ from the Company's, and they may cause such entities to take actions which are not in the Company's best
14
interest. Any of these factors could adversely impact our results of operations and the value of our investment. In fiscal years 2014 and 2013 we incurred a loss on our equity investment in NEC TOKIN of $7.1 million and $1.3 million, respectively.
Acquisitions and other strategic transactions expose us to a variety of operational and financial risks.
Our ability to realize the anticipated benefits of acquisitions depends, to a large extent, on our ability to integrate the acquired companies with our own. The attention and resources devoted to these efforts, which may disrupt the business of each of the companies and, if executed ineffectively, could preclude realization of the full benefits we expect. Failure to realize the anticipated benefits of our acquisitions could cause an interruption of, or a loss of momentum in, the operations of the acquired company. In addition, the efforts required to realize the benefits of our acquisitions may result in material unanticipated problems, expenses, liabilities, competitive responses, loss of customer relationships, the diversion of management's attention, and may cause our stock price to decline. The risks associated with such acquisitions and other strategic transactions include:
• | difficulties in integrating or retaining key employees of the acquired company; |
• | difficulties in integrating the operations of the acquired company, such as information technology resources, and financial and operational data; |
• | entering geographic or product markets in which we have no or limited prior experience; |
• | difficulties in assimilating product lines or integrating technologies of the acquired company into our products; |
• | disruptions to our operations; |
• | diversion of our management's attention; |
• | potential incompatibility of business cultures; and |
• | the assumption of debt and other liabilities, both known and unknown. |
Many of these factors will be outside of our control, and any one of them could result in increased costs, decreases in the amount of expected revenues and diversion of management's time and energy.
Additionally, we may finance acquisitions or future payments with cash from operations, additional indebtedness and/or the issuance of additional securities, any of which may impair the operation of our business or present additional risks, such as reduced liquidity or increased interest expense. Such acquisition financing could result in a decrease of our ratio of earnings to fixed charges. We may also seek to restructure our business in the future by disposing of certain of our assets, which may harm our future operating results, divert significant managerial attention from our operations and/or require us to accept non-cash consideration, the market value of which may fluctuate.
Failure to implement our acquisition strategy, including successfully integrating acquired businesses, could have an adverse effect on our business, financial condition and results of operations.
Our inability to attract, train and retain effective employees and management could harm our business.
Our success depends upon the continued contributions of our executive officers and certain other employees, many of whom have many years of experience with us and would be extremely difficult to replace. We must also attract and retain experienced and highly skilled engineering, sales and marketing and managerial personnel. Competition for qualified personnel is intense in our industry, and we may not be successful in hiring and retaining these people. If we lost the services of our executive officers or our other highly qualified and experienced employees or cannot attract and retain other qualified personnel, our business could suffer through less effective management due to loss of accumulated knowledge of our business or through less successful products due to a reduced ability to design, manufacture and market our products.
We must continue to develop innovative products to maintain relationships with our customers and to offset potential price erosion in older products.
While most of the fundamental technologies used in the passive components industry have been available for a long time, the market is nonetheless characterized by rapid changes in product designs and technological advances allowing for better performance, smaller size and/or lower cost. New applications are frequently found for existing technologies, and new technologies occasionally replace existing technologies for some applications or open up new business opportunities in other areas of application. We believe that successful innovation is critical for maintaining profitability in order to offset potential erosion of selling prices for existing products and to ensure the flow of new products and robust manufacturing processes that will keep us at the forefront of our customers' product designs. Non-customized commodity products are especially vulnerable to price pressure, but customized products have also experienced price pressure in recent years. Developing and marketing new products requires start-up costs that may not be recouped if these products or production techniques are not successful. There are numerous risks inherent in product development, including the risks that we will be unable to anticipate the direction of technological change or that we will be unable to develop and market new products and applications in a timely fashion to satisfy customer demands. If this occurs, we could lose customers and experience adverse effects on our results of operations.
15
We may be exposed to claims alleging product defects.
Our business exposes us to claims alleging product defects or nonconformance with product specifications. We may be held liable for, or incur costs related to, such claims if any of our products, or products in which our products are incorporated, are found to have caused end market product application failures, product recalls, property damage or personal injury. Provisions in our customer and distributor agreements are designed to limit our exposure to potential material product defect claims, including warranty, indemnification, waiver and limitation of liability provisions, but such provisions may not be effective under the laws of some jurisdictions. If we cannot successfully defend ourselves against product defect claims, we may incur substantial liabilities. Regardless of the merits or eventual outcome, defect claims could entail substantial expense and require the time and attention of key management personnel.
Our insurance program may not be adequate to cover all liabilities arising out of product defect claims and, at any time, insurance coverage may not be available on commercially reasonable terms or at all. If liability coverage is insufficient, a product defect claim could result in liability to us, which could materially and adversely affect our results of operations or financial condition. Even if we have adequate insurance coverage, product defect claims or recalls could result in negative publicity or force us to devote significant time and attention to those matters.
Various laws and regulations that apply to our business, including those relating to conflict minerals and environmental matters, could limit our ability to operate as we are currently and could result in additional costs.
We are subject to various laws and regulations of federal, state and local authorities in the countries in which we operate regarding a wide variety of matters, including conflict minerals, environmental, employment, land use, anti-trust, and others that affect the day-to-day operations of our business. The liabilities and requirements associated with the laws and regulations that affect us may be costly and time-consuming. There can be no assurance that we have been or will be at all times in compliance with such applicable laws and regulations. Failure to comply may result in the assessment of administrative, civil and criminal penalties, the issuance of injunctions to limit or cease operations, the suspension or revocation of permits and other enforcement measures that could have the effect of limiting our operations. If we are pursued for sanctions, costs or liabilities in respect of these matters, our operations and, as a result, our profitability could be materially and adversely affected.
On August 22, 2012, the SEC adopted a new reporting rule requiring issuers for whom tantalum, tin, tungsten and gold are necessary to the functionality or production of a product manufactured by such person to disclose annually whether any of those minerals originated in the Democratic Republic of the Congo or an adjoining country. As defined by the SEC, tantalum, tin, tungsten and gold are commonly referred to as “conflict minerals” or “3TG”. If an issuer’s conflict minerals originated in those countries, the rule requires the issuer to submit a report to the Commission that includes a description of the measures it took to exercise due diligence on the conflict minerals’ source and chain of custody. We use tantalum, tin and to a lesser degree other of the 3TG minerals, in our production processes and in our products. The first such report is due by June 2, 2014 (the first business day after the filing deadline of May 31, 2014). Our tantalum supply base has been and continues to be validated as being sourced conflict free. All of our processed tantalum material providers have been validated as compliant with the EICC/GeSI Conflict-Free Smelter Program ("CFSP"). As this program expands and gains maturity in the supply chain the validation requirement is being applied to suppliers of other conflict minerals. We have exercised due diligence on the source and chain of custody during the reporting period and as required under the rule and will disclose a description of these measures in a special disclosure prior to the filing deadline. However, the rule may cause changes to the pricing of 3TG minerals, which could adversely affect our profitability. In addition, it is possible that some of our disclosures pursuant to the rule related to our inquiries and supply chain custody diligence could cause reputational harm and cause the company to lose customers or sales.
In addition, we are subject to a variety of U.S. federal, state and local, as well as foreign, environmental laws and regulations relating, among other things, to wastewater discharge, air emissions, handling of hazardous materials, disposal of solid and hazardous wastes, and remediation of soil and groundwater contamination. We use a number of chemicals or similar substances, and generate wastes, that are considered hazardous. We are required to hold environmental permits to conduct many of our operations. Violations of environmental laws and regulations could result in substantial fines, penalties, and other sanctions. Changes in environmental laws or regulations (or in their enforcement) affecting or limiting, for example, our chemical uses, certain of our manufacturing processes, or our disposal practices, could restrict our ability to operate as we are currently operating or impose additional costs. In addition, we may experience releases of certain chemicals or discover existing contamination, which could cause us to incur material cleanup costs or other damages.
16
Our international sales and operations are subject to applicable laws relating to trade, export controls and foreign corrupt practices, the violation of which could adversely affect our operations.
We must comply with all applicable export control laws and regulations of the United States and other countries. United States laws and regulations applicable to us include the Arms Export Control Act, the International Traffic in Arms Regulations ("ITAR"), the Export Administration Regulations ("EAR") and the trade sanctions laws and regulations administered by the United States Department of the Treasury's Office of Foreign Assets Control ("OFAC"). EAR restricts the export of dual-use products and technical data to certain countries, while ITAR restricts the export of defense products, technical data and defense services. The U.S. government agencies responsible for administering EAR and ITAR have significant discretion in the interpretation and enforcement of these regulations. We also cannot provide services to certain countries subject to United States trade sanctions unless we first obtain the necessary authorizations from OFAC. In addition, we are subject to the Foreign Corrupt Practices Act and other anti-bribery laws that, generally, bar bribes or unreasonable gifts to foreign governments or officials.
Violations of these laws or regulations could result in significant additional sanctions including fines, more onerous compliance requirements, more extensive debarments from export privileges, loss of authorizations needed to conduct aspects of our international business and criminal penalties and may harm our ability to enter contracts with customers who have contracts with the U.S. government. A violation of the laws or the regulations enumerated above could materially adversely affect our business, financial condition and results of operations.
Volatility of financial and credit markets could affect our access to capital.
The uncertainty in the global financial and credit markets could impact our ability to implement new financial arrangements or to modify our existing financial arrangements. An inability to obtain new financing or to further modify existing financing could adversely impact the execution of our restructuring plans and delay the realization of the expected cost reductions. Our ability to generate adequate liquidity will depend on our ability to execute our operating plans and to manage costs in light of developing economic conditions. An unanticipated decrease in sales, or other factors that would cause the actual outcome of our plans to differ from expectations, could create a shortfall in cash available to fund our liquidity needs. Being unable to access new capital, experiencing a shortfall in cash from operations to fund our liquidity needs and the failure to implement an initiative to offset the shortfall in cash would likely have a material adverse effect on our business.
We must consistently reduce the total costs of our products to remain competitive.
Our industry is intensely competitive and prices for existing commodity products tend to decrease steadily over their life cycle. There is substantial and continuing pressure from customers to reduce the total cost of capacitors. To remain competitive, we must achieve continuous cost reductions through process and product improvements.
We must also be in a position to minimize our customers' shipping and inventory financing costs and to meet their other goals for rationalization of supply and production. Our growth and the profit margins of our products will suffer if our competitors are more successful in reducing the total cost to customers of their products than we are. We must also continue to introduce new products that offer performance advantages over our existing products and can thereby achieve premium prices, offsetting the price declines in our more mature products.
Our use of net operating losses to offset possible future taxable income could be limited by ownership changes.
In addition to the general limitations on the carryback and carryforward of net operating losses under Section 172 of the Internal Revenue Code (the "Code"), Section 382 of the Code imposes further limitations on the utilization of net operating losses by a corporation following ownership changes which result in more than a 50 percentage point change in ownership of a corporation within a three year period. If Section 382 applies, the post-ownership change utilization of our net operating losses may be subject to limitation for federal income tax purposes related to regular and alternative minimum tax. The application of Section 382 of the Code now or in the future could limit a substantial part of our future utilization of available net operating losses. Such limitation could require us to pay substantial additional income taxes and adversely affect our liquidity and financial position.
We do not believe we have experienced an ownership change to date. However, the Section 382 rules are complex and there is no assurance our view is correct. For example, the issuance of a warrant (the "Platinum Warrant") in May 2009 to K Financing, LLC ("K Financing"), in connection with the entry into a credit facility (the "Platinum Credit Facility") with K Financing, may be deemed to have resulted in an "ownership change" for purposes of Section 382 of the Code. If such an ownership change is deemed to have occurred, the amount of our post-ownership change taxable income that could be offset by our pre-ownership change net operating loss carryforwards would be severely limited. While we believe that the issuance of the Platinum Warrant did not result in an ownership change for purposes of Section 382 of the Code, there is no assurance that our view will be unchallenged.
17
Even if we have not experienced an ownership change to date, we could experience an ownership change in the near future if there are certain significant purchases of our common stock or other events outside our control.
Our debt agreements contain restrictions that limit our flexibility in operating our business.
The agreement governing our revolving credit facility and the indenture governing the notes and certain of our other debt agreements contain various covenants that, subject to exceptions, limit our ability to, among other things: incur additional indebtedness; create liens on assets; make capital expenditures; engage in mergers, consolidations, liquidations and dissolutions; sell assets (including pursuant to sale leaseback transactions); pay dividends and distributions on or repurchase capital stock; make investments (including acquisitions), loans, or advances; prepay certain junior indebtedness; engage in certain transactions with affiliates; enter into restrictive agreements; amend material agreements governing certain junior indebtedness; and change lines of business. The agreement governing our revolving credit facility also includes a fixed charge coverage ratio covenant that we must satisfy if an event of default occurs or in the event that we do not meet certain excess availability requirements under our revolving credit facility. Our ability to comply with this covenant is dependent on our future performance, which may be subject to many factors, some of which are beyond our control.
K Equity may obtain significant influence over all matters submitted to a stockholder vote, which may limit the ability of other shareholders to influence corporate activities and may adversely affect the market price of our common stock.
As part of the consideration for entering into the Platinum Credit Facility on May 5, 2009, K Financing received the Platinum Warrant to purchase up to 26,848,484 shares of our common stock (subject to certain adjustments), representing 49.9% of our outstanding common stock at the time of issuance on a post-exercise basis. This Platinum Warrant was subsequently transferred to K Equity, an affiliate of K Financing. As of March 31, 2014, 8,416,815 shares remain subject to the Platinum Warrant. To the extent that K Equity exercises the remainder of the Platinum Warrant in whole or in part but does not sell all or a significant part of the shares it acquires upon exercise, K Equity may own up to 15.7% of our outstanding common stock. As a result, K Equity may have substantial influence over the outcome of votes on all matters requiring approval by our stockholders, including the election of directors, the adoption of amendments to our restated certificate of incorporation and by-laws and approval of significant corporate transactions. K Equity could also take actions that have the effect of delaying or preventing a change in control of us or discouraging others from making tender offers for our shares, which could prevent stockholders from receiving a premium for their shares. These actions may be taken even if other stockholders oppose them. Moreover, this concentration of stock ownership may make it difficult for stockholders to replace management. In addition, this significant concentration of stock ownership may adversely affect the trading price for our common stock because investors often perceive disadvantages in owning stock in companies with controlling stockholders. This concentration of control could be disadvantageous to other stockholders with interests different from those of our officers, directors and principal stockholders, and the trading price of shares of our common stock could be adversely affected.
ITEM 1B. UNRESOLVED STAFF COMMENTS.
None.
ITEM 2. PROPERTIES.
We are headquartered in Simpsonville, South Carolina, and have a total of 21 manufacturing plants (two facilities contain manufacturing operations for both Solid Capacitors and Film and Electrolytic) located in North America, Europe and Asia. Some of our plants manufacture products for multiple business groups. Our existing manufacturing and assembly facilities have approximately 3.4 million square feet of floor space and are highly automated with proprietary manufacturing processes and equipment.
Our facilities in Mexico operate under the Maquiladora Program. In general, a company that operates under this program is afforded certain duty and tax preferences and incentives on products brought into the United States. Our manufacturing standards, including compliance with worker safety laws and regulations, are essentially identical in North America, Europe and Asia. Our operations in Mexico, Europe and Asia, similar to our United States operations, have won numerous quality, environmental and safety awards.
We have developed just-in-time manufacturing and sourcing systems. These systems enable us to meet customer requirements for faster deliveries while minimizing the need to carry significant inventory levels. We continue to emphasize flexibility in all of our manufacturing operations to improve product delivery response times.
We believe that substantially all of our property and equipment is in good condition, and that overall, we have sufficient capacity to meet our current and projected manufacturing and distribution needs.
18
The following table provides certain information regarding our principal facilities:
Location | Square Footage (in thousands) | Type of Interest | Description of Use | ||||
Simpsonville, South Carolina U.S.A. | 372 | Owned | Headquarters, Innovation Center, Advanced Tantalum Manufacturing and Film Manufacturing | ||||
Solid Capacitor Business Group | |||||||
Matamoros, Mexico(1) | 341 | (1) | (1) | ||||
Monterrey, Mexico(2) | 532 | Owned | Manufacturing | ||||
Suzhou, China(2)(3) | 353 | Leased | Manufacturing | ||||
Ciudad Victoria, Mexico | 265 | Owned | Manufacturing | ||||
Evora, Portugal(3) | 140 | Owned | Manufacturing | ||||
Carson City, Nevada U.S.A. | 87 | Owned | Manufacturing | ||||
Film and Electrolytic Business Group | |||||||
Evora, Portugal(3) | 93 | Owned | Manufacturing | ||||
Suzhou, China(3) | 134 | Leased | Manufacturing | ||||
Skopje, Macedonia | 126 | Owned | Manufacturing | ||||
Granna, Sweden | 132 | Owned | Manufacturing | ||||
Suomussalmi, Finland | 106 | Leased | Manufacturing | ||||
Batam, Indonesia | 86 | Owned | Manufacturing | ||||
Knoxville, Tennessee U.S.A. | 78 | Owned | Manufacturing | ||||
Kyustendil, Bulgaria | 82 | Owned | Manufacturing | ||||
Landsberg, Germany | 81 | Leased | Manufacturing and Innovation Center | ||||
Pontecchio, Italy(4) | 226 | Owned | Manufacturing | ||||
Weymouth, United Kingdom | 96 | Leased | Innovation Center | ||||
Anting, China | 38 | Owned | Manufacturing | ||||
Farjestaden, Sweden | 28 | Leased | Manufacturing and Innovation Center | ||||
_______________________________________________________________________________
1. | Includes two manufacturing facilities, one owned and one leased facility. The leased facility processes raw materials. |
2. | Includes two manufacturing facilities. |
3. | Facility contains manufacturing operations for both Solid Capacitors and Film and Electrolytic, square footage noted relates to portion of each plant used by the respective business group. |
4. | We began manufacturing in Pontecchio, Italy in the fourth quarter of fiscal year 2014. This facility replaced the Sasso Marconi, Monghidoro and Vergato facilities, each in Italy. |
ITEM 3. LEGAL PROCEEDINGS.
We or our subsidiaries are at any one time parties to a number of lawsuits arising out of their respective operations, including workers' compensation or work place safety cases, some of which involve claims of substantial damages. Although there can be no assurance, based upon information known to us, we do not believe that any liability which might result from an adverse determination of such lawsuits would have a material adverse effect on our financial condition or results of operations.
ITEM 4. MINE SAFTETY DISCLOSURES.
Not applicable.
19
ITEM 4A. EXECUTIVE OFFICERS OF THE REGISTRANT
The name, age, business experience, positions and offices held and period served in such positions or offices for each of the executive officers and certain key employees of the Company is as listed below.
Name | Age | Position | Years with Company | |||||
Per-Olof Lööf | 63 | Chief Executive Officer and Director | 9 | |||||
William M. Lowe, Jr. | 61 | Executive Vice President and Chief Financial Officer | 6 | |||||
Charles C. Meeks, Jr. | 52 | Executive Vice President, Solid Capacitor Business Group | 30 | |||||
Susan B. Barkal | 51 | Senior Vice President Quality, Chief Compliance Officer and Chief of Staff | 14 | |||||
John J. Drabik | 40 | Senior Vice President Global Sales | 17 | |||||
Dr. Phillip M. Lessner | 55 | Senior Vice President and Chief Technology Officer | 18 | |||||
Robert S. Willoughby | 53 | Vice President, Film and Electrolytic Business Group | 28 | |||||
R. James Assaf | 54 | Senior Vice President, General Counsel and Secretary | 6 | |||||
Michael L. Raynor | 48 | Vice President and Corporate Controller | 6 | |||||
Richard J. Vatinelle | 50 | Vice President and Treasurer | 1 | |||||
_______________________________________________________________________________
Executive Officers
Per-Olof Lööf, Chief Executive Officer and Director, was named such in April 2005. Mr. Lööf was previously the Managing Partner of QuanStar Group, LLC, a management consulting firm and had served in such capacity since December 2003. Prior thereto, he served as Chief Executive Officer of Sensormatic Electronics Corporation and in various management roles with Andersen Consulting, Digital Equipment Corporation, AT&T and NCR. Mr. Lööf serves as a board member of Global Options, Inc. Mr. Lööf also serves on several charity boards including Boca Raton Regional Hospital and the International Centre for Missing & Exploited Children. He received a "civilekonom examen" degree in economics and business administration from the Stockholm School of Economics.
William M. Lowe, Jr., Executive Vice President and Chief Financial Officer, was named such in July 2008. Mr. Lowe was previously the Vice President, Chief Operating Officer and Chief Financial Officer of Unifi, Inc., a producer and processor of textured synthetic yarns from January 2004 to October 2007. Prior to holding that position, he was Executive Vice President and Chief Financial Officer for Metaldyne, an automotive components manufacturer. He also held various financial management positions with ArvinMeritor, Inc., a premier global supplier of integrated automotive components. He received his B.S. degree in business administration with a major in accounting from Tri-State University and is a Certified Public Accountant in the state of Ohio.
Charles C. Meeks, Jr., Executive Vice President, Solid Capacitor Business Group, was named such in May 2013. He joined KEMET in December 1983 in the position of Process Engineer, and has held various positions of increased responsibility including the positions of Plant Manager and Director of Operations, Ceramic Business Group. He was named Vice President, Ceramic Business Group in June 2005, Senior Vice President, Ceramic Business Group in October 2007, Senior Vice President, Ceramic and Film and Electrolytic Business Group in March 2010 and Executive Vice President Ceramic and Film and Electrolytic Business Group in May 2011 prior to his appointment to his current position. In addition, since January 2000, Mr. Meeks has served as President of Top Notch Inc., a private company that offers stress management therapy services. Mr. Meeks received a Masters of Business Administration degree and a Bachelor of Science degree in Ceramic Engineering from Clemson University.
Susan B. Barkal, Senior Vice President Quality, Chief Compliance Officer and Chief of Staff, was named such in February 2014. Ms. Barkal joined KEMET in November 1999, and has served as Quality Manager for the Tantalum Business Group (now a part of Solid Capacitors), Technical Product Manager for all Tantalum product lines and Director of Tantalum Product Management. Ms. Barkal was appointed Vice President of Quality and Chief Compliance Officer in December 2008 prior to her appointment to her current position. Ms. Barkal holds a Bachelor of Science degree in Chemical Engineering from Clarkson University and a Master of Science degree in Mechanical Engineering from California Polytechnic University.
John J. Drabik, Senior Vice President-Global Sales, was named such in May 2013. He joined KEMET in 1997 and has held various positions of increased responsibility in Sales and Product Management, including District Sales Manager, Area Sales Manager, Ceramic Product Manager, Director of Product Management - Ceramic Business Group and, from August 2007
20
through April, 2013, Vice President Sales-Americas. He holds a Bachelor of Science in Management with a minor in Marketing from Purdue University and is a 2007 graduate of the KEMET Leadership Forum.
Dr. Philip M. Lessner, Senior Vice President and Chief Technology Officer, was named such in February 2014. He joined KEMET in March 1996 as a Technical Associate in the Tantalum Technology Group. He has held several positions of increased responsibility in the Technology and Product Management areas including Senior Technical Associate, Director Tantalum Technology, Director Technical Marketing Services and Vice President Tantalum Technology. Dr. Lessner was named Vice President, Chief Technology Officer and Chief Scientist in December 2006, Senior Vice President, Chief Technology Officer and Chief Scientist in May 2011 and Senior Vice President and Chief Technology and Marketing Officer in November 2012 prior to his appointment to his current position. Dr. Lessner received a PhD in Chemical Engineering from the University of California, Berkeley and a Bachelor of Engineering in Chemical Engineering from Cooper Union.
Robert S. Willoughby, Vice President-Film and Electrolytic Business Group, was named such in May 2013. He joined KEMET in December 1985 and has held positions of increasing responsibility in Diagnostic, Quality, New Product and Process Engineering. Mr. Willoughby served as Director - Ceramic Operations from July 2007 until March 2010 and served as Vice President of Operations - Film and Paper Business Unit from March 2010 until May 2013. He holds a Bachelor of Science degree in Industrial Engineering from Clemson University and is a 2007 graduate of the KEMET Leadership Forum.
Other Key Employees
R. James Assaf, Senior Vice President, General Counsel and Secretary, was named such in February 2014. Mr. Assaf joined KEMET as Vice President, General Counsel in March 2008, and was appointed Vice President, General Counsel and Secretary in July 2008 prior to his appointment to his current position. Before joining KEMET, Mr. Assaf served as General Manager for InkSure Inc., a start-up seller of product authentication solutions. He had also previously held several positions with Sensormatic Electronics Corporation, including Associate General Counsel and Director of Business Development, Mergers & Acquisitions. Prior to Sensormatic, Mr. Assaf served as an Associate Attorney with the international law firm Squire Sanders & Dempsey. Mr. Assaf received his Bachelor of Arts degree from Kenyon College and his Juris Doctor degree from Case Western Reserve University School of Law.
Michael L. Raynor, Vice President and Corporate Controller, was named such in November 2012. Mr. Raynor joined the Company in July 2007 as the Assistant Corporate Controller; in November of 2008 Mr. Raynor was named Director of Financial Planning & Analysis prior to his appointment to his current position. Prior to joining KEMET, Mr. Raynor held various controller level positions with distribution and manufacturing companies. Mr. Raynor received a Bachelor of Arts degree in Economics and a Masters of Accounting from the University of North Carolina at Chapel Hill and is a Certified Public Accountant in the state of North Carolina.
Richard J. Vatinelle, Vice President and Treasurer, was named such in March 2014. Mr. Vatinelle joined the Company in November 2012 as Controller - Tantalum Business Group. Prior to joining KEMET, Mr. Vatinelle served for two years as Regional Controller - Latin America for Leo Pharma A/S, a global manufacturer of pharmaceutical products. From 2007 to 2009 he served as Director of Finance, Policies and Reporting, for Stiefel Laboratories, a pharmaceutical company specialized in dermatology. Mr. Vatinelle’s career in finance includes eight years with Conagra Foods Inc., where he held various international finance roles, and eleven years with Banque Sudameris, an international banking group where he began his career. Mr. Vatinelle holds a Bachelor of Science degree in Finance and International Management from Georgetown University.
21
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market for Common Stock of the Company
Our common stock trades on the NYSE under the ticker symbol "KEM" (NYSE: KEM). We had 158 stockholders of record as of May 23, 2014. The following table represents the high and low sale prices of our common stock for the periods indicated:
Fiscal Year 2014 | Fiscal Year 2013 | |||||||||||||||
Quarter | High | Low | High | Low | ||||||||||||
First | $ | 6.83 | $ | 4.00 | $ | 9.63 | $ | 5.38 | ||||||||
Second | 4.98 | 3.93 | 6.26 | 4.36 | ||||||||||||
Third | 6.22 | 4.07 | 5.20 | 3.75 | ||||||||||||
Fourth | 6.41 | 5.11 | 6.94 | 4.94 | ||||||||||||
Dividend Policy
We have not declared or paid any cash dividends on our common stock since our initial public offering in October 1992. We do not anticipate paying dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of our Board and will depend upon, among other factors, the capital requirements, operating results, and our financial condition. In addition, we are restricted from paying cash dividends under the terms of the 10.5% Senior Notes Indenture. See "Management's Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources."
22
PERFORMANCE GRAPH
The following graph compares our cumulative total stockholder return for the past five fiscal years, beginning on March 31, 2009, with the Russell 3000 and a peer group (the "Peer Group") comprised of certain companies which manufacture capacitors and with which we generally compete. The Peer Group is comprised of AVX Corporation, Littelfuse, Inc. and Vishay Intertechnology, Inc.
COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among KEMET Corporation, the Russell 3000 Index,
and a Peer Group
_______________________________________________________________________________
* | $100 invested on 3/31/09 in stock or index, including reinvestment of dividends. |
Fiscal year ending March 31.
RETURNS
Years Ending March 31,
3/09 | 3/10 | 3/11 | 3/12 | 3/13 | 3/14 | |||||||||||||
KEMET Corporation | 100.00 | 571.43 | 2,017.69 | 1,273.47 | 850.34 | 790.48 | ||||||||||||
Russell 3000 | 100.00 | 152.44 | 117.41 | 107.19 | 114.57 | 137.76 | ||||||||||||
Peer Group | 100.00 | 112.93 | 162.84 | 139.22 | 143.94 | 501.78 | ||||||||||||
23
Unregistered Sales of Equity Securities
We did not sell any of our equity securities during fiscal year 2014 that were not registered under the Securities Act of 1933, as amended (the "Securities Act").
Repurchase of Equity Securities
We did not repurchase any of our equity securities during the three months ended March 31, 2014.
Equity Compensation Plan Disclosure
The following table summarizes equity compensation plans approved by stockholders and equity compensation plans that were not approved by stockholders as of March 31, 2014:
(a) | (b) | (c) | ||||||||
Plan category | Number of securities to be issued upon exercise of outstanding options, warrants, and rights | Weighted-average exercise price of outstanding options, warrants, and rights | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) | |||||||
Equity compensation plans approved by stockholders | 1,733,559 | $ | 9.87 | 1,666,620 | ||||||
Equity compensation plans not approved by stockholders | — | — | — | |||||||
Total | 1,733,559 | $ | 9.87 | 1,666,620 | ||||||
24
ITEM 6. SELECTED FINANCIAL DATA.
The following table summarizes our selected historical consolidated financial information for each of the last five years. The selected financial information under the captions "Income Statement Data," "Per Share Data," "Balance Sheet Data," and "Other Data" shown below has been derived from our audited consolidated financial statements. This table should be read in conjunction with other consolidated financial information of KEMET, including "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the consolidated financial statements, included elsewhere herein. The data set forth below may not be indicative of our future financial condition or results of operations (see Item 1A, "Risk Factors") (amounts in thousands except per share amounts):
Fiscal Years Ended March 31, | ||||||||||||||||||||
2014 | 2013 | 2012(1) | 2011 | 2010 | ||||||||||||||||
Income Statement Data: (2) | ||||||||||||||||||||
Net sales | $ | 833,666 | $ | 823,903 | $ | 924,052 | $ | 986,480 | $ | 714,265 | ||||||||||
Operating income (loss) | (18,211 | ) | (35,080 | ) | 28,083 | 123,891 | 6,223 | |||||||||||||
Interest income | (195 | ) | (139 | ) | (175 | ) | (218 | ) | (188 | ) | ||||||||||
Interest expense | 40,962 | 41,331 | 28,567 | 30,175 | 26,008 | |||||||||||||||
Income (loss) from continuing operations (3) | (64,869 | ) | (78,512 | ) | (2,350 | ) | 58,175 | (70,842 | ) | |||||||||||
Income (loss) from discontinued operations | (3,634 | ) | (3,670 | ) | 9,042 | 4,869 | 1,395 | |||||||||||||
Net income (loss) | (68,503 | ) | (82,182 | ) | 6,692 | 63,044 | (69,447 | ) | ||||||||||||
Per Share Data: | ||||||||||||||||||||
Net income (loss) per basic share: | ||||||||||||||||||||
Income (loss) from continuing operations | $ | (1.44 | ) | $ | (1.75 | ) | $ | (0.05 | ) | $ | 1.95 | $ | (2.63 | ) | ||||||
Income (loss) from discontinued operations | $ | (0.08 | ) | $ | (0.08 | ) | $ | 0.21 | $ | 0.16 | $ | 0.05 | ||||||||
Net income (loss) | $ | (1.52 | ) | $ | (1.83 | ) | $ | 0.16 | $ | 2.11 | $ | (2.58 | ) | |||||||
Net income (loss) per diluted share: | ||||||||||||||||||||
Income (loss) from continuing operations | $ | (1.44 | ) | $ | (1.75 | ) | $ | (0.04 | ) | $ | 1.13 | $ | (2.63 | ) | ||||||
Income (loss) from discontinued operations | $ | (0.08 | ) | $ | (0.08 | ) | $ | 0.17 | $ | 0.09 | $ | 0.05 | ||||||||
Net income (loss) | $ | (1.52 | ) | $ | (1.83 | ) | $ | 0.13 | $ | 1.22 | (2.58 | ) | ||||||||
Balance Sheet Data: | ||||||||||||||||||||
Total assets | $ | 843,667 | $ | 911,591 | $ | 980,862 | $ | 884,309 | $ | 740,961 | ||||||||||
Working capital | 233,744 | 261,945 | 396,494 | 316,605 | 226,600 | |||||||||||||||
Long-term debt, less current portion(4) | 391,292 | 372,707 | 345,380 | 231,215 | 231,629 | |||||||||||||||
Other non-current obligations | 55,864 | 69,022 | 101,229 | 59,727 | 55,626 | |||||||||||||||
Stockholders' equity(3) | 221,884 | 276,916 | 358,996 | 359,753 | 284,272 | |||||||||||||||
Other Data: | ||||||||||||||||||||
Cash flow provided by (used in) operating activities | $ | (6,746 | ) | $ | (22,827 | ) | $ | 80,730 | $ | 113,968 | $ | 54,620 | ||||||||
Capital expenditures | 32,147 | 46,174 | 49,314 | 34,989 | 12,921 | |||||||||||||||
Research and development | 24,466 | 26,876 | 27,765 | 24,597 | 21,639 | |||||||||||||||
_______________________________________________________________________________
(1) | In fiscal year 2012, the Company acquired KEMET Foil on June 13, 2011 and Blue Powder on February 21, 2012. |
(2) | All periods have been revised due to the classification in fiscal year 2014 of the machinery division as a discontinued operation. |
(3) | In fiscal year 2010, the Platinum Warrant was initially classified as a derivative and the Company recorded a mark-to-market adjustment of $81.1 million through earnings. As of September 29, 2009, the strike price of the Platinum Warrant became fixed and the Company reevaluated the Platinum Warrant concluding that the Platinum Warrant is indexed to the Company's own stock and should be classified as a component of equity. The Company reclassified the warrant liability of $112.5 million into the line item "Additional paid-in capital". In addition, in fiscal year 2010 the Company incurred a loss on early extinguishment of debt of $38.9 million. |
25
(4) | In fiscal year 2010, the Company repurchased $93.9 million in face value of Convertible Notes and incurred additional borrowings of $57.8 million with K Financing. In fiscal year 2013, 2012 and 2011, the Company issued $15.0 million, $110.0 million and $230 million, respectively of 10.5% Senior Notes. In fiscal year 2013, the Company received a $24.0 million Advance Payment, as defined herein, from an original equipment manufacturer. In fiscal year 2014, the Company had $18.4 million outstanding under a Loan and Security Agreement (the "Loan and Security Agreement"), with Bank of America, N.A. |
26
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
The following discussion and analysis provides information that we believe is useful in understanding our operating results, cash flows, and financial condition for the three fiscal years ended March 31, 2014. The discussion should be read in conjunction with, and is qualified in its entirety by reference to, the consolidated financial statements and related notes appearing elsewhere in this report. Except for the historical information contained herein, the discussions in this document contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties. Our actual future results could differ materially from those discussed here. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the Item 1A, "Risk Factors" and, from time to time, in our other filings with the Securities and Exchange Commission.
Business Overview
We are a leading global manufacturer of a wide variety of tantalum, multilayer ceramic, solid and electrolytic aluminum and film capacitors. Capacitors are electronic components that store, filter, and regulate electrical energy and current flow. As an essential passive component used in most circuit boards, capacitors are typically used for coupling, decoupling, filtering, oscillating and wave shaping and are used in communication systems, data processing equipment, personal computers, cellular phones, automotive electronic systems, defense and aerospace systems, consumer electronics, power management systems and many other electronic devices and systems (basically anything that plugs in or has a battery). We manufacture a broad line of capacitors in many different sizes and configurations using a variety of raw materials. Our product line consists of nearly 5 million distinct part configurations distinguished by various attributes, such as dielectric (or insulating) material, configuration, encapsulation, capacitance (at various tolerances), voltage, performance characteristics and packaging. Most of our customers have multiple capacitance requirements, often within each of their products. Our broad product offering allows us to meet the majority of those needs independent of application and end use. In fiscal years 2014, 2013 and 2012 we shipped 35 billion, 32 billion and 32 billion capacitors, respectively. We believe the long-term demand for various types of capacitors we offer will grow on a regional and global basis due to a variety of factors, including increasing demand for and complexity of electronic products, growing demand for technology in emerging markets and the ongoing development of new solutions for energy generation and conservation.
Our Competitive Strengths
We believe that we benefit from the following competitive strengths:
Strong Customer Relationships. We have a large and diverse customer base. We believe that our persistent emphasis on quality control and history of performance establishes loyalty with OEMs, EMSs and distributors. Our customer base includes most of the world's major electronics OEMs (including Alcatel-Lucent USA, Inc., Bosch Group, Cisco Systems, Inc., Continental AG, Dell Inc., Hewlett-Packard Company, International Business Machines Corporation, Intel Corporation, Motorola, Inc., Nokia Corporation, and TRW Automotive), EMSs (including Celestica Inc., Flextronics International LTD, Jabil Circuit, Inc. and Sanmina-SCI Corporation) and distributors (including TTI, Inc., Arrow Electronics, Inc. and Avnet, Inc.). Our strong, extensive and efficient worldwide distribution network is one of our differentiating factors. We believe our ability to provide innovative and flexible service offerings, superior customer support and focus on speed-to-market result in a more rewarding customer experience, earning us a high degree of customer loyalty.
Breadth of Our Diversified Product Offering and Markets. We believe that we have the most complete line of primary capacitor types, across a full spectrum of dielectric materials including tantalum, ceramic, solid and electrolytic aluminum, film and paper. As discussed below, our private label partnership with NEC TOKIN has expanded our product offerings and markets. As a result, we believe we can satisfy virtually all of our customers' capacitance needs, thereby strengthening our position as their supplier of choice. We sell our products into a wide range of different end markets, including computing, industrial, telecommunications, transportation, consumer, defense and healthcare markets across all geographic regions. No single end market segment accounted for more than 30% and a single customer, an electronics distributor, accounted for more than 10% of our net sales in fiscal year 2014. No single end use customer accounted for more than 6% of our net sales in fiscal year 2014. We believe that well-balanced product, geographic and customer diversification helps us mitigate some of the negative financial impact through economic cycles.
Leading Market Positions and Operating Scale. Based on net sales, we believe that we are the largest manufacturer of tantalum capacitors in the world and one of the largest manufacturers of direct current film capacitors in the world and have a significant market position in the specialty ceramic and custom wet aluminum electrolytic markets. As discussed below, our private label partnership with NEC TOKIN allows us to achieve true scale in operations to manage raw materials sourcing as
27
well as maximize efficiencies. We believe that our leading market positions and operating scale allow us to realize production efficiencies, leverage economies of scale and capitalize on growth opportunities in the global capacitor market.
Strong Presence in Specialty Products. We engage in design collaboration with our customers in order to meet their specific needs and provide them with customized products satisfying their engineering specifications. During fiscal years 2014 and 2013, respectively, specialty products accounted for 46.1% and 41.1% of our revenue. By allocating an increasing portion of our management resources and research and development ("R&D") investment (particularly though our partnership with NEC TOKIN discussed below) to specialty products, we have established ourselves as one of the leading innovators in this fast growing emerging segment of the market, which includes healthcare, renewable energy, telecommunication infrastructure and oil and gas.
Low-Cost and Strategic Locations. We believe our plants in China, Mexico, Bulgaria and Macedonia have some of the lowest cost production facilities in the industry. Many of our key customers have relocated their production facilities to Asia, particularly China. We believe our manufacturing facilities in China are in close proximity to the large and growing Chinese market. In addition, we have the ability to increase capacity and change product mix to meet our customers' needs.
Our Brand. Founded by Union Carbide in 1919 as KEMET Laboratories, we believe that we have established a reputation as a high quality, efficient and affordable partner that sets our customers' needs as the top priority. This has allowed us to successfully attract loyal clientele and enabled us to expand our operations and market share over the past few years. We believe our commitment to addressing the needs of the industry in which we operate has differentiated us from our competitors and established us as the "Easy-To-Buy-From" company.
Our People. We believe that we have successfully developed a unique corporate culture based on innovation, customer focus and commitment. We have a strong, highly experienced and committed team in each of our markets. Many of our professionals have developed unparalleled experience in building leadership positions in new markets, as well as successfully integrating acquisitions. Our 16 member executive management team has an average of 17 years of experience with us and an average of over 24 years of experience in the manufacturing industry.
Business Strategy
Our strategy is to use our position as a leading, high-quality manufacturer of capacitors to capitalize on the increasingly demanding requirements of our customers. Key elements of our strategy include:
One KEMET Campaign. We continue to focus on improving our business capabilities through various initiatives that all fall under our One KEMET campaign. The One KEMET campaign aims to ensure that we as a company are focused on the same goals and working with the same processes and systems to ensure consistent quality and service. This effort was launched to ensure that as we continue to grow we not only remain grounded in our core principles but that we also use those principles, operating procedures and systems as the foundation from which to expand. These initiatives include implementing Oracle 11i EBS throughout most locations, our Lean and Six Sigma culture evolution and our global customer accounts management program.
Develop Our Significant Customer Relationships and Industry Presence. We intend to continue to be responsive to our customers' needs and requirements and to make order entry and fulfillment easier, faster, more flexible and more reliable for our customers, by focusing on building products around customers' needs, by giving decision making authority to customer-facing personnel and by providing purpose-built systems and processes.
Continue to Pursue Low-Cost Production Strategy. We continue to evaluate and are actively pursuing measures that will allow us to maintain our position as a low-cost producer of capacitors with facilities close to our customers. We have shifted and will continue to shift production to low cost locations in order to reduce material and labor costs. We have expanded our manufacturing to Macedonia which has low production costs. Additionally, we are focused on developing more cost-efficient manufacturing equipment and processes, designing manufacturing plants for more efficient production and reducing work-in-process ("WIP") inventory by building products from start to finish in one factory. Furthermore, we continue to implement the Lean and Six Sigma methodology to drive towards zero product defects so that quality remains a given in the minds of our customers.
Leverage Our Technological Competence and Expand Our Leadership in Specialty Products. We continue to leverage our technological competence and partnership with NEC TOKIN to introduce new products in a timely and cost-efficient manner and generate an increasing portion of our sales from new and customized solutions to meet our customers' varied and evolving capacitor needs as well as to improve financial performance. We believe that by continuing to build on our strength in the higher growth and higher margin specialty segments of the capacitor market, we will be well-positioned to achieve our
28
long-term growth objectives while also improving our profitability. During fiscal year 2014, we introduced 16,829 new products of which 2,377 were first to market, and specialty products accounted for 46.1% of our revenue over this period.
Further Expand Our Broad Capacitance Capabilities. We identify ourselves as "The Electronic Components Company" and strive to be the supplier of choice for all our customers' capacitance needs across the full spectrum of dielectric materials including tantalum, ceramic, solid and electrolytic aluminum, film and paper. As discussed below, through our partnership with NEC TOKIN we have further expanded our product offerings. While we believe we have the most complete line of capacitor technologies across these primary capacitor types, we intend to continue to research and pursue additional capacitance technologies and solutions in order to maximize the breadth of our product offerings.
Selectively Target Complementary Acquisitions and Equity Investments. As strategic opportunities are identified, we will evaluate and possibly pursue them if they would enable us to enhance our competitive position and expand our market presence. Our strategy is to acquire complementary capacitor and other related businesses that would allow us to leverage our business model, potentially including those involved in other passive components that are synergistic with our customers' technologies and our current product offerings. For example, in fiscal year 2012, we acquired Cornell Dubilier Foil, LLC (whose name was subsequently changed to KEMET Foil ) and Blue Powder which has allowed us to vertically integrate certain manufacturing processes within Film and Electrolytic and Solid Capacitors, respectively. In addition, on February 1, 2013 KEC, a wholly owned subsidiary of the Company, acquired a 34% economic interest in NEC TOKIN, a manufacturer of tantalum capacitors and electro-magnetic, electro-mechanical and access devices.
Promote the KEMET Brand Globally. We are focused on promoting the KEMET brand globally by highlighting the high-quality and high reliability of our products and our superior customer service. We will continue to market our products to new and existing customers around the world in order to expand our business. We continue to be recognized by our customers as a leading global supplier. For example, in calendar year 2013, we received the “Supplier Excellence Award” from TTI, Inc. and the “Supplier Engagement” and “Perfect Order Index” awards from Arrow Electronics, Inc., both of which are electronics distributors.
Global Sales & Marketing Strategy. Our motto "Think Global Act Local" describes our approach to sales and marketing. Each of our three sales regions (Americas, EMEA and APAC) has account managers, field application engineers and strategic marketing managers in the region. In addition, we also have local customer and quality-control support in each region. This organizational structure allows us to respond to the needs of our customers on a timely basis and in their native language. The regions are managed locally and report to a senior manager who is on the KEMET Leadership Team. Furthermore, this organizational structure ensures the efficient communication of our global goals and strategies and allows us to serve the language, cultural and other region-specific needs of our customers.
KEMET is organized into two business groups: Solid Capacitors and Film and Electrolytic. Each business group is responsible for the operations of certain manufacturing sites as well as all related research and development efforts. The sales, marketing and corporate functions are shared by each of the business groups. See Note 9, "Segment and Geographic Information" to our consolidated financial statements.
Recent Developments and Trends
Net sales of $833.7 million in fiscal year 2014 have increased 1.2% from $823.9 million in fiscal year 2013. Capacitor unit sales volumes increased 11.0 % for fiscal year 2014 as compared to fiscal year 2013. Average selling prices for capacitors decreased 9.3% for fiscal year 2014 as compared to fiscal year 2013 due to excess capacity in the market which decreased average selling prices across the market. We have continued to focus on vertical integration and restructure our operations by shifting production to lower cost locations. Through our recent acquisition of Blue Powder and equity investment in NEC TOKIN Corporation ("NEC TOKIN"), as described herein, we believe we can enhance our competitive position.
Equity Investment
On February 1, 2013, KEC closed on a transaction to acquire 51% (which represents a 34% economic interest calculated based on the number of common shares held by KEC, directly and indirectly, in proportion to the aggregate number of common and preferred shares of NEC TOKIN outstanding as of such date) of the common stock of NEC TOKIN, a manufacturer of tantalum capacitors, electro-magnetic, electro-mechanical and access devices. The Company accounts for its investment in NEC TOKIN using the equity method for a non-consolidated variable interest entity since KEC does not have the power to direct significant activities of NEC TOKIN.
In connection with KEC's entry into the Stock Purchase Agreement, KEC entered into a Stockholders' Agreement (the "Stockholders' Agreement") with NEC TOKIN and NEC, which provides for restrictions on transfers of NEC TOKIN's capital stock, certain tag-along and first refusal rights on transfer, restrictions on NEC's ability to convert the preferred stock of NEC
29
TOKIN held by it, certain management services to be provided to NEC TOKIN by KEC (or an affiliate of KEC) and certain board representation rights. KEC holds four of seven NEC TOKIN director positions. However, NEC has significant board rights.
Concurrent with entry into the Stock Purchase Agreement and the Stockholders' Agreement, KEC entered into an Option Agreement (the "Option Agreement") with NEC whereby KEC may purchase additional shares of NEC TOKIN common stock from NEC TOKIN for a purchase price of $50.0 million resulting in an economic interest of approximately 49% while maintaining ownership of 51% of NEC TOKIN's common stock (the "First Call Option") by providing notice of the First Call Option between the Initial Closing and August 31, 2014. Upon providing such notice, KEC may also exercise an option to purchase all outstanding capital stock of NEC TOKIN from its stockholders, primarily NEC, for a purchase price based on the greater of six times LTM EBITDA (as defined in the Option Agreement) less the previous payments and certain other adjustments, or the outstanding amount of NEC TOKIN's debt obligation to NEC (the "Second Call Option") by providing notice of the Second Call Option by May 31, 2018. From August 1, 2014 through May 31, 2018, NEC may require KEC to purchase all outstanding capital stock of NEC TOKIN from its stockholders, primarily NEC. However, NEC may only exercise this right (the "Put Option") from August 1, 2014 through April 1, 2016 if NEC TOKIN achieves certain financial performance. The purchase price for the Put Option will be based on the greater six times LTM EBITDA less previous payments and certain other adjustments, or the outstanding amount of NEC TOKIN's debt obligation to NEC as of the date the Put Option is exercised. The purchase price for the Put Option is reduced by the amount of NEC TOKIN's debt obligation to NEC which KEC will assume. The determination of the purchase price will be modified in the event there is an unresolved agreement between NEC and us under the Stockholders' Agreement. In the event the Put Option is exercised, NEC will be required to maintain in place the outstanding debt obligation owed by NEC TOKIN to NEC.
Partnership with NEC TOKIN.
Through our cross licensing agreement and private label partnership with NEC TOKIN we have expanded product offerings and markets for both KEMET and NEC TOKIN. KEMET’s strong presence in the western hemisphere and the excellent NEC TOKIN position in Japan and Asia significantly enhance the customer reach for both companies. Through this partnership we can achieve true scale in operations allowing us to manage raw materials sourcing as well as maximize efficiencies and best practices in manufacturing and product development. We believe that the international management team of KEMET and NEC TOKIN allows us to be more sensitive and aware of region-specific business needs than our competitors. Combining our R&D capabilities and university relationships will allow us to be on the forefront of new developments and technological advancements in the capacitor industry. Leveraging R&D investment in both Japan and the U.S enables KEMET to diversify beyond capacitors in the passives market as a result of the NEC TOKIN partnership.
Vertical Integration.
Through the acquisition of Blue Powder and the creation of a tantalum K-Salt facility in Matamoros, Mexico, we have successfully vertically integrated our tantalum supply chain. This has allowed us to purchase ore directly from mines and stabilize the supply chain. In addition, vertical integration has provided KEMET complete oversight of our closed loop supply chain for Tantalum, thereby facilitating compliance with new conflict minerals regulations.
Write Down of Long-Lived Assets
In fiscal year 2014, we incurred impairment charges totaling $4.5 million, recorded on the Consolidated Statements of Operations line item “Write down of long-lived assets”. We are in the process of restructuring our Evora, Portugal manufacturing operations, which is expected to be completed during the quarter ending June 30, 2014. As a part of our restructuring activities, we have moved certain Solid Capacitors manufacturing operations from the Evora, Portugal facility to a manufacturing facility in Mexico and the remaining Solid Capacitors equipment in Portugal will be disposed. During fiscal year 2013, the Company incurred impairment charges totaling $3.1 million. In fiscal year 2014 we incurred $3.9 million in additional impairment charges due to a decrease in forecasted revenues. We utilized an income approach to estimate the fair value of the assets to be disposed. In addition, during fiscal year 2014, the Company incurred impairment charges totaling $0.6 million in Film and Electrolytic which were related to manufacturing equipment in a facility in Italy.
Restructuring
In fiscal year 2010, we initiated the first phase of a plan to restructure Film and Electrolytic and to reduce overhead within the Company as a whole. Since that time, the restructuring plan has been expanded to all business groups and includes implementing programs to make the Company more competitive by removing excess capacity, moving production to lower cost locations and eliminating unnecessary costs throughout the Company. We incurred $14.1 million in restructuring charges in the fiscal year ended March, 31, 2014 including $10.6 million related to personnel reduction costs which are primarily comprised of the following: $1.9 million related to the closure of a portion of our innovation center in the U.S.; $1.2 million related to the reduction of the solid capacitor production workforce in Mexico; $1.1 million related to the Company’s initiative to reduce
30
overhead; $0.5 million in termination benefits associated with converting the Weymouth, United Kingdom manufacturing facility into a technology center; $4.5 million related to headcount reductions of 126 employees in Evora, Portugal due to the relocation of certain Solid Capacitors manufacturing operations to Mexico and $0.4 million related to an additional Cassia Integrazione Guadagni Straordinaria (“CIGS”) plan in Italy. In addition, $0.9 million is related to a headcount reduction of 31 employees due to the consolidation of manufacturing facilities in Italy. In addition to these personnel reduction costs, we incurred manufacturing relocation costs of $3.6 million due to the consolidation of manufacturing facilities within Italy and relocation of manufacturing equipment to Evora, Portugal, Skopje, Macedonia and Mexico.
During the remainder of the restructuring plan, we expect to incur charges of $10.7 million for relocation, severance and other restructuring related costs in Film and Electrolytic. The two legacy facilities in Italy are currently being marketed for sale but do not meet accounting guidelines to be classified as 'held for sale' as the facilities are not available for immediate sale. We expect the restructuring plan to result in a $5.3 million reduction in our operating cost structure in Europe in fiscal year 2015 compared to fiscal year 2014 and anticipate that benefits from the restructuring plan will continue to improve during fiscal year 2016.
Discontinued Operation
In December 2013 KEMET signed a letter of intent to sell the machinery division within Film and Electrolytic. At that time the division qualified as held for sale and was classified as a discontinued operation. All historical financial results contained in this Form 10-K have been revised due to the classification of the machinery division as a discontinued operation. On April 30, 2014, the transaction closed.
Off-Balance Sheet Arrangements
As of March 31, 2014, other than operating lease commitments as described in Note 15, "Commitments and Contingencies", we are not a party to any material off-balance sheet financing arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources.
Critical Accounting Policies
Our accounting policies are summarized in Note 1, "Organization and Significant Accounting Policies" to the consolidated financial statements. The following identifies a number of policies which require significant judgments and estimates, or are otherwise deemed critical to our financial statements.
Our estimates and assumptions are based on historical data and other assumptions that we believe are reasonable. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period.
Our judgments are based on our assessment as to the effect certain estimates, assumptions, or future trends or events may have on the financial condition and results of operations reported in the consolidated financial statements. Readers should understand that actual future results could differ from these estimates, assumptions, and judgments.
A quantitative sensitivity analysis is provided where that information is reasonably available, can be reliably estimated and provides material information to investors. The amounts used to assess sensitivity (i.e., 1%, 10%, etc.) are included to allow readers of this Annual Report on Form 10-K to understand a general cause and effect of changes in the estimates and do not represent our predictions of variability. For all of these estimates, it should be noted that future events rarely develop exactly as forecast, and estimates require regular review and adjustment. We believe the following critical accounting policies contain the most significant judgments and estimates used in the preparation of the consolidated financial statements:
REVENUE RECOGNITION. We ship products to customers based upon firm orders and revenue is recognized when the sales process is complete. This occurs when products are shipped to the customer in accordance with the terms of an agreement of sale, there is a fixed or determinable selling price, title and risk of loss have been transferred and collectability is reasonably assured. Shipping and handling costs are included in cost of sales.
A portion of sales is related to products designed to meet customer specific requirements. These products typically have stricter tolerances making them useful to the specific customer requesting the product and to customers with similar or less stringent requirements. We recognize revenue when title to the products transfers to the customer.
31
A portion of sales is made to distributors under agreements allowing certain rights of return and price protection on unsold merchandise held by distributors. Our distributor policy includes inventory price protection and SFSD programs common in the industry. The price protection policy protects the value of the distributors' inventory in the event we reduce our published selling price to distributors. This program allows the distributor to debit us for the difference between our list price and the lower authorized price for specific parts. We establish price protection reserves on specific parts residing in distributors' inventories in the period that the price protection is formally authorized by KEMET.
KEMET's SFSD program provides authorized distributors with the flexibility to meet marketplace prices by allowing them, upon a case-by-case pre-approved basis, to adjust their purchased inventory cost to correspond with current market demand. Requests for SFSD adjustments are considered on an individual basis, require a pre-approved cost adjustment quote from their local KEMET sales representative and apply only to a specific customer, part, a specified special price amount, a specified quantity, and is only valid for a specific period of time. To estimate potential SFSD adjustments corresponding with current period sales, KEMET records a sales reserve based on historical SFSD credits, distributor inventory levels, and certain accounting assumptions, all of which are reviewed quarterly. We believe this methodology enables us to make reliable estimates of future adjustments under the SFSD program. If the historical SFSD run rates used in our calculation were changed by 1% in fiscal year 2014, net sales would be impacted by $0.9 million.
The establishment of these reserves is recognized as a component of the line item "Net sales" on the Consolidated Statements of Operations, while the associated reserves are included in the line item "Accounts receivable" on the Consolidated Balance Sheets. Estimates used in determining sales allowances are subject to various factors. This includes, but is not limited to, changes in economic conditions, pricing changes, product demand, inventory levels in the supply chain, the effects of technological change, and other variables that might result in changes to our estimates.
INVENTORIES. Inventories are valued at the lower of cost or market. For most of the inventory, cost is determined under the first-in, first-out method. For tool crib, a component of our raw material inventory, cost is determined under the average cost method. The valuation of inventories requires us to make estimates. We also must assess the prices at which we believe the finished goods inventory can be sold compared to its cost. A sharp decrease in demand could adversely impact earnings as the reserve estimates could increase.
PENSION AND POST-RETIREMENT BENEFITS. Our management, with the assistance of actuarial firms, performs actuarial valuations of the fair values of our pension and post-retirement plans' benefit obligations. We make certain assumptions that have a significant effect on the calculated fair value of the obligations such as the:
• | weighted-average discount rate—used to arrive at the net present value of the obligation; |
• | salary increases—used to calculate the impact future pay increases will have on post-retirement obligations; and |
• | medical cost inflation—used to calculate the impact future medical costs will have on post-retirement obligations. |
We understand that these assumptions directly impact the actuarial valuation of the obligations recorded on the Consolidated Balance Sheets and the income or expense that flows through the Consolidated Statements of Operations.
We base our assumptions on either historical or market data that we consider reasonable. Variations in these assumptions could have a significant effect on the amounts reported in Consolidated Balance Sheets and the Consolidated Statements of Operations. The most critical assumption relates to the discount rate. A 25 basis point increase or decrease in the discount rate would result in changes to the projected benefit obligation of $(1.6) million and $1.8 million, respectively.
GOODWILL AND LONG-LIVED ASSETS. Goodwill, which represents the excess of purchase price over fair value of net assets acquired, and intangible assets with indefinite useful lives are no longer amortized but are tested for impairment at least on an annual basis. We perform our impairment test during the first quarter of each fiscal year and when otherwise warranted.
We evaluate our goodwill on a reporting unit basis. This requires us to estimate the fair value of the reporting units based on the future net cash flows expected to be generated. The impairment test involves a comparison of the fair value of each reporting unit, with the corresponding carrying amounts. If the reporting unit's carrying amount exceeds its fair value, then an indication exists that the reporting unit's goodwill may be impaired. The impairment to be recognized is measured by the amount by which the carrying value of the reporting unit's goodwill being measured exceeds its implied fair value. The implied fair value of goodwill is the excess of the fair value of the reporting unit over the sum of the amounts assigned to identified net assets. As a result, the implied fair value of goodwill is generally the residual amount that results from subtracting the value of net assets including all tangible assets and identified intangible assets from the fair value of the reporting unit's fair value. We
32
determine the fair value of our reporting units using an income-based, discounted cash flow ("DCF") analysis, and market-based approaches (Guideline Publicly Traded Company Method and Guideline Transaction Method) which examine transactions in the marketplace involving the sale of the stocks of similar publicly-owned companies, or the sale of entire companies engaged in operations similar to KEMET. In addition to the above described reporting unit valuation techniques, our goodwill impairment assessment also considers our aggregate fair value based upon the value of our outstanding shares of common stock.
Long-lived assets and intangible assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset or group of assets may not be recoverable. A long-lived asset classified as held for sale is initially measured and reported at the lower of its carrying amount or fair value less cost to sell.
Long-lived assets to be disposed of other than by sale are classified as held and used until the long-lived asset is disposed of.
Tests for the recoverability of a long-lived asset to be held and used are performed by comparing the carrying amount of the long-lived asset to the sum of the estimated future undiscounted cash flows expected to be generated by the asset. In estimating the future undiscounted cash flows, we use future projections of cash flows directly associated with, and which are expected to arise as a direct result of, the use and eventual disposition of the assets. These assumptions include, among other estimates, periods of operation and projections of sales and cost of sales. Changes in any of these estimates could have a material effect on the estimated future undiscounted cash flows expected to be generated by the asset. If it is determined that the book value of a long-lived asset is not recoverable, an impairment loss would be calculated equal to the excess of the carrying amount of the long-lived asset over its fair value. The fair value is calculated as the discounted cash flows of the underlying assets.
In the first quarter of fiscal year 2013, due to reduced earnings and cash flows caused by macro-economic factors and excess capacity issues in our industry, the Company recorded a $1.1 million goodwill impairment charge, which represented all of the goodwill related to the KEMET Foil reporting unit.
The Company completed its impairment test on goodwill and intangible assets with indefinite useful lives as of January 1, 2014 and concluded that goodwill and indefinite-lived assets were not impaired. A one percent increase or decrease in the discount rate used in the valuation would have resulted in changes in the fair value of $(34.7) million and $21.2 million, respectively.
INCOME TAXES. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates. Valuation allowances are recognized to reduce deferred tax assets to the amount that is more likely than not to be realized.
We believe that it is more likely than not that a portion of the deferred tax assets in various jurisdictions will not be realized, based on the scheduled reversal of deferred tax liabilities, the recent history of cumulative losses, and the insufficient evidence of projected future taxable income to overcome the loss history. We have provided a valuation allowance related to any benefits from income taxes resulting from the application of a statutory tax rate to the deferred tax assets. We continue to have net deferred tax assets (future tax benefits) in several jurisdictions which we expect to realize assuming, based on certain estimates and assumptions, sufficient taxable income can be generated to utilize these deferred tax benefits. If these estimates and related assumptions change in the future, we may be required to reduce the value of the deferred tax assets resulting in additional tax expense.
The accounting rules require that we recognize in our financial statements, the impact of a tax position, if that position is "more likely than not" of being sustained on audit, based on the technical merits of the position. Any accruals for estimated interest and penalties would be recorded as a component of income tax expense.
To the extent that the provision for income taxes changed by 1% of loss before income taxes, consolidated net loss would change by $0.6 million in fiscal year 2014.
33
Results of Operations
Historically, revenues and earnings may or may not be representative of future operating results due to various economic and other factors. The following table sets forth the Consolidated Statements of Operations for the periods indicated (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Net sales | $ | 833,666 | $ | 823,903 | $ | 924,052 | ||||||
Operating costs and expenses: | ||||||||||||
Cost of sales | 712,925 | 697,076 | 731,312 | |||||||||
Selling, general and administrative expenses | 95,856 | 107,620 | 106,534 | |||||||||
Research and development | 24,466 | 26,876 | 27,765 | |||||||||
Restructuring charges | 14,122 | 18,719 | 14,254 | |||||||||
Write down of long-lived assets | 4,476 | 7,582 | 15,786 | |||||||||
Goodwill Impairment | — | 1,092 | — | |||||||||
Net loss on sales and disposals of assets | 32 | 18 | 318 | |||||||||
Operating (loss) income | (18,211 | ) | (35,080 | ) | 28,083 | |||||||
Interest income | (195 | ) | (139 | ) | (175 | ) | ||||||
Interest expense | 40,962 | 41,331 | 28,567 | |||||||||
Other (income) expense, net | (2,681 | ) | (2,295 | ) | 965 | |||||||
Loss from continuing operations before income taxes and equity loss from NEC TOKIN | (56,297 | ) | (73,977 | ) | (1,274 | ) | ||||||
Income tax expense | 1,482 | 3,281 | 1,076 | |||||||||
Loss from continuing operations before equity loss from NEC TOKIN | (57,779 | ) | (77,258 | ) | (2,350 | ) | ||||||
Equity loss from NEC TOKIN | (7,090 | ) | (1,254 | ) | — | |||||||
Loss from continuing operations | (64,869 | ) | (78,512 | ) | (2,350 | ) | ||||||
Income (loss) from discontinued operations | (3,634 | ) | (3,670 | ) | 9,042 | |||||||
Net income (loss) | $ | (68,503 | ) | $ | (82,182 | ) | $ | 6,692 | ||||
Consolidated Comparison of Fiscal Year 2014 to Fiscal Year 2013
Net sales:
Net sales of $833.7 million in fiscal year 2014 increased 1.2% from $823.9 million in fiscal year 2013. Film and Electrolytic and Solid Capacitor sales increased by $5.6 million and $4.2 million, respectively. Capacitor unit sales volumes increased 11.0 % for fiscal year 2014 as compared to fiscal year 2013. Average selling prices for capacitors decreased 9.3% for fiscal year 2014 as compared to fiscal year 2013 due to an unfavorable product mix shift in Film and Electrolytic and a shift within Solid Capacitors to increased unit sales volumes of lower priced ceramic product line across all regions.
In fiscal years 2014 and 2013, net sales by region were as follows (dollars in millions):
Fiscal Year 2014 | Fiscal Year 2013 | |||||||||||||||
Net Sales | % of Total | Net Sales | % of Total | |||||||||||||
Americas | $ | 262.9 | 31 | % | Americas | $ | 244.9 | 30 | % | |||||||
APAC | 282.3 | 34 | % | APAC | 294.5 | 36 | % | |||||||||
EMEA | 288.5 | 35 | % | EMEA | 284.5 | 34 | % | |||||||||
Total | $ | 833.7 | Total | $ | 823.9 | |||||||||||
34
In fiscal years 2014 and 2013, the percentages of net sales by channel to total net sales were as follows:
Fiscal Year 2014 | Fiscal Year 2013 | |||||||||||||||
Net Sales | % of Total | Net Sales | % of Total | |||||||||||||
Distributors | $ | 377.0 | 45 | % | Distributors | $ | 376.9 | 46 | % | |||||||
EMS | 139.4 | 17 | % | EMS | 143.2 | 17 | % | |||||||||
OEM | 317.3 | 38 | % | OEM | 303.8 | 37 | % | |||||||||
Total | $ | 833.7 | Total | $ | 823.9 | |||||||||||
Gross margin:
Gross margin for the fiscal year ended March 31, 2014 of $120.7 million (14.5% of net sales) decreased $6.1 million or 4.8% from $126.8 million (15.4% of net sales) in the prior fiscal year. The primary contributor to the gross margin decline was a $10.5 million gross margin decrease in Solid Capacitors for the fiscal year 2014 compared to fiscal year 2013 corresponding with a decrease in average selling prices. These were partially offset by a $4.4 million increase in Film and Electrolytic gross margin for the fiscal year 2014 compared to fiscal year 2013.
Selling, general and administrative expenses ("SG&A"):
SG&A expenses of $95.9 million, or 11.5% of net sales for fiscal year 2014 decreased $11.8 million or 10.9% compared to $107.6 million, or 13.1% of net sales for fiscal year 2013. The decrease consists primarily of the following items: a $5.1 million decrease in compensation expenses that resulted from headcount reductions, a $3.5 million decrease in ERP integration costs, a $1.3 million decrease in training and travel as part of overall cost saving initiatives, a $1.2 million decrease in incentive compensation related to stock based compensation, a $0.4 million decrease in Information Technology related to data transmission costs, a $0.4 million decrease in charitable contributions, and a $2.3 million decrease in acquisition fees related to our investment in NEC TOKIN. Partially offsetting these decreases was a $2.5 million increase in depreciation expense.
Restructuring charges:
Restructuring charges of $14.1 million in fiscal year 2014 decreased $4.6 million or 24.6% from $18.7 million in fiscal year 2013.
Restructuring charges in the fiscal year ended March 31, 2014 include personnel reduction costs of $10.6 million and manufacturing relocation costs of $3.6 million. The personnel reduction costs are comprised of the following: $1.9 million related to the closure of a portion of our innovation center in the U.S.; $1.2 million related to the reduction of the solid capacitor production workforce in Mexico; $1.1 million related to the Company’s initiative to reduce overhead; $0.5 million in termination benefits associated with converting the Weymouth, United Kingdom manufacturing facility into a technology center; $4.5 million related to headcount reductions of 126 employees in Evora, Portugal due to the relocation of certain Solid Capacitors manufacturing operations to Mexico; $0.9 million related to a headcount reduction of 31 employees due to the consolidation of manufacturing facilities in Italy and $0.4 million related to an additional Cassia Integrazione Guadagni Straordinaria (“CIGS”) plan in Italy.
In addition to these personnel reduction costs, the Company incurred manufacturing relocation costs of $3.6 million due to the consolidation of Film and Electrolytic manufacturing facilities within Italy and relocation of Film and Electrolytic manufacturing equipment to Evora, Portugal and Skopje, Macedonia and Solid Capacitors manufacturing equipment to Mexico.
The restructuring charges in fiscal year 2013 included termination benefits of $6.1 million related to facility closures in Italy that commenced during fiscal year 2013 and charges of $4.5 million that were incurred by the Company to participate in a plan to save labor costs whereby a company may temporarily "lay off" employees while the government continues to pay their wages for a certain period of time. In addition, we incurred $1.7 million in personnel reduction costs primarily due to headcount reductions within Solid Capacitors' operations in Mexico. In addition to these personnel reduction costs, we incurred manufacturing relocation costs of $1.9 million for relocation of equipment to China and Mexico.
Research and development:
R&D expenses of $24.5 million, or 2.9% of net sales for fiscal year 2014 decreased $2.4 million or 9.0% compared to $26.9 million, or 3.3% of net sales for fiscal year 2013. The decrease is primarily a result of headcount reductions achieved by leveraging the technology and licensing agreement in place with NEC TOKIN.
35
Write down of long-lived assets:
The Company's restructuring of its Evora, Portugal manufacturing operations, is expected to be substantially complete by June 30, 2014. As a part of the ongoing restructuring activities, the Company has relocated certain Solid Capacitor manufacturing operations from the Evora, Portugal facility to a manufacturing facility in Mexico and the remaining Solid Capacitor manufacturing equipment in Portugal will be disposed. During fiscal year 2013, using an income approach to estimate the fair value of assets to be disposed, the Company incurred impairment charges totaling $3.1 million related to Solid Capacitors. In fiscal year 2014 Solid Capacitors incurred $3.9 million in additional impairment charges due to a decrease in forecasted revenues. In addition, during fiscal year 2014, the Company incurred impairment charges totaling $0.6 million related to Film and Electrolytic related to manufacturing equipment in a facility in Italy.
Also in fiscal year 2013 and in connection with the consolidation of two Film and Electrolytic manufacturing facilities within Italy, we incurred impairment charges totaling $4.2 million. Appraisals for these manufacturing facilities indicated there was a decrease in market value and, therefore, the carrying amounts of these manufacturing facilities were reviewed for recoverability. It was determined that the carrying amounts of the manufacturing facilities were not recoverable since they exceeded the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). The impairment was measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeded its fair value.
In addition, in fiscal year 2013 we incurred a $0.3 million charge related to the write-off of a trademark which is no longer utilized.
Operating loss:
Operating loss for fiscal year 2014 of $18.2 million improved $16.9 million or 48.1% compared to an operating loss of $35.1 million in fiscal year 2013. The improvement was primarily due to a $11.8 million decrease in SG&A expenses, $4.6 million decrease in restructuring charges, a $3.1 million decrease in write down of long-lived assets, a $2.4 million decrease in R&D expenses and the goodwill impairment of $1.1 million in fiscal year 2013. These improvements were partially offset by a $6.1 million decrease in gross margin.
Non-operating (income) expense, net:
Non-operating (income) expense, net was a net expense of $38.1 million in fiscal year 2014 compared to a net expense of $38.9 million in fiscal year 2013. The decrease is primarily attributable to a $3.1 million increase in the value of the NEC TOKIN options recognized in fiscal year 2014 and a $0.4 million decrease in interest expense. Partially offsetting these improvements was a $0.8 million decrease in non-product scrap and reclaim income and a $1.4 million charge related to the write off of a long-term note receivable.
Income taxes:
The effective income tax rate for fiscal year 2014 was (2.6)%, resulting in an income tax expense from continuing operations of $1.5 million. This compares to an effective income tax rate of (4.4)% for fiscal year 2013 that resulted in an income tax expense of $3.3 million. The fiscal year 2014 income tax expense is comprised of an income tax expense resulting from operations in certain foreign jurisdictions totaling $2.8 million, $0.3 million of state income tax and a $1.7 million income tax benefit allocated from outside of continuing operations to continuing operations. No U.S. federal income tax benefit is recognized for the U.S. taxable loss for fiscal year 2014 due to a valuation allowance provided for U.S. net operating losses.
Equity loss from NEC TOKIN:
In fiscal year 2014 we incurred an equity loss from our investment in NEC TOKIN of $7.1 million, compared to a loss of $1.3 million in fiscal year 2013. The increased equity loss primarily relates to an impairment loss recorded by NEC TOKIN related to certain of its fixed assets.
36
Segment Comparison of Fiscal Year 2014 to Fiscal Year 2013:
The following table sets forth the operating income (loss) for each of our business segments for the fiscal years 2014 and 2013. The table also sets forth each of the segments' net sales as a percentage of total net sales and the operating income (loss) components as a percentage of total net sales (amounts in thousands, except percentages):
For the Fiscal Years Ended | ||||||||||||||
March 31, 2014 | March 31, 2013 | |||||||||||||
Amount | % to Total Sales | Amount | % to Total Sales | |||||||||||
Net sales | ||||||||||||||
Solid Capacitors | $ | 626,494 | 75.1 | % | $ | 622,305 | 75.5 | % | ||||||
Film and Electrolytic | 207,172 | 24.9 | % | 201,598 | 24.5 | % | ||||||||
Total | $ | 833,666 | 100.0 | % | $ | 823,903 | 100.0 | % | ||||||
Operating income (loss) | ||||||||||||||
Solid Capacitors | $ | 91,848 | $ | 94,986 | ||||||||||
Film and Electrolytic | (17,587 | ) | (31,109 | ) | ||||||||||
Corporate | (92,472 | ) | (98,957 | ) | ||||||||||
Total | $ | (18,211 | ) | (2.2 | )% | $ | (35,080 | ) | (4.3 | )% | ||||
Solid Capacitors
The table below sets forth Net sales, Operating income and Operating income as a percentage of net sales for Solid Capacitors for fiscal years 2014 and 2013 (amounts in thousands, except percentages):
For the Fiscal Years Ended | ||||||||||||||
March 31, 2014 | March 31, 2013 | |||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | |||||||||||
Tantalum product line net sales | $ | 390,422 | $ | 412,791 | ||||||||||
Ceramic product line net sales | 236,072 | 209,514 | ||||||||||||
Net sales | 626,494 | 622,305 | ||||||||||||
Segment operating income | 91,848 | 14.7 | % | 94,986 | 15.3 | % | ||||||||
Net sales—Net sales of $626.5 million in fiscal year 2014 increased $4.2 million or 0.7% from $622.3 million in fiscal year 2013. Ceramic product line net sales of $236.1 million in fiscal year 2014 increased $26.6 million or 12.7% from $209.5 million in fiscal year 2013. Tantalum product line net sales of $390.4 million in fiscal year 2014 decreased $22.4 million or 5.4% from $412.8 million in fiscal year 2013. Unit sales volume for fiscal year 2014 increased 11.4% compared to fiscal year 2013. Average selling prices decreased 9.6% in fiscal year 2014 compared to fiscal year 2013 primarily related to a change in product line sales mix driven by a shift to higher volumes of lower priced ceramic products across all regions.
Segment Operating Income—Segment operating income of $91.8 million for fiscal year 2014 declined $3.1 million or 3.3% from $95.0 million for fiscal year 2013. The decrease in segment operating income is primarily attributable to the following: a decrease in gross margin of $10.5 million, an increase in restructuring charges of $0.8 million and an $0.8 million increase in write down of long-lived assets. These were partially offset by a $6.0 million decrease in SG&A expenses related to lower ERP Integration costs as well as a pension curtailment recognized in fiscal year 2013. In addition, we recognized a $2.5 million decrease in R&D expenses and a $0.5 million improvement on the gain on disposals of fixed assets.
37
Film and Electrolytic
The table below sets forth Net sales, Operating loss and Operating loss as a percentage of net sales for Film and Electrolytic for the fiscal years 2014 and 2013 (amounts in thousands, except percentages):
For the Fiscal Years Ended | ||||||||||||||
March 31, 2014 | March 31, 2013 | |||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | |||||||||||
Net sales | $ | 207,172 | $ | 201,598 | ||||||||||
Segment operating loss | (17,587 | ) | (8.5 | )% | (31,109 | ) | (15.4 | )% | ||||||
Net sales—Net sales of $207.2 million in fiscal year 2014 increased $5.6 million or 2.8% from $201.6 million in fiscal year 2013. Capacitor unit sales volume for fiscal year 2014 increased 19.3% compared to fiscal year 2013 due to an overall increase in customer demand in APAC and EMEA. Capacitor sales were favorably impacted by $4.2 million related to foreign exchange. These increases were partially offset by an decrease in capacitor average selling prices of 15.2% at comparable exchange rates for fiscal year 2014 compared to fiscal year 2013 due to an unfavorable shift in product line mix.
Segment Operating loss—Segment operating loss of $17.6 million in fiscal year 2014 improved $13.5 million or 43.5%, from $31.1 million of segment operating loss in fiscal year 2013. The improvement was attributable to a $3.7 million decrease in write down of long-lived assets, a $4.0 million decrease in restructuring charges, a $1.2 million decrease in SG&A expenses and a $4.4 million improvement in gross margin. The improvement in gross margin is due to an increase in unit sales volume as well as reduced costs as a result of our restructuring efforts. In addition, a $1.1 million goodwill impairment related to the KEMET Foil reporting unit was recognized in fiscal year 2013. These improvements were partially offset by a $0.6 million increase in the loss on disposal of fixed assets and a $0.3 million increase in R&D expenses.
Consolidated Comparison of Fiscal Year 2013 to Fiscal Year 2012
Net sales:
Net sales for fiscal year 2013 of $823.9 million decreased $100.1 million or 10.8% from $924.1 million for fiscal year 2012. Film and Electrolytic and Solid Capacitor net sales decreased by $91.7 million and $8.5 million, respectively. Average selling prices for capacitors decreased 10.8% for fiscal year 2013 compared to fiscal year 2012 due to excess capacity in the market, a general softening of the markets and a shift in sales from higher priced products sold in EMEA to lower priced products sold in APAC.
In fiscal years 2013 and 2012, net sales by region were as follows (dollars in millions):
Fiscal Year 2013 | Fiscal Year 2012 | |||||||||||||||
Net Sales | % of Total | Net Sales | % of Total | |||||||||||||
Americas | $ | 244.9 | 30 | % | Americas | $ | 259.0 | 28 | % | |||||||
APAC | 294.5 | 36 | % | APAC | 359.9 | 39 | % | |||||||||
EMEA | 284.5 | 34 | % | EMEA | 305.2 | 33 | % | |||||||||
Total | $ | 823.9 | Total | $ | 924.1 | |||||||||||
In fiscal years 2013 and 2012, the percentages of net sales by channel to total net sales were as follows:
Fiscal Year 2013 | Fiscal Year 2012 | |||||||||||||||
Net Sales | % of Total | Net Sales | % of Total | |||||||||||||
Distributors | $ | 376.9 | 46 | % | Distributors | $ | 417.4 | 45 | % | |||||||
EMS | 143.2 | 17 | % | EMS | 148.2 | 16 | % | |||||||||
OEM | 303.8 | 37 | % | OEM | 358.5 | 39 | % | |||||||||
Total | $ | 823.9 | Total | $ | 924.1 | |||||||||||
Gross margin:
Gross margin for the fiscal year ended March 31, 2013 of $126.8 million (15.4% of net sales) decreased $65.9 million or 34.2% from $192.7 million (20.9% of net sales) in fiscal year 2012. The primary contributor to the gross margin decline was a
38
$45.0 million gross margin decrease in Film and Electrolytic for the fiscal year 2013 compared to fiscal year 2012 corresponding with a decrease in unit sales volume of 30.7% leading to lower plant capacity utilization and lower efficiencies which created unfavorable fixed cost absorption. In addition, excess capacity in the market led to a decrease in average selling prices in Solid Capacitors which decreased gross margin. In addition, we incurred $6.1 million of plant start-up costs in the year ended March 31, 2013 compared to $3.6 million in the year ended March 31, 2012.
Selling, general and administrative expenses ("SG&A"):
SG&A expenses of $107.6 million (13.1% of net sales) for fiscal year 2013 increased $1.1 million or 1.0% compared to $106.5 million (11.5% of net sales) for fiscal year 2012. The increase in SG&A expenses included a $1.9 million increase in incentive compensation related to stock based compensation, an increase of $3.1 million related to our investment in NEC TOKIN, a $0.7 million increase in travel expenses, and a $0.4 million increase in office rent. In addition, in fiscal year 2013, we incurred a $1.1 million expense related to our investment to improve the health and educational facilities in the community of the Katanga Province of the Democratic Republic of the Congo. Partially offsetting these increases, were a $3.3 million decrease in selling and incentive expenses consistent with the decrease in sales, a $1.5 million decrease in human resources and information technology expenses due to cost savings initiatives, and a $1.4 million decrease in marketing activities and projects.
Restructuring charges:
Restructuring charges of $18.7 million in fiscal year 2013 increased $4.5 million or 31.3% from $14.3 million in fiscal year 2012.
Restructuring charges in the fiscal year ended March 31, 2013 included personnel reduction costs of $16.4 million and manufacturing relocation costs of $2.3 million. The personnel reduction costs were comprised of the following: $2.8 million in termination benefits associated with converting the Landsberg, Germany manufacturing facility into a technology center; $2.9 million in termination benefits associated with converting the Weymouth, United Kingdom manufacturing facility into a technology center; $1.5 million for reductions in production workforce in Mexico; $1.1 million for reductions in production workforce in Portugal; $0.5 million for headcount reductions at an innovation center; $2.7 million for reductions in administrative overhead primarily in the Corporate headquarters and $4.9 million for reductions in production workforce and administrative overhead across the entire Company.
In addition to these personnel reduction costs, we incurred manufacturing relocation costs of $1.8 million for relocation of equipment to Bulgaria, China, Macedonia and Mexico and for the consolidation of manufacturing operations within Italy and $0.6 million in lease termination costs related to the relocation of a sales office.
The restructuring charges in fiscal year 2012 included termination benefits of $6.1 million related to facility closures in Italy that commenced during fiscal year 2013 and charges of $4.5 million that were incurred by the Company to participate in a plan to save labor costs whereby a company may temporarily "lay off" employees while the government continues to pay their wages for a certain period of time. In addition, we incurred $1.7 million in personnel reduction costs primarily due to headcount reductions within Solid Capacitors' operations in Mexico. In addition to these personnel reduction costs, we incurred manufacturing relocation costs of $1.9 million for relocation of equipment to China and Mexico.
Research and development:
R&D expenses of $26.9 million (3.3% of net sales) for fiscal year 2013 decreased $0.9 million or 3.2% compared to $27.8 million (3.0% of net sales) for fiscal year 2012. The decrease resulted from headcount reductions taken in fiscal year 2013 to align the R&D expenses within an acceptable percentage of net sales.
Write down of long-lived assets:
During fiscal year 2013 and corresponding with a restructuring of our Solid Capacitors operations in the Evora, Portugal manufacturing facility, we incurred impairment charges totaling $3.1 million. Also in fiscal year 2013 and in connection with the consolidation of two Film and Electrolytic manufacturing facilities within Italy, we incurred impairment charges totaling $4.2 million. Appraisals for these manufacturing facilities indicated there was a decrease in market value and, therefore, the carrying amounts of these manufacturing facilities were reviewed for recoverability. It was determined that the carrying amounts of the manufacturing facilities were not recoverable since they exceeded the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). The impairment was measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeded its fair value.
In addition, in fiscal year 2013 we incurred a $0.3 million charge related to the write-off of a trademark which is no longer utilized.
39
During fiscal year 2012, we incurred impairment charges of $15.8 million related to certain Solid Capacitor equipment which was disposed of since the equipment could not meet customer demands for lower equivalent series resistance capacitors. The impairment amount of $15.8 million was the carrying amount of the equipment less the estimated scrap value net of disposal costs. The impairment charge is recorded on the Consolidated Statements of Operations line item "Write down of long-lived assets" in fiscal year 2012.
Operating income:
Operating loss for fiscal year 2013 was $35.1 million compared to operating income of $28.1 million in the prior fiscal year. The decrease was primarily due to the $65.9 million decrease in gross margin in fiscal year 2013 as compared to fiscal year 2012. Additionally, when comparing fiscal year 2013 to fiscal year 2012, restructuring charges increased $4.5 million, SG&A expenses increased $1.1 million and we incurred a goodwill impairment of $1.1 million in fiscal year 2013. These increases were partially offset by an $8.2 million decrease in write-down of long-lived assets, and a $0.9 million decrease in research and development expenses. Also, during fiscal year 2013 we recognized less than $0.1 million loss on disposal of assets compared to a $0.3 million loss on sales and disposals of assets in fiscal year 2012.
Non-operating (income) expense, net:
Non-operating (income) expense, net was a net expense of $38.9 million in fiscal year 2013 compared to a net expense of $29.4 million in fiscal year 2012, representing an increase of $9.5 million. The increase is attributable to a $12.8 million increase in interest expense in fiscal year 2013 as compared to fiscal year 2012 primarily related to an increase in our 10.5% Senior Notes outstanding of approximately $110.0 million at the end of fiscal year 2012 and $15.0 million in April 2012. In addition, we recognized less than $0.1 million of a loss on foreign currency translation in fiscal year 2013 as compared to a $0.9 million loss on foreign currency translation in fiscal year 2012 primarily due to the change in the value of the Euro and Mexican Peso compared to the U.S. dollar.
Income taxes:
The effective income tax rate for fiscal year 2013 was (4.4)%, resulting in an income tax expense of $3.3 million. This compares to an effective income tax rate of (84.5)% for fiscal year 2012 that resulted in an income tax expense of $1.1 million. The fiscal year 2013 income tax expense was comprised of an income tax expense resulting from operations in certain foreign jurisdictions totaling $2.7 million, $0.7 million of state income tax expense and a $0.1 million federal income tax benefit. No U.S. federal income tax benefit was recognized for the U.S. taxable loss for fiscal year 2013 due to a valuation allowance provided for U.S. net operating losses.
Equity loss from NEC TOKIN:
In fiscal year 2013 we incurred an equity loss from our investment in NEC TOKIN of $1.3 million.
Segment Comparison of Fiscal Year 2013 to Fiscal Year 2012:
The following table sets forth the operating income (loss) for each of our business segments for the fiscal years 2013 and 2012. The table also sets forth each of the segments' net sales as a percentage of total net sales and the operating income (loss) components as a percentage of total net sales (amounts in thousands, except percentages):
For the Fiscal Years Ended | ||||||||||||||
March 31, 2013 | Fiscal Year 2012 | |||||||||||||
Amount | % to Total Sales | Amount | % to Total Sales | |||||||||||
Net sales | ||||||||||||||
Solid Capacitors | $ | 622,305 | 75.5 | % | $ | 630,762 | 68.3 | % | ||||||
Film and Electrolytic | 201,598 | 24.5 | % | 293,290 | 31.7 | % | ||||||||
Total | $ | 823,903 | 100.0 | % | $ | 924,052 | 100.0 | % | ||||||
Operating income (loss) | ||||||||||||||
Solid Capacitors | $ | 94,986 | $ | 111,769 | ||||||||||
Film and Electrolytic | (31,109 | ) | 12,347 | |||||||||||
Corporate | (98,957 | ) | (96,033 | ) | ||||||||||
Total | $ | (35,080 | ) | -4.3 | % | $ | 28,083 | 3.0 | % | |||||
40
Solid Capacitors
The table sets forth Net sales, Operating income and Operating income as a percentage of net sales for Solid Capacitors for the fiscal years 2013 and 2012 (amounts in thousands, except percentages):
For the Fiscal Years Ended | ||||||||||||||
March 31, 2013 | March 31, 2012 | |||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | |||||||||||
Tantalum product line net sales | $ | 412,791 | $ | 416,995 | ||||||||||
Ceramic product line net sales | 209,514 | 213,767 | ||||||||||||
Net sales | 622,305 | 630,762 | ||||||||||||
Segment operating income | 94,986 | 15.3 | % | 111,769 | 17.7 | % | ||||||||
Net sales—Net sales decreased $8.5 million or 1.3% during fiscal year 2013, compared to fiscal year 2012. Unit sales volume for fiscal year 2013 decreased 0.4% compared to fiscal year 2012. Average selling prices decreased 1.0% in fiscal year 2013 compared to fiscal year 2012 primarily due to a change in product line sales mix driven by a shift to higher priced polymer product line products.
Segment Operating Income—Segment operating income for fiscal year 2013 was $95.0 million compared to operating income of $111.8 million for fiscal year 2012. The $16.8 million decrease in segment operating income in fiscal year 2013 compared to fiscal year 2012 is primarily attributable to the following: a decrease in gross margin of $20.9 million, an increase in restructuring charges of $6.2 million, an increase in SG&A expenses of $2.7 million, and an increase in R&D expenses of $0.2 million during fiscal year 2013 as compared to fiscal year 2012. These decreases were partially offset by a $3.3 million write down of long-lived assets that was recorded in fiscal year 2013 compared to $15.8 million write down in fiscal year 2012 and a $0.2 million gain recognized on sales and disposals of assets in fiscal year 2013 compared to a $0.3 million loss on sales and disposals of assets in fiscal year 2012.
Film and Electrolytic
The table sets forth Net sales, Operating income (loss) and Operating income (loss) as a percentage of net sales for Film and Electrolytic for the fiscal years 2013 and 2012 (amounts in thousands, except percentages):
For the Fiscal Years Ended | ||||||||||||||
March 31, 2013 | March 31, 2012 | |||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | |||||||||||
Net sales | $ | 201,598 | $ | 293,290 | ||||||||||
Segment operating (loss) income | (31,109 | ) | (15.4 | )% | 12,347 | 4.2 | % | |||||||
Net sales—Net sales decreased by $91.7 million or 31.3% in fiscal year 2013, as compared to fiscal year 2012. Capacitor unit sales volume for fiscal year 2013 decreased 30.7% compared to fiscal year 2012 due to an overall decrease in customer demand seen across all regions and channels. Capacitor sales were unfavorably impacted by $9.4 million related to foreign exchange. These decreases were partially offset by an increase in capacitor average selling prices of 4.1% at comparable exchange rates for fiscal year 2013 as compared to fiscal year 2012 due to a favorable shift in product line mix.
Segment Operating income (loss)—Segment operating loss was $31.1 million in fiscal year 2013, as compared to $12.3 million of segment operating income in fiscal year 2012. The $43.5 million decline in segment operating results was attributable primarily to a $45.0 million decrease in gross margin when comparing fiscal year 2013 to fiscal year 2012 and in fiscal year 2013 we recognized a $4.2 million write down of long-lived assets, a goodwill impairment of $1.1 million and a $0.2 million loss on sales and disposals of assets which were not incurred in fiscal year 2012. These expense increases were partly offset by the following decreases in fiscal year 2013 as compared to fiscal year 2012: a $3.5 million decrease in restructuring charges, a $2.5 million decrease in SG&A expenses and a $1.1 million decrease in R&D expenses.
41
Liquidity and Capital Resources
Our liquidity needs arise from working capital requirements, acquisitions, capital expenditures, principal and interest payments on debt, and costs associated with the implementation of our restructuring plan. Historically, these cash needs have been met by cash flows from operations, borrowings under credit agreements and existing cash and cash equivalents balances.
Issuance of 10.5% Senior Notes
On May 5, 2010, we completed the issuance of our 10.5% Senior Notes with an aggregate principal amount of $230.0 million which resulted in net proceeds to the Company of $222.2 million. The Company used a portion of the proceeds to repay all of its outstanding indebtedness under the Company's credit facility with K Financing, LLC, the Company's €60 million credit facility and €35 million credit facility with UniCredit Corporate Banking S.p.A. ("UniCredit") and the Company's term loan with a subsidiary of Vishay and used a portion of the remaining proceeds to fund a previously announced tender offer to purchase $40.5 million in aggregate principal amount of the Company's 2.25% Convertible Senior Notes (the "Convertible Notes") and to pay costs incurred in connection with the issuance, the tender offer and the foregoing repayments.
The 10.5% Senior Notes were issued pursuant to a 10.5% Senior Notes Indenture, dated as of May 5, 2010, by and among us, our domestic restricted subsidiaries (the "Guarantors") and Wilmington Trust Company, as trustee (the "Trustee"). The 10.5% Senior Notes will mature on May 1, 2018, and bear interest at a stated rate of 10.5% per annum, payable semi-annually in cash in arrears on May 1 and November 1 of each year, beginning on November 1, 2010. The 10.5% Senior Notes are our senior obligations and are guaranteed by each of the Guarantors and secured by a first priority lien on 51% of the capital stock of certain of our foreign restricted subsidiaries.
The terms of the 10.5% Senior Notes Indenture, among other things, limit our ability and the ability of our restricted subsidiaries to (i) incur additional indebtedness or issue certain preferred stock; (ii) pay dividends on, or make distributions in respect of, our capital stock or repurchase our capital stock; (iii) make certain investments or other restricted payments; (iv) sell certain assets; (v) create liens or use assets as security in other transactions; (vi) enter into sale and leaseback transactions; (vii) merge, consolidate or transfer or dispose of substantially all assets; (viii) engage in certain transactions with affiliates; and (ix) designate subsidiaries as unrestricted subsidiaries. These covenants are subject to a number of important limitations and exceptions that are described in the 10.5% Senior Notes Indenture.
The 10.5% Senior Notes are redeemable, in whole or in part, at any time on or after May 1, 2014, at the redemption prices specified in the 10.5% Senior Notes Indenture. At any time prior to May 1, 2013, we had the option to redeem up to 35% of the aggregate principal amount of the 10.5% Senior Notes with the net cash proceeds from certain equity offerings at a redemption price equal to 110.5% of the principal amount thereof, together with accrued and unpaid interest, if any, to the redemption date. In addition, at any time prior to May 1, 2014, we may redeem the 10.5% Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 10.5% Senior Notes so redeemed, plus a "make whole" premium and together with accrued and unpaid interest, if any, to the redemption date.
Upon the occurrence of a change of control triggering event specified in the 10.5% Senior Notes Indenture, we must offer to purchase the 10.5% Senior Notes at a redemption price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the date of purchase.
The 10.5% Senior Notes Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods), which include nonpayment, breach of covenants in the 10.5% Senior Notes Indenture, payment defaults or acceleration of other indebtedness, a failure to pay certain judgments and certain events of bankruptcy and insolvency. The 10.5% Senior Notes Indenture also provides for events of default with respect to the collateral, which include default in the performance of (or repudiation, disaffirmation or judgment of unenforceability or assertion of unenforceability) by us or a Guarantor with respect to the provision of security documents under the 10.5% Senior Notes Indenture. These events of default are subject to a number of important qualifications, limitations and exceptions that are described in the 10.5% Senior Notes Indenture. Generally, if an event of default occurs, the Trustee or holders of at least 25% in principal amount of the then outstanding 10.5% Senior Notes may declare the principal of and accrued but unpaid interest, including additional interest, on all the 10.5% Senior Notes to be due and payable.
On March 27, 2012 and April 3, 2012, the Company completed the sale of $110.0 million and $15.0 million aggregate principal amount of its 10.5% Senior Notes due 2018, respectively, at an issue price of 105.5% of the principal amount plus accrued interest from November 1, 2011. The issuance resulted in a debt premium of $6.1 million which is being amortized over the term of the 10.5% Senior Notes. The Senior Notes were issued as additional notes under the indenture, dated May 5, 2010, among the Company, the guarantors party thereto and Wilmington Trust Company, as trustee.
42
Revolving Line of Credit
On September 30, 2010, KEMET Electronics Corporation ("KEC") and KEMET Electronics Marketing (S) Pte Ltd. ("KEMET Singapore") (each a "Borrower" and, collectively, the "Borrowers") entered into the Loan and Security Agreement, with Bank of America, N.A, as the administrative agent and the initial lender. The Loan and Security Agreement provides a $50 million revolving line of credit, which is bifurcated into a U.S. facility (for which KEC is the Borrower) and a Singapore facility (for which KEMET Singapore is the Borrower). The size of the U.S. facility and the Singapore facility can fluctuate as long as the Singapore facility does not exceed $30 million and the total facility does not exceed $50 million. A portion of the U.S. facility and the Singapore facility can be used to issue letters of credit. Subsequent to March 31, 2014, the Loan and Security Agreement was amended and as a result the expiration was extended to December, 31, 2015. The principal features of the amendment to the Loan and Security Agreement (the "Amendment") are reflected in the description below.
Revolving loans may be used to pay fees and transaction expenses associated with the closing of the credit facilities, to pay obligations outstanding under the Loan and Security Agreement and for working capital and other lawful corporate purposes of KEC and KEMET Singapore. Borrowings under the U.S. and Singapore facilities are subject to a borrowing base. The borrowing base consists of:
• | in the case of the U.S. facility, (A) 85% of KEC's accounts receivable that satisfy certain eligibility criteria plus (B) the lesser of (i) $6.0 million and (ii) (a) on or prior to agent’s receipt of an updated inventory appraisal and agent’s approval thereof, 40% of the value of Eligible Inventory (as defined in the agreement) and (b) upon agent’s receipt of an updated Inventory Appraisal, 85% of the net orderly liquidation value of the Eligible Inventory (as defined in the agreement) plus (C) the lesser of $5.1 million and 80% of the net orderly liquidation percentage of the appraised value of equipment that satisfies certain eligibility criteria, as reduced on the first day of each fiscal quarter occurring after April 30, 2014 in an amount equal to one-twentieth (1/20) of such appraised value less (D) certain reserves, including certain reserves imposed by the administrative agent in its permitted discretion; and |
• | in the case of the Singapore facility, (A) 85% of KEMET Singapore's accounts receivable that satisfy certain eligibility criteria as further specified in the Amendment, less (B) certain reserves, including certain reserves imposed by the administrative agent in its permitted discretion. |
Interest is payable on borrowings monthly at a rate equal to the London Interbank Offer Rate ("LIBOR") or the base rate, plus an applicable margin, as selected by the Borrower. Depending upon the fixed charge coverage ratio of KEMET Corporation and its subsidiaries on a consolidated basis as of the latest test date, the applicable margin under the U.S. facility varies between 2.50% and 3.00% for LIBOR advances and 1.50% and 2.00% for base rate advances, and under the Singapore facility varies between 2.75% and 3.25% for LIBOR advances and 1.75% and 2.25% for base rate advances.
The base rate is subject to a floor that is 100 basis points above LIBOR.
An unused line fee is payable monthly in an amount equal to a per annum rate equal to (a) 0.50%, if the average daily balance of Revolver Loans and stated amount of letters of credit was 50% or less of the Revolver Commitments during the preceding calendar month, or (b) 0.375%, if the average daily balance of Revolver Loans and stated amount of letters of credit was more than 50% of the Revolver Commitment during the preceding calendar month. A customary fee is also payable to the administrative agent on a quarterly basis.
KEC's ability to draw funds under the U.S. facility and KEMET Singapore's ability to draw funds under the Singapore facility are conditioned upon, among other matters:
• | the absence of the existence of a Material Adverse Effect (as defined in the Loan and Security Agreement); |
• | the absence of the existence of a default or an event of default under the Loan and Security Agreement; and |
• | the representations and warranties made by KEC and KEMET Singapore in the Loan and Security Agreement continuing to be correct in all material respects. |
The parent corporation of KEC—KEMET Corporation—and the Guarantors guarantee the U.S. facility obligations and the U.S. facility obligations are secured by a lien on substantially all of the assets of KEC and the Guarantors (other than assets that secure the 10.5% Senior Notes). The collection accounts of the Borrowers and Guarantors are subject to a daily sweep into a concentration account and the concentration account will become subject to full cash dominion in favor of the administrative agent (i) upon an event of default, (ii) if for five consecutive business days, aggregate availability of all facilities has been less than the greater of (A) 15% of the aggregate revolver commitments at such time and (B) $7.5 million, or (iii) if for five consecutive business days, availability of the U.S. facility has been less than $3.75 million (each such event, a "Cash Dominion Trigger Event").
KEC and the Guarantors guarantee the Singapore facility obligations. In addition to the assets that secure the U.S. facility, the Singapore obligations are also secured by a pledge of 100% of the stock of KEMET Singapore and a security
43
interest in substantially all of KEMET Singapore's assets. As required by the Loan and Security Agreement, KEMET Singapore's bank accounts were transferred over to Bank of America and upon a Cash Dominion Trigger Event (as defined in the Loan and Security Agreement) will become subject to full cash dominion in favor of the administrative agent.
A fixed charge coverage ratio of at least 1.1:1.0 must be maintained as of the last day of each fiscal quarter ending immediately prior to or during any period in which any of the following occurs and is continuing until none of the following occurs for a period of at least forty-five consecutive days: (i) an event of default, (ii) aggregate availability of all facilities has been less than the greater of (A) 15% of the aggregate revolver commitments at such time and (B) $7.5 million, or (iii) availability of the U.S. facility has been less than $3.75 million. The fixed charge coverage ratio tests the EBITDA and fixed charges of KEMET Corporation and its subsidiaries on a consolidated basis.
In addition, the Loan and Security Agreement includes various covenants that, subject to exceptions, limit the ability of KEMET Corporation and its direct and indirect subsidiaries to, among other things: incur additional indebtedness; create liens on assets; make capital expenditures; engage in mergers, consolidations, liquidations and dissolutions; sell assets (including pursuant to sale leaseback transactions); pay dividends and distributions on or repurchase capital stock; make investments (including acquisitions), loans, or advances; prepay certain junior indebtedness; engage in certain transactions with affiliates; enter into restrictive agreements; amend material agreements governing certain junior indebtedness; and change its lines of business.
The Loan and Security Agreement includes certain customary representations and warranties, affirmative covenants and events of default, which are set forth in more detail in the Loan and Security Agreement. There were $18.4 million and zero borrowings against the revolving line of credit as of March 31, 2014 and 2013, respectively. Based upon the March 31, 2014 financial statements, the Company's available borrowing capacity under the Loan and Security Agreement was $7.1 million (after $16.9 million used for letters of credit as described below).
Advanced Payment from OEM
On August 28, 2012, the Company entered into and amended an agreement (the "Agreement"), with an original equipment manufacturer (the "OEM") pursuant to which the OEM agreed to advance KEMET $24.0 million (the "Advance Payment"). As of March 31, 2014 and 2013, the Company had $20.4 million and $24.0 million, respectively, outstanding due to the OEM. On a monthly basis starting in June 2013, (eight months following the receipt of the Advance Payment), the Company began repaying the OEM an amount equal to a percentage of the aggregate purchase price of the capacitors sold to the OEM the preceding month, not to exceed $1.0 million per month. Pursuant to the terms of the Agreement, the percentage of the aggregate purchase price of capacitors sold to the OEM that will be used to repay the Advance Payment will double, and the total amount to be repaid will not exceed $2.0 million per month, in the event that (1)the OEM provides evidence that the price charged by KEMET for a particular capacitor during any prior quarter was equal to or greater than 110% of the price paid by the OEM or its affiliates for a third-party part qualified for the same product, and shipping in volume during such period, and (2) agreement cannot be reached between the OEM and the Company for a price adjustment during the current quarter which would bring KEMET's price within 110% of the third-party price. In June 2015 (thirty-two months after the date of the Advance Payment), the remaining outstanding balance, if any, is due in full. Pursuant to the terms of the Agreement, an irrevocable standby letter of credit in the amount of $16.0 million was delivered to the OEM on October 8, 2012 and on October 22, 2012 the Company received the Advance Payment from the OEM.
In addition, in fiscal year 2014, the Company issued two letters of credit for EUR 1.1 million ($1.5 million) and EUR 0.7 million ($0.9 million) related to the construction of the new manufacturing location in Italy. The letter of credit for EUR 1.1 million ($1.5 million) was cancelled in February 2014.
Short-term Liquidity
KEMET's total cash and restricted cash balance as of March 31, 201 was $71.4 million. Unrestricted cash and cash equivalents totaled $57.9 million as of March 31, 2014, representing a decrease of $38.0 million as compared to $96.0 million as of March 31, 2013. Our net working capital (current assets less current liabilities) as of March 31, 2014 was $233.7 million compared to $261.9 million of net working capital as of March 31, 2013. Cash and cash equivalents held by our foreign subsidiaries totaled $35.1 million million and $26.7 million at March 31, 2014 and March 31, 2013, respectively. Our operating income outside the U.S. is deemed to be permanently reinvested in foreign jurisdictions. As a result, we currently do not intend nor foresee a need to repatriate cash and cash equivalents held by foreign subsidiaries. If these funds are needed in the U.S. for our operations, we may be required to accrue U.S. taxes on the undistributed foreign earnings.
We have taken steps to improve our operating results by decreasing global headcount and vertically integrating our supply chain. Based on our current operating plans, we believe that existing cash and cash equivalents, cash provided by operations and cash from the revolving line of credit will continue to be sufficient to fund our operating requirements for the next twelve months, including $39.0 million in interest payments, expected capital expenditures in the range of $20.0 million to
44
$25.0 million, $6.3 million related to the Advance Payment discussed above, deferred acquisition payments of $19.6 million, payments of $6.2 million related to restructuring liabilities, and $1.3 million in other debt principal payments.
Our cash and cash equivalents decreased by $38.0 million during the year ended March 31, 2014, decreased $114.5 million during the year ended March 31, 2013 and increased $58.5 million during the year ended March 31, 2012 as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Net cash (used in) provided by operating activities | $ | (6,746 | ) | $ | (22,827 | ) | $ | 80,730 | ||||
Net cash used in investing activities | (25,253 | ) | (111,977 | ) | (91,853 | ) | ||||||
Net cash provided by (used in) financing activities | (6,877 | ) | 20,852 | 70,292 | ||||||||
Effects of foreign currency fluctuations on cash | 827 | (591 | ) | (699 | ) | |||||||
Net (decrease) increase in cash and cash equivalents | $ | (38,049 | ) | $ | (114,543 | ) | $ | 58,470 | ||||
Fiscal Year 2014 compared to Fiscal Year 2013
Operations
Cash used in operating activities totaled $6.7 million in fiscal year 2014, representing a $16.1 million improvement compared to cash used in operating activities of $22.8 million in fiscal year 2013. A portion of the improvement relates to a $3.1 million improvement in cash flows related to operations (change in net income adjusted for the change in: net cash provided by operating activities of discontinued operations, equity loss on NEC TOKIN, change in value of NEC TOKIN options, write down of long-lived assets, depreciation and amortization, deferred income taxes, net gain/loss on sales and disposals of assets, amortization of debt discounts and debt issuance costs, stock-based compensation, pension and other post-retirement benefits, write down of receivables and other non-cash changes to net income) for fiscal year 2014 compared to fiscal year 2013.
In addition, we generated $2.4 million through changes in assets and liabilities in fiscal year 2014 as compared to using $10.6 million through changes in assets and liabilities in fiscal year 2013. The cash generation of $2.4 million in fiscal year 2014 is primarily related to a reduction in inventory of $14.9 million achieved through vertical integration, yield improvement and cycle time improvement. This was partially offset by a decrease in other operating liabilities of $9.7 million primarily due to a decrease in accrued restructuring.
The cash use of $10.6 million in fiscal year 2013 was primarily related to an $11.2 million increase in prepaid inventory and the timing of value added tax receivables and other assets. This was partially offset by decreasing our accounts receivable balance in fiscal year 2013 by $4.9 million.
Investing
Cash used in investing activities of $25.3 million in fiscal year 2014 decreased $86.7 million from $112.0 million in fiscal year 2013.
In fiscal year 2014, capital expenditures of $32.1 million were primarily related to the completion of our manufacturing facility in Pontecchio, Italy as well as various information technology related projects. Restricted cash related to the Advance Payment provided cash of $4.0 million and we received $2.8 million from the sale of assets.
In fiscal year 2013, cash used for investment in NEC TOKIN in fiscal year 2013 totaled $50.9 million. Capital expenditures in 2013 of $46.2 million were primarily related to new manufacturing facilities in Skopje, Macedonia and Pontecchio, Italy. Restricted cash related to the Advance Payment resulted in a use of cash of $15.3 million and we received $0.4 million from the sale of assets in fiscal year 2013.
Financing
Cash used in financing activities of $6.9 million in fiscal year 2014 decreased $27.7 million from cash provided by financing activities of $20.9 million in fiscal year 2013.
In fiscal year 2014, we used $22.0 million for deferred acquisition payments related to the KEMET Foil and Blue Powder acquisitions and $3.6 million for debt payments. This was partially offset by $21.0 million in proceeds from the revolving line of credit.
45
In fiscal year 2013, we received a $24.0 million Advance Payment from an OEM and $15.8 million in proceeds from the issuance of debt related to the private placement of our 10.5% Senior Notes. In fiscal year 2013, we used $16.9 million for deferred acquisition payments related to the KEMET Foil and Blue Powder acquisitions and $1.9 million for debt payments.
Commitments
At March 31, 2014, we had contractual obligations in the form of non-cancelable operating leases and debt, including interest payments (see Note 2, "Debt" and Note 15, "Commitments and Contingencies" to our consolidated financial statements), European social security, pension benefits, other post-retirement benefits, inventory purchase obligations, fixed asset purchase obligations, acquisition related obligations, and construction obligations as follows (amounts in thousands):
Payment Due by Period | ||||||||||||||||||||
Contractual obligations | Total | Year 1 | Years 2 - 3 | Years 4 - 5 | More than 5 years | |||||||||||||||
Debt obligations | $ | 395,768 | $ | 7,575 | $ | 33,193 | $ | 355,000 | $ | — | ||||||||||
Interest obligations | 154,051 | 39,015 | 74,551 | 40,485 | — | |||||||||||||||
Acquisition related obligations | 19,581 | 19,581 | — | — | — | |||||||||||||||
Construction obligations | 4,464 | 4,464 | — | — | — | |||||||||||||||
Employee separation liability | 15,487 | 1,039 | 1,039 | 693 | 12,716 | |||||||||||||||
Restructuring liability | 6,217 | 6,217 | — | — | — | |||||||||||||||
Pension and other post-retirement benefits(1) | 19,780 | 1,565 | 3,425 | 3,728 | 11,062 | |||||||||||||||
Operating lease obligations | 22,103 | 8,482 | 8,163 | 3,595 | 1,863 | |||||||||||||||
Purchase commitments | 481 | 481 | — | — | — | |||||||||||||||
Total | $ | 637,932 | $ | 88,419 | $ | 120,371 | $ | 403,501 | $ | 25,641 | ||||||||||
_______________________________________________________________________________
(1) | Reflects expected benefit payments through 2022. |
Uncertain Income Tax Positions
We have recognized a liability for our unrecognized uncertain income tax positions of approximately $5.7 million as of March 31, 2014. We do not believe we are likely to pay any amounts during the year ending March 31, 2015. The ultimate resolution and timing of payment for remaining matters continues to be uncertain and are, therefore, excluded from the above table.
Non-GAAP Financial Measures
To complement our consolidated statements of operations and cash flows, we use non-GAAP financial measures of Adjusted operating income, Adjusted net income and Adjusted EBITDA. We believe that Adjusted operating income, Adjusted net income and Adjusted EBITDA are complements to U.S. GAAP amounts and such measures are useful to investors. The presentation of these non-GAAP measures is not meant to be considered in isolation or as an alternative to net income as an indicator of our performance, or as an alternative to cash flows from operating activities as a measure of liquidity.
46
Adjusted operating income is calculated as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Operating (loss) income | $ | (18,211 | ) | $ | (35,080 | ) | $ | 28,083 | ||||
Adjustments: | ||||||||||||
Restructuring charges | 14,122 | 18,719 | 14,254 | |||||||||
Write down of long-lived assets | 4,476 | 7,582 | 15,786 | |||||||||
ERP integration costs | 3,880 | 7,398 | 7,128 | |||||||||
Plant shut-down costs | 2,668 | — | — | |||||||||
Plant start-up costs | 3,336 | 6,122 | 3,574 | |||||||||
Stock-based compensation | 2,909 | 4,599 | 3,075 | |||||||||
NEC TOKIN investment related expenses | 2,299 | 4,581 | 1,476 | |||||||||
Infrastructure tax | 1,079 | — | — | |||||||||
Goodwill impairment | — | 1,092 | — | |||||||||
Net curtailment and settlement gain on benefit plans | — | 266 | — | |||||||||
Loss on sales and disposals of assets | 32 | 18 | 318 | |||||||||
Inventory write downs | 3,886 | — | — | |||||||||
Adjusted operating income | $ | 20,476 | $ | 15,297 | $ | 73,694 | ||||||
Adjusted net income is calculated as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Net income (loss) | $ | (68,503 | ) | $ | (82,182 | ) | $ | 6,692 | ||||
Adjustments: | ||||||||||||
Restructuring charges | 14,122 | 18,719 | 14,254 | |||||||||
Write down of long-lived assets | 4,476 | 7,582 | 15,786 | |||||||||
Amortization included in interest expense | 3,596 | 4,138 | 3,600 | |||||||||
ERP integration costs | 3,880 | 7,398 | 7,128 | |||||||||
(Income) loss from discontinued operations | 3,634 | 3,670 | (9,042 | ) | ||||||||
Plant start-up costs | 3,336 | 6,122 | 3,574 | |||||||||
Stock-based compensation | 2,909 | 4,599 | 3,075 | |||||||||
Plant shut-down costs | 2,668 | — | — | |||||||||
NEC TOKIN investment related expenses | 2,299 | 4,581 | 1,476 | |||||||||
Infrastructure tax | 1,079 | — | — | |||||||||
Goodwill impairment | — | 1,092 | — | |||||||||
Equity loss from NEC TOKIN | 7,090 | 1,254 | — | |||||||||
Net curtailment and settlement gain on benefit plans | — | 266 | — | |||||||||
Loss on sales and disposals of assets | 32 | 18 | 318 | |||||||||
Net foreign exchange (gain) loss | (304 | ) | (28 | ) | 919 | |||||||
Registration related fees | — | 20 | 281 | |||||||||
Long-term receivable write down | 1,444 | — | — | |||||||||
Change in value of NEC TOKIN options | (3,111 | ) | — | — | ||||||||
Inventory write downs | 3,886 | — | — | |||||||||
Income tax effect of non-GAAP adjustments* | (27 | ) | (906 | ) | (3,203 | ) | ||||||
Adjusted net income (loss) | $ | (17,494 | ) | $ | (23,657 | ) | $ | 44,858 | ||||
* | Includes the income tax effect of law changes related to the utilization of net operating loss carryforwards. |
47
Adjusted EBITDA is calculated as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Net income (loss) | $ | (68,503 | ) | $ | (82,182 | ) | $ | 6,692 | ||||
Adjustments: | ||||||||||||
Income tax expense | 1,482 | 3,281 | 1,076 | |||||||||
Interest expense, net | 40,767 | 41,192 | 28,392 | |||||||||
Depreciation and amortization | 49,527 | 45,158 | 43,401 | |||||||||
Restructuring charges | 14,122 | 18,719 | 14,254 | |||||||||
Write down of long-lived assets | 4,476 | 7,582 | 15,786 | |||||||||
ERP integration costs | 3,880 | 7,398 | 7,128 | |||||||||
(Income) loss from discontinued operations | 3,634 | 3,670 | (9,042 | ) | ||||||||
Plant start-up costs | 3,336 | 6,122 | 3,574 | |||||||||
Stock-based compensation | 2,909 | 4,599 | 3,075 | |||||||||
Plant shut-down costs | 2,668 | — | — | |||||||||
NEC TOKIN investment related expenses | 2,299 | 4,581 | 1,476 | |||||||||
Infrastructure tax | 1,079 | — | — | |||||||||
Goodwill impairment | — | 1,092 | — | |||||||||
Equity loss from NEC TOKIN | 7,090 | 1,254 | — | |||||||||
Net curtailment and settlement gain on benefit plans | — | 266 | — | |||||||||
Loss on sales and disposals of assets | 32 | 18 | 318 | |||||||||
Net foreign exchange (gain) loss | (304 | ) | (28 | ) | 919 | |||||||
Registration related fees | — | 20 | 281 | |||||||||
Long-term receivable write down | 1,444 | — | — | |||||||||
Change in value of NEC TOKIN options | (3,111 | ) | — | — | ||||||||
Inventory write downs | 3,886 | — | — | |||||||||
Adjusted EBITDA | $ | 70,713 | $ | 62,742 | $ | 117,330 | ||||||
Adjusted operating income represents operating income (loss), excluding adjustments which are outlined in the quantitative reconciliation provided above. We use Adjusted operating income to facilitate our analysis and understanding of our business operations and believe that Adjusted operating income is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company. Adjusted operating income should not be considered as an alternative to operating income or any other performance measure derived in accordance with U.S. GAAP.
Adjusted net income (loss) represents net income (loss), excluding adjustments which are outlined in the quantitative reconciliation provided above. We use Adjusted net income to evaluate the Company's operating performance and believe that Adjusted net income is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company. Adjusted net income should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP.
Adjusted EBITDA represents net income (loss) before income tax expense, interest expense, net, and depreciation and amortization, excluding adjustments which are outlined in the quantitative reconciliation provided above. We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt. We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.
We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity because cash expenditures on interest are, by definition, available to pay interest and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other items excluded from Adjusted EBITDA are excluded in order to better reflect our continuing operations.
In evaluating Adjusted EBITDA, one should be aware that in the future we may incur expenses similar to the adjustments noted above. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be
48
unaffected by these types of adjustments. Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.
Our Adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:
• | it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments; |
• | it does not reflect changes in, or cash requirements for, our working capital needs; |
• | it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt; |
• | although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements; |
• | it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows; |
• | it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations; |
• | it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and |
• | other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure. |
Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.
Recent Accounting Pronouncements
In April 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU 2014-08). ASU 2014-08 changes the definition of a discontinued operation and modifies related disclosure requirements. The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. This new guidance is not expected to have a material impact on the Company's Consolidated Financial Statements.
In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830). ASU 2013-05 revised the authoritative guidance on accounting for cumulative translation adjustment specifying that a cumulative translation adjustment should be released into earnings when an entity ceases to have a controlling financial interest in a subsidiary or a group of assets within a consolidated foreign entity and the sale or transfer results in the complete or substantially complete liquidation of the foreign entity. For sales of an equity method investment that is a foreign entity, a pro rata portion of cumulative translation adjustment attributable to the investment would be recognized in earnings upon sale of the investment. The guidance is effective for fiscal years beginning after December 15, 2013. The Company does not expect the adoption of this guidance to have a material impact on its financial position, results of operations, comprehensive income or liquidity.
In February 2013, the FASB issued ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income ("ASU 2013-02"). ASU 2013-02 requires registrants to provide information about the amounts reclassified out of AOCI by component. In addition, an entity is required to present significant amounts reclassified out of AOCI by the respective line items of net income. ASU 2013-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2012. ASU 2013-02 was effective for the Company on April 1, 2013 and did not have a material effect on the Company's net income or other comprehensive income in the financial statements, the Company's financial position, results of operations or cash flows.
There are currently no other accounting standards that have been issued that will have a significant impact on the Company's financial position, results of operations or cash flows upon adoption.
49
Effect of Inflation
Inflation generally affects us by increasing the cost of labor, equipment, and raw materials. We do not believe that inflation has had any material effect on our business over the past three fiscal years except for the following discussion in Commodity Price Risk.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
Interest Rate Risk
We are exposed to interest rate risk through our revolving line of credit, which had an outstanding balance as of March 31, 2014, of $18.4 million. This debt has a variable interest rate and a 1% change in the interest rate would yield a $0.2 million change in interest expense.
Foreign Currency Exchange Rate Risk
Given our international operations and sales, we are exposed to movements in foreign exchange rates. Of these, the most significant are currently the Euro and the Mexican peso. A portion of our sales to our customers and operating costs in Europe are denominated in Euro creating an exposure to foreign currency exchange rates. Also, a portion of our costs in our operations in Mexico are denominated in Mexican pesos, creating an exposure to foreign currency exchange rates. Additionally, certain of our non-U.S. subsidiaries make sales denominated in U.S. dollars which expose them to foreign currency transaction gains and losses. Historically, in order to minimize our exposure, we periodically entered into forward foreign exchange contracts in which the future cash flows were hedged against the U.S. dollar. The Company does not presently have in place any forward foreign exchange contracts, but does periodically evaluate the use of such contracts as a means of hedging its foreign exchange exposure.
Commodity Price Risk
As a result of our tantalum vertical integration efforts which began in fiscal year 2012, we have reduced our exposure to price volatility and supply uncertainty in the tantalum supply chain. A majority of our tantalum needs are now met through our direct sourcing of conflict free tantalum ore or tantalum scrap reclaim, which is then processed into the intermediate product potassium heptafluorotantalate (commonly known as K-salt) at our own facility in Mexico, before final processing into tantalum powder at Blue Powder. Price increases for tantalum ore, or for the remaining tantalum powder that we source from third parties, could impact our financial performance as we may be unable to pass all such price increases on to our customers.
Palladium is a precious metal used in the manufacture of multilayer ceramic capacitors and is mined primarily in Russia and South Africa. We continue to pursue ways to reduce palladium usage in ceramic capacitors in order to minimize the price risk. The amount of palladium that we require has generally been available in sufficient quantities; however the price of palladium is driven by the market which has shown significant price fluctuations. For instance, in fiscal year 2014 the price of palladium fluctuated between $640 to $792 per troy ounce. Price increases and the possibility of our inability to pass such increases on to our customers could have an adverse effect on profitability.
Silver and aluminum have generally been available in sufficient quantities, and we believe there are a sufficient number of suppliers from which we can purchase our requirements. An increase in the price of silver and aluminum that we are unable to pass on to our customers, however, could have an adverse effect on our profitability.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
The response to this item is submitted as a separate section of this Form 10-K. See Item 15.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
ITEM 9A. CONTROLS AND PROCEDURES.
Disclosure Controls and Procedures
As of March 31, 2014, an evaluation of the effectiveness of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) was performed under the supervision and with the participation of the Company's management, including the Chief Executive Officer and Chief Financial Officer. Based on that
50
evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in its reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act is accumulated and communicated to the Company's management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Internal Control over Financial Reporting
The Company's management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act). Internal control over financial reporting is a process, designed by, or under the supervision of, an entity's principal executive and principal financial officers, and effected by an entity's board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and the dispositions of the assets of the entity; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the entity are being made only in accordance with authorizations of the management and directors of the entity; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the entity's assets that could have a material effect on its consolidated financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Under the supervision and with the participation of the Company's management, including the Company's Chief Executive Officer and Chief Financial Officer, the Company's management conducted an assessment of the effectiveness of its internal control over financial reporting based on the criteria set forth in the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 framework).
Based on that assessment, as of March 31, 2014, the Company's management concluded that its internal control over financial reporting was effective. Ernst & Young LLP, our independent registered public accounting firm has issued an attestation report on the Company's internal control over financial reporting, which is on page 59 of this annual report on Form 10-K.
Changes in Internal Control over Financial Reporting
We have completed the implementation of Oracle 11i EBS on a worldwide basis at most locations. This software implementation project has resulted in changes in our business processes and related internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act). Management continues to monitor, evaluate and update the related processes and internal controls as necessary during the post implementation period to ensure adequate internal control over financial reporting.
Other than the change described above, there was no change in the Company's internal control over financial reporting during the fiscal quarter ended March 31, 2014, that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.
ITEM 9B. OTHER INFORMATION.
None.
51
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
Other than the information under "Executive Officers" and "Other Key Employees" under Part I, Item 4A, the other information required by Item 10 is incorporated by reference from the Company's definitive proxy statement for its annual stockholders meeting to be held on July 24, 2014 under the headings "Nominees for Board of Directors," "Continuing Directors," "Section 16(a) Beneficial Ownership Reporting Compliance" and "Information about the Board of Directors."
ITEM 11. EXECUTIVE COMPENSATION.
The information required by Item 11 is incorporated by reference from the Company's definitive proxy statement for its annual stockholders' meeting to be held on July 24, 2014 under the headings "Compensation Discussion and Analysis," "Summary Compensation Table," "Grants of Plan-Based Awards Table," "Outstanding Equity Awards at Fiscal Year-End Table," "Options Exercises and Stock Vested Table," "Pension Benefits Table," "Nonqualified Deferred Compensation Table," "Potential Payments Upon Termination or Change in Control Table," "Director Compensation Table," "Report of the Compensation Committee," and "Compensation Committee Interlocks and Insider Participation."
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
The information required by Item 12 is incorporated by reference from the Company's definitive proxy statement for its annual stockholders' meeting to be held on July 24, 2014 under the heading "Security Ownership", and from "Equity Compensation Plan Disclosure" in Item 5 hereof.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
The information required by Item 13 is incorporated by reference from the Company's definitive proxy statement for its annual stockholders' meeting to be held on July 24, 2014 under the headings "Review, Approval or Ratification of Transactions with Related Persons" and "Information about the Board of Directors."
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
The information required by Item 14 is incorporated by reference from the Company's definitive proxy statement for its annual stockholders' meeting to be held on July 24, 2014 under the heading "Audit and Non-Audit Fees."
52
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.
(a) | (1) Financial Statements |
The following financial statements are filed as a part of this report:
Consolidated Financial Statements: | |
(a) | (2) Financial Statement Schedules |
Financial statement schedules are omitted because they are not applicable or because the required information is included in the consolidated financial statements or notes thereto.
(a) | (3) List of Exhibits |
The following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the SEC:
2.1 | Stock Purchase Agreement, dated as of February 2, 2012, by and among KEMET Corporation, Niotan Incorporated and Niotan Investment Holdings LLC (incorporated by reference to Exhibit 99.2 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on February 2, 2012) | ||
2.2 | Stock Purchase Agreement, dated as of March 12, 2012, by and among KEMET Electronics Corporation, NEC Corporation and NEC TOKIN Corporation (incorporated by reference to Exhibit 99.2 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on March 15, 2012) | ||
2.3 | Amendment No. 1 to the Stock Purchase Agreement dated as of December 12, 2012, by and among KEMET Electronics Corporation, NEC Corporation and NEC TOKIN Corporation (incorporated by reference to Exhibit 99.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on December 14, 2012) | ||
3.1 | Second Restated Certificate of Incorporation of the Company, as amended to date (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended June 30, 2011) | ||
3.2 | Amended and Restated By-laws of KEMET Corporation, effective June 5, 2008 (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on June 5, 2008) | ||
4.1 | Indenture, dated May 5, 2010, by and among the Company, certain subsidiary guarantors named therein and Wilmington Trust Company, as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 5, 2010) | ||
4.2 | Registration Rights Agreement, dated May 5, 2010, by and among the Company, certain subsidiary guarantors named therein and the initial purchasers named therein (incorporated by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 5, 2010) | ||
4.3 | Supplemental Indenture, dated as of August 10, 2011, among KEMET Foil Manufacturing LLC (f/k/a Cornell Dubilier Foil, LLC), KEMET Corporation, the other Guarantors named therein and Wilmington Trust Company, as trustee (incorporated by reference to Exhibit 4.1 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended September 30, 2011) | ||
53
4.4 | Registration Rights Agreement, dated March 27, 2012, among KEMET Corporation, the guarantors named therein and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Deutsche Bank Securities Inc., as initial purchasers (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on March 28, 2012) | ||
4.5 | Registration Rights Agreement, dated as of April 3, 2012, among KEMET Corporation, the guarantors named therein and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Deutsche Bank Securities Inc., as initial purchasers (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on April 4, 2012) | ||
4.6 | Supplemental Indenture, dated April 17, 2012, among KEMET Corporation, the guarantors named therein and Wilmington Trust Company, as trustee (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on April 18, 2012) | ||
4.7 | Form of 10 1/2% Senior Note due 2018 (included in Exhibit 4.1) | ||
10.1 | Registration Agreement, dated as of December 21, 1990, by and among the Company and each of the investors and executives listed on the schedule of investors and executives attached thereto (incorporated by reference to Exhibit 10.3 to the Company's Registration Statement on Form S-1 (Reg. No. 33-48056)) | ||
10.2 | Form of Amendment No. 1 to Registration Agreement, dated as of April 28, 1994 (incorporated by reference to Exhibit 10.3.1 to the Company's Registration Statement on Form S-1 (Reg. No. 33-61898)) | ||
10.3 | Form of KEMET Electronics Corporation Distributor Agreement (incorporated by reference to Exhibit 10.16 to the Company's Registration Statement on Form S-1 (Reg. No. 33-48056)) | ||
10.4 | Form of KEMET Electronics Corporation Standard Order Acknowledgment, Quotation, and Volume Purchase Agreement (incorporated by reference to Exhibit 10.17 to the Company's Registration Statement on Form S-1 (Reg. No. 33-48056)) | ||
10.5 | Form of KEMET Electronics Corporation Product Warranty (incorporated by reference to Exhibit 10.18 to the Company's Registration Statement on Form S-1 (Reg. No. 33-48056)) | ||
10.6 | 1995 Executive Stock Option Plan by and between the Company and each of the executives listed on the schedule attached thereto (incorporated by reference to Exhibit 10.33 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 1996)* | ||
10.7 | Executive Bonus Plan by and between the Company and each of the executives listed on the schedule attached thereto (incorporated by reference to Exhibit 10.34 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 1996)* | ||
10.8 | Amendment No. 3 to Services Agreement dated as of January 1, 1996, by and between the Company and KEMET Electronics Corporation (incorporated by reference to Exhibit 10.4.2 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 1996) | ||
10.9 | 1992 Key Employee Stock Option Plan (incorporated by reference to Exhibit 10.16 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2009)* | ||
10.10 | Amendment No. 1 to KEMET Corporation 1992 Key Employee Stock Option Plan effective October 23, 2000 (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended December 31, 2000)* | ||
10.11 | 2004 Long-Term Equity Incentive Plan (incorporated by reference to Exhibit 4.3 to the Company's Registration Statement on Form S-8 (Reg. No. 333-123308))* | ||
10.12 | Amendment to the Compensation Plan of the Chief Executive Officer and other executive officers effective May 3, 2006 (incorporated by reference to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 9, 2006)* | ||
54
10.13 | Amendment to the Compensation Plan of the Chief Executive Officer and other executive officers effective July 19, 2006 (incorporated by reference to the Company's Current Report on Form 8-K (File No. 1-15491) filed on July 25, 2006)* | ||
10.14 | Amendment to the Compensation Plan of the Chief Executive Officer and other executive officers effective March 28, 2007 (incorporated by reference to the Company's Current Report on Form 8-K (File No. 1-15491) filed on April 3, 2007)* | ||
10.15 | Amendment to the Compensation Plan of the Chief Executive Officer and other executive officers effective May 8, 2007 (incorporated by reference to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 15, 2007)* | ||
10.16 | Amendment to the Compensation Plan of the Chief Executive Officer and other executive officers effective May 16, 2007 (incorporated by reference to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 23, 2007)* | ||
10.17 | Amendment to the Compensation Plan of the Chief Executive Officer and other executive officers dated May 5, 2008 (incorporated by reference to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 12, 2008)* | ||
10.18 | Asset Purchase Agreement, dated as of September 15, 2008, by and between KEMET Electronics Corporation and Siliconix Technology C.V. (incorporated by reference to Exhibit 10.8 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended September 30, 2008) | ||
10.19 | Summary of Non-Employee Director Compensation (incorporated by reference to exhibit 10.35 to the Company's Annual Report on Form 10-K (File No. 1-15491), for the year ended March 31, 2012)* | ||
10.20 | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on April 23, 2009)* | ||
10.21 | Amendment to the Compensation Plan of the Company's executive officers (incorporated by reference to the Company's Current Report on Form 8-K (File No. 1-15491) filed on August 4, 2009)* | ||
10.22 | Warrant to Purchase Common Stock, dated June 30, 2009, issued by the Company to K Financing, LLC (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on June 30, 2009) | ||
10.23 | Investor Rights Agreement, dated June 30, 2009, between the Company and K Financing, LLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on June 30, 2009) | ||
10.24 | Corporate Advisory Services Agreement, dated June 30, 2009, between the Company and Platinum Equity Advisors, LLC (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on June 30, 2009) | ||
10.25 | Purchase Agreement, dated April 21, 2010, by and among the Company, certain subsidiary guarantors named therein and Banc of America Securities LLC, as representative of the several initial purchasers (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on April 22, 2010) | ||
10.26 | Employment Agreement between the Company and Per Olof-Lööf dated January 27, 2010 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on February 2, 2010)* | ||
10.27 | Amendment No. 1 to Employment Agreement between KEMET Corporation and Per Olof-Lööf, dated March 28, 2012 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on April 2, 2012)* | ||
10.28 | Second Amended and Restated KEMET Corporation Deferred Compensation Plan (incorporated by reference to Exhibit 10.56 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2009)* | ||
55
10.29 | Loan and Security Agreement, dated as of September 30, 2010, by and among KEMET Electronics Corporation, KEMET Electronics Marketing (S) Pte Ltd., and Bank of America, N.A., as agent and Banc of America Securities LLC, as lead arranger and bookrunner (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on October 5, 2010) | ||
10.30 | KEMET Executive Secured Benefit Plan (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended December 31, 2010)* | ||
10.31 | KEMET Corporation 2011 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on August 2, 2011)* | ||
10.32 | Form of Change in Control Severance Compensation Agreement entered into with executive officers of the Company (incorporated by reference to Exhibit 10.58 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2012)* | ||
10.33 | Option Agreement, dated as of March 12, 2012, by and among NEC Corporation and KEMET Electronics Corporation (incorporated by reference to Exhibit 99.3 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on March 15, 2012) | ||
10.34 | Stockholders' Agreement, dated as of March 12, 2012, by and among KEMET Electronics Corporation, NEC Corporation and NEC TOKIN Corporation (incorporated by reference to Exhibit 99.4 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on March 15, 2012) | ||
10.35 | Form of Restricted Stock Unit Grant Agreement for Employees (incorporated by reference to Exhibit 10.61 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2012)* | ||
10.36 | Form of Restricted Stock Unit Grant Agreement for Directors (incorporated by reference to Exhibit 10.62 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2012)* | ||
10.37 | Amendment No. 1 to Loan and Security Agreement, Waiver and Consent, dated as of March 19, 2012, by and among KEMET Electronics Corporation, KEMET Electronics Marketing (S) Pte Ltd., the financial institutions party thereto as lenders and Bank of America, N.A., as agent (incorporated by reference to Exhibit 10.63 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2012) | ||
10.38 | Development and Cross-Licensing Agreement between NEC TOKIN Corporation and KEMET Electronics Corporation (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 8, 2013) | ||
10.39 | Form of Long-Term Incentive Plan Award Agreement (incorporated by reference to Exhibit 10.39 to the Company's Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2013)* | ||
10.40 | Consolidated Amendment to Loan and Security Agreement, dated as of July 8, 2013, by and among KEMET Electronics Corporation, KEMET Foil Manufacturing, LLC, KEMET Blue Powder Corporation, KEMET Electronics Marketing (S) PTE LTD., the financial institutions party thereto as lenders and Bank of America, N.A., as agent (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491) filed on August 2, 2013) | ||
10.41 | Release Agreement, dated as of August 29, 2013, between KEMET Corporation and Marc Kotelon (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491)for the quarter ended September 30, 2013)* | ||
10.42 | Settlement Agreement, dated as of September 6, 2013, between KEMET Electronics SAS and Mark Kotelon (English translation) (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended September 30, 2013)* | ||
10.43 | Amendment No. 5 to Loan and Security Agreement, dated April 30, 2014, among KEMET Electronics Corporation and its subsidiaries KEMET Foil Manufacturing, LLC, KEMET Blue Powder Corporation, and KEMET Electronics Marketing (S) PTE LTD., as Borrowers, and Bank of America, N.A., as agent for the Lenders (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 5, 2014) | ||
56
18.1 | Preferability Letter (incorporated by reference to Exhibit 18.1 to the Company's Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended December 31, 2012) | ||
21.1 | Subsidiaries of KEMET Corporation | ||
23.1 | Consent of Independent Registered Public Accounting Firm, Ernst & Young LLP | ||
23.2 | Consent of Paumanok Publications, Inc. | ||
31.1 | Certification of the Chief Executive Officer Pursuant to Section 302 | ||
31.2 | Certification of the Chief Financial Officer Pursuant to Section 302 | ||
32.1 | Certification of the Chief Executive Officer Pursuant to Section 906 | ||
32.2 | Certification of the Chief Financial Officer Pursuant to Section 906 | ||
101 | The following financial information from KEMET Corporation's Annual Report on Form 10-K for the year ended March 31, 2013, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets at March 31, 2014, and March 31, 2013, (ii) Consolidated Statements of Income for the years ended March 31, 2014, 2013 and 2012, (iii) Consolidated Statements of Comprehensive Income for the years ended March 31, 2014, 2013 and 2012, (iv) Consolidated Statements of Changes in Stockholders' Equity for the years ended March 31, 2014, 2013 and 2011, (v) Consolidated Statements of Cash Flows for the years ended March 31, 2013, 2012 and 2012 and (vi) the Notes to Condensed Consolidated Financial Statements, tagged as blocks of text | ||
_______________________________________________________________________________
* | Exhibit is a management contract or a compensatory plan or arrangement. |
57
Report of Independent Registered Public Accounting Firm
The Board of Directors and Stockholders of KEMET Corporation
We have audited the accompanying consolidated balance sheets of KEMET Corporation and subsidiaries as of March 31, 2014 and 2013, and the related consolidated statements of operations, comprehensive income (loss), stockholders' equity, and cash flows for the three years in the period ended March 31, 2014. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of KEMET Corporation and subsidiaries at March 31, 2014 and 2013, and the consolidated results of their operations and their cash flows for the three years ended March 31, 2014, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), KEMET Corporation's internal control over financial reporting as of March 31, 2014, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 framework) and our report dated May 30, 2014 expressed an unqualified opinion thereon.
/s/ Ernst & Young LLP | ||
Greenville, South Carolina
May 30, 2014
58
Report of Independent Registered Public Accounting Firm
The Board of Directors and Stockholders of KEMET Corporation
We have audited KEMET Corporation and subsidiaries' internal control over financial reporting as of March 31, 2014, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 framework) (the COSO criteria). KEMET Corporation and subsidiaries' management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Managements' Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the company's internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company's assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, KEMET Corporation and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of March 31, 2014, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of KEMET Corporation and subsidiaries as of March 31, 2014 and 2013, and the related consolidated statements of operations, comprehensive income (loss), stockholders' equity and cash flows for each of the three years in the period ended March 31, 2014 of KEMET Corporation and subsidiaries and our report dated May 30, 2014 expressed an unqualified opinion thereon.
/s/ Ernst & Young LLP | ||
Greenville, South Carolina
May 30, 2014
59
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(Amounts in thousands except per share data)
March 31, | ||||||||
2014 | 2013 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 57,929 | $ | 95,978 | ||||
Accounts receivable, net | 98,947 | 93,774 | ||||||
Inventories, net | 187,974 | 198,888 | ||||||
Prepaid and other current assets | 36,871 | 41,101 | ||||||
Deferred income taxes | 6,695 | 4,167 | ||||||
Current assets of discontinued operations | 12,160 | 9,517 | ||||||
Total current assets | 400,576 | 443,425 | ||||||
Property, plant and equipment, net | 292,648 | 303,682 | ||||||
Goodwill | 35,584 | 35,584 | ||||||
Intangible assets, net | 37,184 | 38,646 | ||||||
Investment in NEC TOKIN | 46,419 | 52,738 | ||||||
Restricted cash | 13,512 | 17,397 | ||||||
Deferred income taxes | 6,778 | 7,994 | ||||||
Other assets | 10,130 | 10,149 | ||||||
Noncurrent assets of discontinued operations | 836 | 1,976 | ||||||
Total assets | $ | 843,667 | $ | 911,591 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Current portion of long-term debt | $ | 7,297 | $ | 10,793 | ||||
Accounts payable | 74,818 | 70,774 | ||||||
Accrued expenses | 76,468 | 93,178 | ||||||
Income taxes payable and deferred income taxes | 980 | 1,074 | ||||||
Current liabilities of discontinued operations | 7,269 | 5,661 | ||||||
Total current liabilities | 166,832 | 181,480 | ||||||
Long-term debt | 391,292 | 372,707 | ||||||
Other non-current obligations | 55,864 | 69,022 | ||||||
Deferred income taxes | 5,203 | 8,542 | ||||||
Noncurrent liabilities of discontinued operations | 2,592 | 2,924 | ||||||
Commitments and contingencies | ||||||||
Stockholders' equity: | ||||||||
Preferred stock, par value $0.01, authorized 10,000 shares, none issued | — | — | ||||||
Common stock, par value $0.01, authorized 175,000 shares, issued 46,508 shares at March 31, 2014 and 2013 | 465 | 465 | ||||||
Additional paid-in capital | 465,027 | 467,096 | ||||||
Retained deficit | (231,738 | ) | (163,235 | ) | ||||
Accumulated other comprehensive income | 18,184 | 7,694 | ||||||
Treasury stock, at cost (1,301 and 1,519 shares at March 31, 2014 and 2013, respectively) | (30,054 | ) | (35,104 | ) | ||||
Total stockholders' equity | 221,884 | 276,916 | ||||||
Total liabilities and stockholders' equity | $ | 843,667 | $ | 911,591 | ||||
See accompanying notes to consolidated financial statements.
60
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
(Amounts in thousands except per share data)
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Net sales | $ | 833,666 | $ | 823,903 | $ | 924,052 | ||||||
Operating costs and expenses: | ||||||||||||
Cost of sales | 712,925 | 697,076 | 731,312 | |||||||||
Selling, general and administrative expenses | 95,856 | 107,620 | 106,534 | |||||||||
Research and development | 24,466 | 26,876 | 27,765 | |||||||||
Restructuring charges | 14,122 | 18,719 | 14,254 | |||||||||
Write down of long-lived assets | 4,476 | 7,582 | 15,786 | |||||||||
Goodwill impairment | — | 1,092 | — | |||||||||
Net loss on sales and disposals of assets | 32 | 18 | 318 | |||||||||
Total operating costs and expenses | 851,877 | 858,983 | 895,969 | |||||||||
Operating (loss) income | (18,211 | ) | (35,080 | ) | 28,083 | |||||||
Other (income) expense: | ||||||||||||
Interest income | (195 | ) | (139 | ) | (175 | ) | ||||||
Interest expense | 40,962 | 41,331 | 28,567 | |||||||||
Other (income) expense, net | (2,681 | ) | (2,295 | ) | 965 | |||||||
Loss from continuing operations before income taxes and equity loss from NEC TOKIN | (56,297 | ) | (73,977 | ) | (1,274 | ) | ||||||
Income tax expense | 1,482 | 3,281 | 1,076 | |||||||||
Loss from continuing operations before equity loss from NEC TOKIN | (57,779 | ) | (77,258 | ) | (2,350 | ) | ||||||
Equity loss from NEC TOKIN | (7,090 | ) | (1,254 | ) | — | |||||||
Loss from continuing operations | (64,869 | ) | (78,512 | ) | (2,350 | ) | ||||||
Income (loss) from discontinued operations | (3,634 | ) | (3,670 | ) | 9,042 | |||||||
Net income (loss) | $ | (68,503 | ) | $ | (82,182 | ) | $ | 6,692 | ||||
Net income (loss) per basic share: | ||||||||||||
Loss from continuing operations | $ | (1.44 | ) | $ | (1.75 | ) | $ | (0.05 | ) | |||
Income (loss) from discontinued operations | $ | (0.08 | ) | $ | (0.08 | ) | $ | 0.21 | ||||
Net income (loss) | $ | (1.52 | ) | $ | (1.83 | ) | $ | 0.16 | ||||
Net income (loss) per diluted share: | ||||||||||||
Loss from continuing operations | $ | (1.44 | ) | $ | (1.75 | ) | $ | (0.04 | ) | |||
Income (loss) from discontinued operations | $ | (0.08 | ) | $ | (0.08 | ) | $ | 0.17 | ||||
Net income (loss) | $ | (1.52 | ) | $ | (1.83 | ) | $ | 0.13 | ||||
Weighted-average shares outstanding: | ||||||||||||
Basic | 45,102 | 44,897 | 43,285 | |||||||||
Diluted | 45,102 | 44,897 | 52,320 | |||||||||
See accompanying notes to consolidated financial statements.
61
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income (Loss)
(Amounts in thousands)
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Net income (loss) | $ | (68,503 | ) | $ | (82,182 | ) | $ | 6,692 | ||||
Other comprehensive income (loss): | ||||||||||||
Foreign currency translation gains (losses), net of tax | 9,797 | (4,569 | ) | (8,969 | ) | |||||||
Defined benefit pension plans, net of tax impact | 276 | 420 | (1,449 | ) | ||||||||
Defined benefit post-retirement plan adjustments | (354 | ) | (177 | ) | (117 | ) | ||||||
Equity interest in investee's other comprehensive loss | 771 | — | — | |||||||||
Other comprehensive income (loss) | 10,490 | (4,326 | ) | (10,535 | ) | |||||||
Total comprehensive loss | $ | (58,013 | ) | $ | (86,508 | ) | $ | (3,843 | ) | |||
See accompanying notes to consolidated financial statements.
62
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Changes in Stockholders' Equity
(Amounts in thousands)
Shares Outstanding | Common Stock | Additional Paid-In Capital | Retained Deficit | Accumulated Other Comprehensive Income (Loss) | Treasury Stock | Total Stockholders' Equity | |||||||||||||||||||||
Balance at March 31, 2011 | 37,138 | $ | 395 | $ | 479,322 | $ | (87,745 | ) | $ | 22,555 | $ | (54,774 | ) | $ | 359,753 | ||||||||||||
Net income | — | — | — | 6,692 | — | — | 6,692 | ||||||||||||||||||||
Other comprehensive income | — | — | — | — | (10,535 | ) | — | (10,535 | ) | ||||||||||||||||||
Issuance of restricted shares | 398 | — | (9,483 | ) | — | — | 9,204 | (279 | ) | ||||||||||||||||||
Stock-based compensation expense | — | — | 3,075 | — | — | — | 3,075 | ||||||||||||||||||||
Issuance of shares to K Equity, LLC | 7,000 | 70 | (70 | ) | — | — | — | — | |||||||||||||||||||
Exercise of stock options | 133 | — | (2,785 | ) | — | — | 3,075 | 290 | |||||||||||||||||||
Balance at March 31, 2012 | 44,669 | 465 | 470,059 | (81,053 | ) | 12,020 | (42,495 | ) | 358,996 | ||||||||||||||||||
Net loss | — | — | — | (82,182 | ) | — | — | (82,182 | ) | ||||||||||||||||||
Other comprehensive loss | — | — | — | — | (4,326 | ) | — | (4,326 | ) | ||||||||||||||||||
Issuance of restricted shares | 270 | — | (6,511 | ) | — | — | 6,229 | (282 | ) | ||||||||||||||||||
Stock-based compensation expense | — | — | 4,599 | — | — | — | 4,599 | ||||||||||||||||||||
Exercise of stock options | 50 | — | (1,051 | ) | — | — | 1,162 | 111 | |||||||||||||||||||
Balance at March 31, 2013 | 44,989 | 465 | 467,096 | (163,235 | ) | 7,694 | (35,104 | ) | 276,916 | ||||||||||||||||||
Net loss | — | — | — | (68,503 | ) | — | — | (68,503 | ) | ||||||||||||||||||
Other comprehensive income | — | — | — | — | 10,490 | — | 10,490 | ||||||||||||||||||||
Issuance of restricted shares | 129 | — | (3,164 | ) | — | — | 2,986 | (178 | ) | ||||||||||||||||||
Stock-based compensation expense | — | — | 2,909 | — | — | — | 2,909 | ||||||||||||||||||||
Exercise of stock options | 89 | — | (1,814 | ) | — | — | 2,064 | 250 | |||||||||||||||||||
Balance at March 31, 2014 | 45,207 | $ | 465 | $ | 465,027 | $ | (231,738 | ) | $ | 18,184 | $ | (30,054 | ) | $ | 221,884 | ||||||||||||
See accompanying notes to consolidated financial statements.
63
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Amounts in thousands)
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Sources (uses) of cash and cash equivalents | ||||||||||||
Operating activities: | ||||||||||||
Net income (loss) | $ | (68,503 | ) | $ | (82,182 | ) | $ | 6,692 | ||||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||||||||
Net cash provided by operating activities of discontinued operations | 336 | 4,828 | 1,774 | |||||||||
Depreciation and amortization | 49,527 | 45,158 | 43,401 | |||||||||
Amortization of debt discount and debt issuance costs | 3,596 | 4,138 | 3,599 | |||||||||
Equity loss from NEC TOKIN | 7,090 | 1,254 | — | |||||||||
Change in value of NEC TOKIN options | (3,111 | ) | — | — | ||||||||
Net loss on sales and disposals of assets | 32 | 18 | 318 | |||||||||
Stock-based compensation expense | 2,909 | 4,599 | 3,075 | |||||||||
Pension and other post-retirement benefits | (78 | ) | 1,071 | (2,991 | ) | |||||||
Deferred income taxes | (6,369 | ) | (317 | ) | (4,554 | ) | ||||||
Write down of long-lived assets | 4,476 | 7,582 | 15,786 | |||||||||
Write down of receivables | 1,484 | — | — | |||||||||
Goodwill impairment | — | 1,092 | — | |||||||||
Other, net | (521 | ) | 566 | 700 | ||||||||
Changes in assets and liabilities: | ||||||||||||
Accounts receivable | (4,618 | ) | 4,882 | 42,603 | ||||||||
Inventories | 14,891 | (323 | ) | (1,385 | ) | |||||||
Prepaid expenses and other assets | 3,748 | (11,151 | ) | (3,494 | ) | |||||||
Accounts payable | (2,070 | ) | 300 | (15,829 | ) | |||||||
Accrued income taxes | 172 | (1,052 | ) | (1,893 | ) | |||||||
Other operating liabilities | (9,737 | ) | (3,290 | ) | (7,072 | ) | ||||||
Net cash (used in) provided by operating activities | (6,746 | ) | (22,827 | ) | 80,730 | |||||||
Investing activities: | ||||||||||||
Capital expenditures | (32,147 | ) | (46,174 | ) | (49,314 | ) | ||||||
Investment in NEC TOKIN (excludes non cash investment) | — | (50,917 | ) | — | ||||||||
Change in restricted cash | 4,047 | (15,284 | ) | — | ||||||||
Acquisitions, net of cash received | — | — | (42,613 | ) | ||||||||
Proceeds from sales of assets | 2,847 | 398 | 74 | |||||||||
Net cash used in investing activities | (25,253 | ) | (111,977 | ) | (91,853 | ) | ||||||
64
Consolidated Statements of Cash Flows (Continued)
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Financing activities: | ||||||||||||
Proceeds from revolving line of credit | 21,000 | — | — | |||||||||
Payments of revolving line of credit | (2,551 | ) | — | — | ||||||||
Proceeds from issuance of debt | — | 39,825 | 116,050 | |||||||||
Deferred acquisition payments | (21,977 | ) | (16,900 | ) | — | |||||||
Payment of long-term debt | (3,599 | ) | (1,909 | ) | (40,581 | ) | ||||||
Net (payments) borrowings under other credit facilities | — | — | (3,154 | ) | ||||||||
Debt issuance costs | — | (275 | ) | (2,313 | ) | |||||||
Proceeds from exercise of stock options | 250 | 111 | 290 | |||||||||
Net cash provided by (used in) financing activities | (6,877 | ) | 20,852 | 70,292 | ||||||||
Net (decrease) increase in cash and cash equivalents | (38,876 | ) | (113,952 | ) | 59,169 | |||||||
Effect of foreign currency fluctuations on cash | 827 | (591 | ) | (699 | ) | |||||||
Cash and cash equivalents at beginning of fiscal year | 95,978 | 210,521 | 152,051 | |||||||||
Cash and cash equivalents at end of fiscal year | $ | 57,929 | $ | 95,978 | $ | 210,521 | ||||||
Supplemental Cash Flow Statement Information: | ||||||||||||
Interest paid, net of capitalized interest | $ | 38,809 | $ | 32,232 | $ | 25,342 | ||||||
Income taxes paid | 5,521 | 6,029 | 7,078 | |||||||||
See accompanying notes to consolidated financial statements.
65
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
Note 1: Organization and Significant Accounting Policies
Nature of Business and Organization
KEMET Corporation, which together with its subsidiaries is referred to herein as "KEMET" or the "Company" is a leading manufacturer of tantalum capacitors, multilayer ceramic capacitors, film capacitors, electrolytic capacitors, paper capacitors and solid aluminum capacitors. The Company is headquartered in Simpsonville, South Carolina, which is part of the greater Greenville metropolitan area, and has manufacturing plants and distribution centers located in the United States, Mexico, Europe and Asia. Additionally, the Company has wholly-owned foreign subsidiaries which primarily provide sales support for KEMET's products in foreign markets.
KEMET is organized into two business groups: the Solid Capacitor Business Group ("Solid Capacitors") and the Film and Electrolytic Business Group ("Film and Electrolytic"). Each business group is responsible for the operations of certain manufacturing sites as well as all related research and development efforts. The business groups are responsible for their respective manufacturing sites as well as their respective research and development efforts.
Consistent with management reporting, the Company does not allocate indirect Selling, general and administrative (“SG&A”) and Research and development (“R&D”) expenses to the business groups. Prior period information has been reclassified to conform to current year presentation.
Basis of Presentation
Certain amounts for fiscal years 2013 and 2012 have been reclassified to conform to the fiscal year 2014 classification of the machinery division as a discontinued operation.
Principles of Consolidation
The accompanying consolidated financial statements of the Company include the accounts of its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investment in entities in which the Company can exercise significant influence, but does not own a majority equity interest or otherwise control, are accounted for using the equity method and are included as investments in equity interests on the consolidated balance sheets.
Cash Equivalents
Cash equivalents of $0.7 million and $30.0 million at March 31, 2014 and 2013, respectively, consist of money market accounts with an original term of three months or less. The Company considers all highly liquid debt instruments with original maturities of three months or less to be cash equivalents.
Restricted Cash
As discussed in Note 2, "Debt", the Company received a $24.0 million prepayment from an original equipment manufacturer ("OEM"), the remaining proceeds of $11.2 million is classified as restricted cash at March 31, 2014.
A guarantee was issued by a European bank on behalf of the Company in August 2006 in conjunction with the establishment of a Value-Added Tax ("VAT") registration in The Netherlands.
The bank guarantee is in the amount of €1.5 million ($2.1 million). An interest-bearing deposit was placed with a European bank for €1.7 million ($2.3 million). The deposit is in KEMET's name and KEMET receives all interest earned by this deposit. However, the deposit is pledged to the European bank, and the bank can use the money should a valid claim be made. The bank guarantee will remain valid until it is discharged by the beneficiary.
Inventories
Inventories are stated at the lower of cost or market. The carrying value of inventory is reviewed and adjusted based on slow moving and obsolete items, historical shipments, customer forecasts and backlog and technology developments. Inventory costs include material, labor and manufacturing overhead and most inventory costs are determined by the "first-in, first-out" ("FIFO") method. For tool crib, a component of the Company's raw material inventory, cost is determined under the average cost method. The Company has consigned inventory at certain customer locations totaling $9.2 million and $10.8 million at March 31, 2014 and 2013, respectively.
66
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 1: Organization and Significant Accounting Policies (Continued)
Property and Equipment
Property and equipment are carried at cost. Depreciation is calculated principally using the straight-line method over the estimated useful lives of the respective assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful lives of the assets or the terms of the respective leases. Maintenance costs are expensed; expenditures for renewals and improvements are generally capitalized. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed and any gain or loss is recognized. A long-lived asset classified as held for sale is initially measured and reported at the lower of its carrying amount or fair value less cost to sell. Long-lived assets to be disposed of other than by sale are classified as held and used until the long-lived asset is disposed of. Depreciation expense was $47.5 million, $43.0 million and $41.6 million for the fiscal years ended March 31, 2014, 2013 and 2012, respectively.
The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Reviews are regularly performed to determine whether facts and circumstances exist which indicate the carrying amount of assets may not be recoverable. The Company assesses the recoverability of its assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. If it is determined that the book value of a long-lived asset or asset group is not recoverable, an impairment loss would be calculated equal to the excess of the carrying amount of the long-lived asset over its fair value. The fair value is calculated as the discounted cash flows of the underlying assets or appraisal values. The Company has to make certain assumptions as to the future cash flows to be generated by the underlying assets. Those assumptions include the amount of volume increases, average selling price decreases, anticipated cost reductions, and the estimated remaining useful life of the equipment. Future changes in assumptions may negatively impact future valuations. Fair market value is based on the undiscounted cash flows that the assets will generate over their remaining useful lives or other valuation techniques. In future tests for recoverability, adverse changes in undiscounted cash flow assumptions could result in an impairment of certain long-lived assets that would require a non-cash charge to the Consolidated Statements of Operations and may have a material effect on the Company's financial condition and operating results. The Company recorded $4.5 million, $7.3 million and $15.8 million in property, plant and equipment impairment charges for fiscal years 2014, 2013 and 2012, respectively.
Goodwill
Goodwill and other intangible assets with indefinite useful lives are not amortized but are subject to annual impairment tests during the first quarter of each fiscal year and when otherwise warranted. The Company evaluates its goodwill and intangible assets with indefinite useful lives on a reporting unit basis which requires the Company to estimate the fair value of the reporting units based on the future net cash flows expected to be generated. The impairment test involves a comparison of the fair value of each reporting unit, with the corresponding carrying amounts. If the reporting unit's carrying amount exceeds its fair value, then an indication exists that the reporting unit's goodwill and intangible asset with indefinite useful lives may be impaired. The impairment to be recognized is measured by the amount by which the carrying value of the reporting unit's goodwill being measured exceeds its implied fair value. The implied fair value of goodwill is the excess of the fair value of the reporting unit over the sum of the amounts assigned to identified net assets. As a result, the implied fair value of goodwill is generally the residual amount that results from subtracting the value of net assets including all tangible assets and identified intangible assets from the fair value of the reporting unit's fair value. The Company determined the fair value of its reporting units using an income-based, discounted cash flow ("DCF") analysis, and market-based approaches (Guideline Publicly Traded Company Method and Guideline Transaction Method) which examine transactions in the marketplace involving the sale of the stocks of similar publicly owned companies, or the sale of entire companies engaged in operations similar to KEMET. In addition to the above described reporting unit valuation techniques, the Company's goodwill and intangible asset with indefinite useful lives impairment assessment also considers the Company's aggregate fair value based upon the value of the Company's outstanding shares of common stock.
The impairment review of goodwill and intangible assets with indefinite useful lives are highly subjective and involve the use of significant estimates and assumptions in order to calculate the impairment charges. Estimates of business enterprise fair value use discounted cash flow and other fair value appraisal models and involve making assumptions for future sales trends, market conditions, growth rates, cost reduction initiatives and cash flows for the next several years. Future changes in assumptions may negatively impact future valuations.
67
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 1: Organization and Significant Accounting Policies (Continued)
Equity Method Investment
Investments and ownership interests are accounted for under the equity method of accounting if the Company has the ability to exercise significant influence, but not control, over the entity. Investments accounted for under the equity method are initially recorded at cost, and the difference between the basis of the Company's investment and the underlying equity in the net assets of NEC TOKIN at the investment date, if any, is amortized over the lives of the related assets that gave rise to the difference. The Company's share of earnings or losses under the equity method investments and basis difference amortization is reported in the consolidated statements of operations as "Equity loss from NEC TOKIN." The Company reviews its investments and ownership interests accounted for under the equity method of accounting for impairment whenever events or changes in circumstances indicate a loss in the value of the investment may be other than temporary.
Deferred Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in fiscal years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets unless it is more likely than not that such assets will be realized.
Stock-based Compensation
Stock-based compensation for stock options is estimated on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes model takes into account volatility in the price of the Company's stock, the risk-free interest rate, the estimated life of the equity-based award, the closing market price of the Company's stock on the grant date and the exercise price. The estimates utilized in the Black-Scholes calculation involve inherent uncertainties and the application of management judgment. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those options expected to vest. Stock-based compensation cost for restricted stock is measured based on the closing fair market value of the Company's common stock on the date of grant. The Company recognizes stock-based compensation cost for arrangements with cliff vesting as expense ratably on a straight-line basis over the requisite service period. The Company recognizes stock-based compensation cost for arrangements with graded vesting as expense on an accelerated basis over the requisite service period.
Concentrations of Credit and Other Risks
The Company sells to customers globally. Credit evaluations of its customers' financial condition are performed periodically, and the Company generally does not require collateral from its customers. One customer, TTI, Inc., an electronics distributor, accounted for $128.4 million, $127.8 million and $125.6 million of the Company's net sales in fiscal years 2014, 2013 and 2012, respectively. There were no customers' accounts receivable balances exceeding 10% of gross accounts receivable at March 31, 2014 or March 31, 2013.
Consistent with industry practice, the Company utilizes electronics distributors for a large percentage of its sales. Electronics distributors are an effective means to distribute the products to the end-users. For fiscal years ended March 31, 2014, 2013, and 2012, net sales to electronics distributors accounted for 45%, 46% and 45%, respectively, of the Company's total net sales.
Foreign Subsidiaries
Financial statements of certain of the Company's foreign subsidiaries are prepared using the U.S. dollar as their functional currency. Translation of these foreign operations, as well as gains and losses from non-U.S. dollar foreign currency transactions, such as those resulting from the settlement of foreign receivables or payables, are reported in the Consolidated Statements of Operations.
Translation of other foreign operations to U.S. dollars occurs using the current exchange rate for balance sheet accounts and an average exchange rate for results of operations. Such translation gains or losses are recognized as a component of equity in accumulated other comprehensive income ("AOCI").
68
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 1: Organization and Significant Accounting Policies (Continued)
Comprehensive Income (Loss)
Comprehensive income (loss) consists of net income (losses), currency translation gains (losses), defined benefit plan adjustments including those adjustments which result from changes in net prior service credit and actuarial gains (losses), equity interest in investee's other comprehensive income (loss) and is presented in the Consolidated Statements of Comprehensive Income (Loss).
The following summary sets forth the components of accumulated other comprehensive income (loss) contained in the stockholders' equity section of the Consolidated Balance Sheets (amounts in thousands):
Foreign Currency Translation Gains (Losses) | Defined Benefit Post-retirement Plan Adjustments | Defined Benefit Pension Plans (3) | Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) | Net Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||
Balance at March 31, 2012 | $ | 18,107 | $ | 1,995 | $ | (8,082 | ) | $ | — | $ | 12,020 | |||||||||
Fiscal year 2013 activity(1) | (4,569 | ) | (177 | ) | 420 | — | (4,326 | ) | ||||||||||||
Balance at March 31, 2013 | 13,538 | 1,818 | (7,662 | ) | — | 7,694 | ||||||||||||||
Fiscal year 2014 activity(2) | 9,797 | (354 | ) | 276 | 771 | 10,490 | ||||||||||||||
Balance at March 31, 2014 | $ | 23,335 | $ | 1,464 | $ | (7,386 | ) | $ | 771 | $ | 18,184 | |||||||||
_______________________________________________________________________________
(1) | Activity within the defined benefit pension plans is net of a tax benefit of $0.7 million. |
(2) | Activity within foreign currency translation gains and defined benefit pension plans are net of a tax benefit of $1.9 million and $0.1 million, respectively. |
(3) | Balance is net of a tax benefit of $2.2 million, $2.1 million, and $2.8 million as of March 31, 2014, March 31, 2013, and March 31, 2012, respectively. |
Warrant Liability
Concurrent with the consummation of a credit facility, the Company issued K Financing, LLC ("K Financing") a warrant (the "Platinum Warrant") to purchase up to 26,848,484 shares of the Company's common stock, subject to certain adjustments, representing approximately 49.9% of the Company's outstanding common stock at the time of issuance on a post-exercise basis. The Platinum Warrant was subsequently transferred to K Equity, LLC ("K Equity"). The Platinum Warrant is exercisable at a purchase price of $1.05 per share. The Platinum Warrant may be exercised in exchange for cash, by means of net settlement of a corresponding portion of amounts owed by the Company under the Revised Amended and Restated Platinum Credit Facility, by cashless exercise to the extent of appreciation in the value of the Company's common stock above the exercise price of the Platinum Warrant, or by combination of the preceding alternatives.
Warrants may be classified as assets or liabilities (derivative accounting), temporary equity, or permanent equity, depending on the terms of the specific warrant agreement. The Platinum Warrant issued to K Financing under the Platinum Credit Facility (as defined below) does not meet the definition of a derivative as it is indexed to the Company's own stock, as such; the Platinum Warrant is classified as a component of equity.
There were 8,416,815 shares subject to the Platinum Warrant as of March 31, 2014.
Fair Value Measurement
The Company utilizes three levels of inputs to measure the fair value of (a) nonfinancial assets and liabilities that are recognized or disclosed at fair value in the Company's consolidated financial statements on a recurring basis (at least annually) and (b) all financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.
The first two inputs are considered observable and the last is considered unobservable. The levels of inputs are as follows:
• | Level 1—Quoted prices in active markets for identical assets or liabilities. |
69
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 1: Organization and Significant Accounting Policies (Continued)
• | Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. |
Assets measured at fair value on a recurring basis as of March 31, 2014 and 2013 are as follows (amounts in thousands):
Carrying Value March 31, 2014 | Fair Value March 31, 2014 | Fair Value Measurement Using | Carrying Value March 31, 2013 | Fair Value March 31, 2013 | Fair Value Measurement Using | |||||||||||||||||||||||||||||||||||
Level 1 | Level 2(2) | Level 3 | Level 1 | Level 2(2) | Level 3 | |||||||||||||||||||||||||||||||||||
Assets: | ||||||||||||||||||||||||||||||||||||||||
Money markets(1) | $ | 714 | $ | 714 | $ | 714 | $ | — | $ | — | $ | 29,984 | $ | 29,984 | $ | 29,984 | $ | — | $ | — | ||||||||||||||||||||
Total debt | 398,589 | 409,284 | 371,863 | 37,421 | — | 383,500 | 393,928 | 369,200 | 24,728 | — | ||||||||||||||||||||||||||||||
NEC TOKIN options, net (3) | 3,600 | 3,600 | — | — | 3,600 | 489 | 489 | — | — | 489 | ||||||||||||||||||||||||||||||
_______________________________________________________________________________
(1) | Included in the line item "Cash and cash equivalents" on the Consolidated Balance Sheets. |
(2) | The valuation approach used to calculate fair value was a discounted cash flow for each respective debt facility. |
(3) | See Note 8, "Investment in NEC TOKIN," for a description of the NEC TOKIN options. The value of the options is interrelated and depends on the enterprise value of NEC TOKIN Corporation and its EBITDA over the duration of the instruments. Therefore, the options have been valued using option pricing methods in a Monte Carlo simulation. |
The table below summarizes NEC TOKIN option valuation activity using significant unobservable inputs (Level 3) (amounts in thousand):
March 31, 2013 | $ | 489 | |
Change in value of NEC TOKIN option | 3,111 | ||
March 31, 2014 | $ | 3,600 | |
Revenue Recognition
The Company ships products to customers based upon firm orders and revenue is recognized when the sales process is complete. This occurs when products are shipped to the customer in accordance with the terms of an agreement of sale, there is a fixed or determinable selling price, title and risk of loss have been transferred and collectability is reasonably assured. Shipping and handling costs are included in cost of sales.
A portion of sales is related to products designed to meet customer specific requirements. These products typically have stricter tolerances making them useful to the specific customer requesting the product and to customers with similar or less stringent requirements. The Company recognizes revenue when title to the products transfers to the customer.
A portion of sales is made to distributors under agreements allowing certain rights of return and price protection on unsold merchandise held by distributors. The Company's distributor policy includes inventory price protection and "ship-from-stock and debit" ("SFSD") programs common in the industry.
KEMET's SFSD program provides authorized distributors with the flexibility to meet marketplace prices by allowing them, upon a case-by-case pre-approved basis, to adjust their purchased inventory cost to correspond with current market demand. Requests for SFSD adjustments are considered on an individual basis, require a pre-approved cost adjustment quote from their local KEMET sales representative and apply only to a specific customer, part, a specified special price amount, a specified quantity, and is only valid for a specific period of time. To estimate potential SFSD adjustments corresponding with current period sales, KEMET records a sales reserve based on historical SFSD credits, distributor inventory levels, and certain accounting assumptions, all of which are reviewed quarterly.
70
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 1: Organization and Significant Accounting Policies (Continued)
Most of the Company's distributors have the right to return to KEMET a certain portion of the purchased inventory, which, in general, does not exceed 6% of their purchases from the previous fiscal quarter. KEMET estimates future returns based on historical patterns of the distributors and records an allowance on the Consolidated Balance Sheets. The Company also offers volume based rebates.
The establishment of sales allowances is recognized as a component of the line item "Net sales" on the Consolidated Statements of Operations, while the associated reserves are included in the line item "Accounts receivable, net" on the Consolidated Balance Sheets. Estimates used in determining sales allowances are subject to various factors. This includes, but is not limited to, changes in economic conditions, pricing changes, product demand, inventory levels in the supply chain, the effects of technological change, and other variables that might result in changes to the Company's estimates.
The Company provides a limited warranty to its customers that the products meet certain specifications. The warranty period is generally limited to one year, and the Company's liability under the warranty is generally limited to a replacement of the product or refund of the purchase price of the product. Warranty costs were less than 1% of net sales for the fiscal years ended March 31, 2014, 2013 and 2012. The Company recognizes warranty costs when losses are both probable and reasonably estimable.
Allowance for Doubtful Accounts
The Company evaluates the collectability of trade receivables through the analysis of customer accounts. When the Company becomes aware that a specific customer has filed for bankruptcy, has begun closing or liquidation proceedings, has become insolvent or is in financial distress, the Company records a specific allowance for the doubtful account to reduce the related receivable to the amount the Company believes is collectible. If circumstances related to specific customers change, the Company's estimates of the recoverability of receivables could be adjusted. Accounts are written off after all means of collection, including legal action, have been exhausted.
Shipping and Handling Costs
The Company's shipping and handling costs are reflected in the line item "Cost of sales" on the Consolidated Statements of Operations. Shipping and handling costs were $19.9 million, $21.1 million, and $22.8 million in the fiscal years ended March 31, 2014, 2013 and 2012, respectively.
Income (Loss) per Share
Basic income (loss) per share is computed using the weighted-average number of shares outstanding. Diluted income (loss) per share is computed using the weighted-average number of shares outstanding adjusted for the incremental shares attributed to the Platinum Warrant, outstanding options to purchase common stock and for any put options issued by the Company, if such effects are dilutive.
Environmental Cost
The Company recognizes liabilities for environmental remediation when it is probable that a liability has been incurred and can be reasonably estimated. The Company determines its liability on a site-by-site basis, and it is not discounted or reduced for anticipated recoveries from insurance carriers. In the event of anticipated insurance recoveries, such amounts would be presented on a gross basis in other current or non-current assets, as appropriate. Expenditures that extend the life of the related property or mitigate or prevent future environmental contamination are capitalized.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make a number of estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include impairment of property and equipment, intangibles and goodwill; valuation allowances for accounts receivables, price protection and customers' returns, and deferred income taxes; and assets and obligations related to employee benefits. Actual results could differ from these estimates and assumptions.
71
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 1: Organization and Significant Accounting Policies (Continued)
Impact of Recently Issued Accounting Standards
In April 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU 2014-08). ASU 2014-08 changes the definition of a discontinued operations and modifies related disclosure requirements. The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. This new guidance is not expected to have a material impact on the Company's Consolidated Financial Statements.
In July 2013, the FASB issued ASU No. 2013-11, Income Taxes (Topic 740). ASU 2013-11 requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013, with early adoption permitted. ASU 2013-11 was effective for the Company on January 1, 2014 and did not have a material effect on the Company's net income or other comprehensive income in the financial statements, the Company's financial position, results of operations or cash flows.
In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830). The ASU revised the authoritative guidance on accounting for cumulative translation adjustment specifying that a cumulative translation adjustment should be released into earnings when an entity ceases to have a controlling financial interest in a subsidiary or a group of assets within a consolidated foreign entity and the sale or transfer results in the complete or substantially complete liquidation of the foreign entity. For sales of an equity method investment that is a foreign entity, a pro rata portion of cumulative translation adjustment attributable to the investment would be recognized in earnings upon sale of the investment. The guidance is effective for fiscal years beginning after December 15, 2013. The Company does not expect the adoption of this guidance to have a material impact on its financial position, results of operations, comprehensive income or liquidity.
In February 2013, the FASB issued ASU 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income ("ASU 2013-02"). ASU 2013-02 requires registrants to provide information about the amounts reclassified out of AOCI by component. In addition, an entity is required to present significant amounts reclassified out of AOCI by the respective line items of net income. ASU 2013-02 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2012. ASU 2013-02 was effective for the Company on April 1, 2013 and did not have a material effect on the Company's net income or other comprehensive income in the financial statements, the Company's financial position, results of operations or cash flows.
There are currently no other accounting standards that have been issued that may have a significant impact on the Company's financial position, results of operations or cash flows upon adoption.
Note 2: Debt
A summary of debt is as follows (amounts in thousands):
March 31, | ||||||||
2014 | 2013 | |||||||
10.5% Senior Notes, net of premium of $3,144 and $3,773 as of March 31, 2014 and 2013, respectively | $ | 358,144 | $ | 358,773 | ||||
Advanced payment from OEM, net of discount of $323 and $1,056 as of March 31, 2014 and 2013, respectively | 20,095 | 22,944 | ||||||
Revolving line of credit | 18,449 | — | ||||||
Other | 1,901 | 1,783 | ||||||
Total debt | 398,589 | 383,500 | ||||||
Current maturities, net of discount of $278 and $440 as of March 31, 2014 and 2013, respectively | (7,297 | ) | (10,793 | ) | ||||
Total long-term debt | $ | 391,292 | $ | 372,707 | ||||
72
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 2: Debt (Continued)
The line item "Interest expense" on the Consolidated Statements of Operations for the fiscal years 2014, 2013 and 2012, respectively, is as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Contractual interest expense | $ | 37,366 | $ | 37,193 | $ | 24,967 | ||||||
Amortization of debt issuance costs | 1,704 | 1,704 | 1,081 | |||||||||
Amortization of debt (premium) discount | 105 | (183 | ) | 1,742 | ||||||||
Imputed interest on acquisition related obligations | 1,787 | 2,617 | 777 | |||||||||
Total interest expense | $ | 40,962 | $ | 41,331 | $ | 28,567 | ||||||
Revolving Line of Credit
On September 30, 2010, KEMET Electronics Corporation ("KEC") and KEMET Electronics Marketing (S) Pte Ltd. ("KEMET Singapore") (each a "Borrower" and, collectively, the "Borrowers") entered into a Loan and Security Agreement (the "Loan and Security Agreement"), with Bank of America, N.A, as the administrative agent and the initial lender. The Loan and Security Agreement provides a $50.0 million revolving line of credit, which is bifurcated into a U.S. facility (for which KEC is the Borrower) and a Singapore facility (for which KEMET Singapore is the Borrower). The size of the U.S. facility and Singapore facility can fluctuate as long as the Singapore facility does not exceed $30.0 million and the total facility does not exceed $50.0 million. A portion of the U.S. facility and the Singapore facility can be used to issue letters of credit. Subsequent to March 31, 2014, the Loan and Security Agreement was amended and as a result the expiration was extended to December, 31, 2015. The principal features of the amendment to the Loan and Security Agreement (the "Amendment") are reflected in the description below.
Borrowings under the U.S. and Singapore facilities are subject to a borrowing base consisting of:
• | in the case of the U.S. facility, (A) 85% of KEC's accounts receivable that satisfy certain eligibility criteria plus (B) the lesser of (i) $6.0 million and (ii) (a) on or prior to agent’s receipt of an updated inventory appraisal and agent’s approval thereof, 40% of the value of Eligible Inventory (as defined in the agreement) and (b) upon agent’s receipt of an updated inventory appraisal, 85% of the net orderly liquidation value of the Eligible Inventory (as defined in the agreement) plus (C) the lesser of $5.1 million and 80% of the net orderly liquidation percentage of the appraised value of equipment that satisfies certain eligibility criteria, as reduced on the first day of each fiscal quarter occurring after April 30, 2014 in an amount equal to one-twentieth (1/20) of such appraised value less (D) certain reserves, including certain reserves imposed by the administrative agent in its permitted discretion; and |
• | in the case of the Singapore facility, (A) 85% of KEMET Singapore's accounts receivable that satisfy certain eligibility criteria as further specified in the Amendment, less (B) certain reserves, including certain reserves imposed by the administrative agent in its permitted discretion. |
Interest is payable on borrowings monthly at a rate equal to the London Interbank Offer Rate ("LIBOR") or the base rate, plus an applicable margin, as selected by the Borrower. Depending upon the fixed charge coverage ratio of KEMET Corporation and its subsidiaries on a consolidated basis as of the latest test date, the applicable margin under the U.S. facility varies between 2.50% and 3.00% for LIBOR advances and 1.50% and 2.00% for base rate advances, and under the Singapore facility varies between 2.75% and 3.25% for LIBOR advances and 1.75% and 2.25% for base rate advances.
The base rate is subject to a floor that is 100 basis points above LIBOR.
An unused line fee is payable monthly in an amount equal to a per annum rate equal to (a) 0.50%, if the average daily balance of revolver loans and stated amount of letters of credit was 50% or less of the revolver commitments during the preceding calendar month, or (b) 0.375%, if the average daily balance of revolver loans and stated amount of letters of credit was more than 50% of the Revolver Commitment during the preceding calendar month. A customary fee is also payable to the administrative agent on a quarterly basis.
73
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 2: Debt (Continued)
KEC's ability to draw funds under the U.S. facility and KEMET Singapore's ability to draw funds under the Singapore facility are conditioned upon, among other matters:
• | the absence of the existence of a Material Adverse Effect (as defined in the Loan and Security Agreement); |
• | the absence of the existence of a default or an event of default under the Loan and Security Agreement; and |
• | the representations and warranties made by KEC and KEMET Singapore in the Loan and Security Agreement continuing to be correct in all material respects. |
KEMET Corporation and the Guarantors guarantee the U.S. facility obligations and the U.S. facility obligations are secured by a lien on substantially all of the assets of KEC and the Guarantors (other than assets that secure the 10.5% Senior Notes due 2018). The collection accounts of the Borrowers and Guarantors are subject to a daily sweep into a concentration account and the concentration account will become subject to full cash dominion in favor of the administrative agent (i) upon an event of default, (ii) if for five consecutive business days, aggregate availability of all facilities has been less than the greater of (A) 15% of the aggregate revolver commitments at such time and (B) $7.5 million, or (iii) if for five consecutive business days, availability of the U.S. facility has been less than $3.75 million (each such event, a "Cash Dominion Trigger Event").
KEC and the Guarantors guarantee the Singapore facility obligations. In addition to the assets that secure the U.S. facility, the Singapore obligations are also secured by a pledge of 100% of the stock of KEMET Singapore and a security interest in substantially all of KEMET Singapore's assets. KEMET Singapore's bank accounts are maintained at Bank of America and upon a Cash Dominion Trigger Event will become subject to full cash dominion in favor of the administrative agent.
A fixed charge coverage ratio of at least 1.1:1.0 must be maintained as at the last day of each fiscal quarter ending immediately prior to or during any period in which any of the following occurs and is continuing until none of the following occurs for a period of at least forty-five consecutive days: (i) an event of default, (ii) aggregate availability of all facilities has been less than the greater of (A) 15% of the aggregate revolver commitments at such time and (B) $7.5 million, or (iii) availability of the U.S. facility has been less than $3.75 million. The fixed charge coverage ratio tests the EBITDA and fixed charges of KEMET Corporation and its subsidiaries on a consolidated basis.
In addition, the Loan and Security Agreement includes various covenants that, subject to exceptions, limit the ability of KEMET Corporation and its direct and indirect subsidiaries to, among other things: incur additional indebtedness; create liens on assets; make capital expenditures; engage in mergers, consolidations, liquidations and dissolutions; sell assets (including pursuant to sale leaseback transactions); pay dividends and distributions on or repurchase capital stock; make investments (including acquisitions), loans, or advances; prepay certain junior indebtedness; engage in certain transactions with affiliates; enter into restrictive agreements; amend material agreements governing certain junior indebtedness; and change its lines of business. The Loan and Security Agreement includes certain customary representations and warranties, affirmative covenants and events of default, which are set forth in more detail in the Loan and Security Agreement.
Debt issuance costs related to the Loan and Security Agreement, net of amortization, were $0.2 million and $0.6 million as of March 31, 2014 and 2013, respectively; these costs will be amortized over the term of the Loan and Security Agreement.
On September 24, 2013, the Company borrowed $9.0 million from the revolving line of credit at a rate of 5.75% (Base Rate, as defined in the Loan and Security Agreement, plus 2.5% ). As this is a base rate borrowing, there is not a specific repayment date and the amount can be repaid at any time prior to the expiration of the facility. On September 27, 2013, the Company borrowed $12.0 million from the revolving line of credit at a rate of 4.0% LIBOR plus 3.75% based upon the fixed charge coverage ratio of KEMET Corporation and its subsidiaries on a consolidated basis). The term on this borrowing was originally 31 days with total interest and principal payable at maturity on October 28, 2013, however, it was extended to May 28, 2014. These borrowings are classified as non-current liabilities as the facilities were amended to expire on December 31, 2015. These were the only borrowings under the revolving line of credit and $18.4 million remained outstanding as of March 31, 2014 after the Company made repayment of $2.6 million during the fiscal year ended March 31, 2014. Based upon the March 31, 2014 financial statements, the Company's available borrowing capacity under the Loan and Security Agreement was $7.1 million (after $16.9 million used for letters of credit as described below).
As described below in the section titled "Advanced Payment from OEM", a standby letter of credit for $16.0 million was delivered to the OEM on October 8, 2012 and in fiscal year 2014, the Company issued two letters of credit for EUR 1.1 million ($1.5 million) and EUR 0.7 million ($0.9 million) related to the construction of the new manufacturing location in Italy. The
74
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 2: Debt (Continued)
letter of credit for EUR 1.1 million ($1.5 million) was cancelled in February 2014. Outstanding letters of credit reduced the Company's availability under the Loan and Security Agreement.
Advanced Payment from OEM
On August 28, 2012, the Company entered into and amended an agreement (the "Agreement"), with an original equipment manufacturer (the "OEM") pursuant to which the OEM agreed to advance KEMET $24.0 million (the "Advance Payment"). As of March 31, 2014 and 2013, the Company had $20.4 million and $24.0 million, respectively, outstanding due to the OEM. On a monthly basis starting in June 2013, (eight months following the receipt of the Advance Payment), the Company began repaying the OEM an amount equal to a percentage of the aggregate purchase price of the capacitors sold to the OEM the preceding month, not to exceed $1.0 million per month. Pursuant to the terms of the Agreement, the percentage of the aggregate purchase price of capacitors sold to the OEM that will be used to repay the Advance Payment will double, and the total amount to be repaid will not exceed $2.0 million per month, in the event that (1) the OEM provides evidence that the price charged by KEMET for a particular capacitor during any prior quarter was equal to or greater than 110% of the price paid by the OEM or its affiliates for a third-party part qualified for the same product, and shipping in volume during such period, and (2) agreement cannot be reached between the OEM and the Company for a price adjustment during the current quarter which would bring KEMET's price within 110% of the third-party price. In June 2015 (thirty-two months after the date of the Advance Payment), the remaining outstanding balance, if any, is due in full. Pursuant to the terms of the Agreement, an irrevocable standby letter of credit in the amount of $16.0 million was delivered to the OEM on October 8, 2012 and on October 22, 2012 the Company received the Advance Payment from the OEM. The debt discount related to the Advance Payment as of March 31, 2014 and 2013 was $0.3 million and $1.1 million, respectively, which will be amortized over the term of the Agreement.
The OEM may demand repayment of the entire balance outstanding or draw upon the Letter of Credit if any of the following events occur while the Agreement is still in effect: (i) the Company commits a material breach of the Agreement, the statement of work or the master purchase agreement between the OEM and the Company; (ii) the Company’s credit rating issued by Standard & Poor’s Financial Services LLC or its successor or Moody’s Investors Services, Inc. or its successors drops below CCC+ or Caa1, respectively; (iii) the Company’s cash balance on the last day of any fiscal quarter is less than $60.0 million ; (iv) the Letter of Credit has been terminated without being replaced prior to repayment of the Advance Payment amount; (v) the Company or substantially all of its assets are sold to a party other than a subsidiary of the Company; (vi) all or substantially all of the assets of a subsidiary of the Company, or any of the shares of such subsidiary, are sold, whose assets are used to develop and produce the Goods; (vii) the Company or any subsidiary which accounts for 20% or more of the Company’s consolidated total assets (“Company Entity”) applies for judicial or extra judicial settlement with its creditors, makes an assignment for the benefit of its creditors, voluntarily files for bankruptcy or has a receiver or trustee in bankruptcy appointed by reason of its insolvency, or in the event of an involuntary bankruptcy action, liquidation proceeding, dissolution or similar proceeding is filed against a Company Entity and not dismissed within sixty ( 60 ) days. To the Company’s best knowledge and belief, none of these events have been met including maintaining a minimum cash balance since the Company's cash balance (including restricted cash under the OEM agreement) exceeds the $60.0 million threshold.
10.5% Senior Notes
On May 5, 2010, the Company issued 10.5% Senior Notes with an aggregate principal amount of $230.0 million which resulted in net proceeds to the Company of $222.2 million.
The 10.5% Senior Notes were issued pursuant to an Indenture (the "10.5% Senior Notes Indenture"), dated as of May 5, 2010, by and among the Company, Guarantors and Wilmington Trust Company, as trustee (the "Trustee"). The 10.5% Senior Notes will mature on May 1, 2018, and bear interest at a stated rate of 10.5% per annum, payable semi-annually in cash in arrears on May 1 and November 1 of each year, beginning on November 1, 2010. The 10.5% Senior Notes are senior obligations of the Company and will be guaranteed by each of the Guarantors and secured by a first priority lien on 51% of the capital stock of certain of the Company's foreign restricted subsidiaries.
The terms of the 10.5% Senior Notes Indenture, among other things, limit the ability of the Company and its restricted subsidiaries to (i) incur additional indebtedness or issue certain preferred stock; (ii) pay dividends on, or make distributions in respect of, their capital stock or repurchase their capital stock; (iii) make certain investments or other restricted payments; (iv) sell certain assets; (v) create liens or use assets as security in other transactions; (vi) enter into sale and leaseback transactions; (vii) merge, consolidate or transfer or dispose of substantially all of their assets; (viii) engage in certain transactions with affiliates; and (ix) designate their subsidiaries as unrestricted subsidiaries. These covenants are subject to a
75
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 2: Debt (Continued)
number of important limitations and exceptions that are described in the 10.5% Senior Notes Indenture. The company is in compliance with these debt covenants.
The 10.5% Senior Notes are redeemable, in whole or in part, at any time on or after May 1, 2014, at the redemption prices specified in the 10.5% Senior Notes Indenture. At any time prior to May 1, 2013, the Company may redeem up to 35% of the aggregate principal amount of the 10.5% Senior Notes with the net cash proceeds from certain equity offerings at a redemption price equal to 110.5% of the principal amount thereof, together with accrued and unpaid interest, if any, to the redemption date. In addition, at any time prior to May 1, 2014, the Company may redeem the 10.5% Senior Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the 10.5% Senior Notes so redeemed, plus a "make whole" premium and together with accrued and unpaid interest, if any, to the redemption date.
Upon the occurrence of a change of control triggering event specified in the 10.5% Senior Notes Indenture, the Company must offer to purchase the 10.5% Senior Notes at a redemption price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the date of purchase.
The 10.5% Senior Notes Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods), which include nonpayment, breach of covenants in the 10.5% Senior Notes Indenture, payment defaults or acceleration of other indebtedness, a failure to pay certain judgments and certain events of bankruptcy and insolvency. The 10.5% Senior Notes Indenture also provides for events of default with respect to the collateral, which include default in the performance of (or repudiation, disaffirmation or judgment of unenforceability or assertion of unenforceability) by the Company or a Guarantor with respect to the provision of security documents under the 10.5% Senior Notes Indenture. These events of default are subject to a number of important qualifications, limitations and exceptions that are described in the 10.5% Senior Notes Indenture. Generally, if an event of default occurs, the Trustee or holders of at least 25% in principal amount of the then outstanding 10.5% Senior Notes may declare the principal of and accrued but unpaid interest, including additional interest, on all the 10.5% Senior Notes to be due and payable.
On March 27, 2012 and April 3, 2012, the Company completed the sale of $110.0 million and $15.0 million aggregate principal amount of its 10.5% Senior Notes due April 2018, respectively, at an issue price of 105.5% of the principal amount plus accrued interest from November 1, 2011. The issuance resulted in a debt premium of $6.1 million which will be amortized over the term of the 10.5% Senior Notes. The Senior Notes were issued as additional notes under the indenture, dated May 5, 2010, among the Company, the guarantors party thereto and Wilmington Trust Company, as trustee.
In total, debt issuance costs related to the 10.5% Senior Notes, net of amortization, were $5.4 million and $6.7 million as of March 31, 2014 and 2013, respectively; these costs will be amortized over the term of the 10.5% Senior Notes. The Company had interest payable related to the 10.5% Senior Notes included in the line item "Accrued expenses" on its Consolidated Balance Sheets of $15.5 million at March 31, 2014 and 2013. The effective interest rate for the Senior Notes was 10.3% and 10.4% for the years ended March 31, 2014 and 2013, respectively.
The following table highlights the Company's annual cash maturities of debt (amounts in thousands):
Annual Maturities of Debt Fiscal Years Ended March 31, | ||||||||||||||||||||
2015 | 2016 | 2017 | 2018 | 2019 | ||||||||||||||||
10.5% Senior Notes | $ | — | $ | — | $ | — | $ | — | $ | 355,000 | ||||||||||
Advanced payment from OEM | 6,266 | 14,152 | — | — | — | |||||||||||||||
Revolving line of credit | — | 18,449 | — | — | — | |||||||||||||||
Other | 1,309 | 592 | — | — | — | |||||||||||||||
$ | 7,575 | $ | 33,193 | $ | — | $ | — | $ | 355,000 | |||||||||||
Note 3. Discontinued Operations
In December 2013 KEMET signed a letter of intent to sell the machinery division within Film and Electrolytic. At that time the division qualified as held for sale and was classified as a discontinued operation. All historical financial results contained in this Form 10-K have been revised due to the classification of the machinery division as a discontinued operation. On April 30, 2014, the transaction closed.
76
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 3: Discontinued Operations (Continued)
Net sales and net operating loss from the Company’s discontinued operation for years ended March 31, 2014, 2013 and 2012 were as follows (in thousands):
Fiscal Years Ended March 31, | |||||||||||
2014 | 2013 | 2012 | |||||||||
Net sales | $ | 11,489 | $ | 19,051 | $ | 60,781 | |||||
Operating income (loss) | (3,730 | ) | (4,203 | ) | 9,718 | ||||||
Note 4: Restructuring
In the second quarter of fiscal year 2010, the Company initiated the first phase of a plan to restructure the Film and Electrolytic Business Group ("Film and Electrolytic") and to reduce overhead within the Company. Since that time the restructuring plan has been expanded to all business groups and includes implementing programs to make the Company more competitive by removing excess capacity, moving production to lower cost locations and eliminating unnecessary costs throughout the Company.
A summary of the expenses aggregated on the Consolidated Statements of Operations line item "Restructuring charges" in the fiscal years ended March 31, 2014, 2013 and 2012, is as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Manufacturing and sales office relocation costs | $ | 3,555 | $ | 2,349 | $ | 1,920 | ||||||
Personnel reduction costs | 10,567 | 16,370 | 12,334 | |||||||||
Restructuring charges | $ | 14,122 | $ | 18,719 | $ | 14,254 | ||||||
Fiscal Year Ended March 31, 2014
The Company incurred $14.1 million in restructuring charges in the fiscal year ended March, 31, 2014 including $10.6 million related to personnel reduction costs which is primarily comprised of the following: $1.9 million related to the closure of a portion of our innovation center in the U.S.; $1.2 million related to the reduction of the Solid Capacitor production workforce in Mexico; $1.1 million related to the Company’s initiative to reduce overhead; $0.5 million in termination benefits associated with converting the Weymouth, United Kingdom manufacturing facility into a technology center; $4.5 million related to headcount reductions of 126 employees in Evora, Portugal due to the relocation of certain Solid Capacitors manufacturing operations to Mexico; $0.9 million is related to a headcount reduction of 31 employees due to the consolidation of manufacturing facilities in Italy and $0.4 million related to an additional Cassia Integrazione Guadagni Straordinaria (“CIGS”) plan in Italy.
The additional expense related to CIGS is as a result of an agreement with the labor union which allowed the Company to place up to 170 workers, on a rotation basis, on the CIGS plan to save labor costs. CIGS is a temporary plan to save labor costs whereby a company may temporarily “lay off” employees while the government continues to pay their wages for a maximum of 12 months during the program. The employees who are in CIGS are not working, but are still employed by the Company. Only employees that are not classified as management or executive level personnel can participate in the CIGS program and upon termination of the plan, the affected employees return to work.
In addition to these personnel reduction costs, the Company incurred manufacturing relocation costs of $3.6 million due to the consolidation of Film and Electrolytic manufacturing facilities within Italy and relocation of Film and Electrolytic manufacturing equipment to Evora, Portugal and Skopje, Macedonia and Solid Capacitors manufacturing equipment to Mexico.
Fiscal Year Ended March 31, 2013
Restructuring charges in the fiscal year ended March 31, 2013 include personnel reduction costs of $16.4 million and manufacturing relocation costs of $2.3 million. The personnel reduction costs are comprised of the following: $2.8 million in
77
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 4: Restructuring (Continued)
termination benefits associated with converting the Landsberg, Germany manufacturing facility into a technology center; $2.9 million in termination benefits associated with converting the Weymouth, United Kingdom manufacturing facility into a technology center; $1.5 million for reductions in production workforce in Mexico; $1.1 million for reductions in production workforce in Portugal; $0.5 million for headcount reductions at an innovation center; $2.7 million for reductions in administrative overhead primarily in the Corporate headquarters and $4.9 million for reductions in production workforce and administrative overhead across the Company.
In addition to these personnel reduction costs, the Company incurred manufacturing relocation costs of $1.8 million for relocation of equipment to Bulgaria, China, Macedonia and Mexico and for the consolidation of manufacturing operations within Italy and $0.6 million in lease termination costs related to the closure of a sales office.
Fiscal Year Ended March 31, 2012
In fiscal year 2012, personnel reduction costs of $12.3 million were primarily comprised of the following: termination benefits of $6.1 million related to facility closures in Italy that commenced during fiscal year 2013 and charges of $4.5 million were incurred by the Company to participate in a plan to save labor costs whereby a company may temporarily "lay off" employees while the government continues to pay their wages for a certain period of time. The program is called Cassia Integrazione Guadagni Straordinaria ("CIGS"). In addition, the Company incurred $1.7 million in personnel reduction costs primarily due to headcount reductions within Solid Capacitor's operations in Mexico. The Company also incurred manufacturing relocation costs of $1.9 million for the relocation of equipment to China and Mexico in fiscal year 2012.
A reconciliation of the beginning and ending liability balances for restructuring charges included in the line items "Accrued expenses" and "Other non-current obligations" on the Consolidated Balance Sheets were as follows (amounts in thousands):
Personnel Reductions | Manufacturing and Sales Office Relocation Costs | |||||||
Balance at March 31, 2011 | $ | 1,827 | $ | — | ||||
Costs charged to expense | 12,334 | 1,920 | ||||||
Costs paid or settled | (2,592 | ) | (1,920 | ) | ||||
Change in foreign exchange | (95 | ) | — | |||||
Balance at March 31, 2012 | 11,474 | — | ||||||
Costs charged to expense | 16,370 | 2,349 | ||||||
Costs paid or settled | (13,976 | ) | (1,782 | ) | ||||
Change in foreign exchange | (359 | ) | — | |||||
Balance at March 31, 2013 | 13,509 | 567 | ||||||
Costs charged to expense | 10,567 | 3,555 | ||||||
Costs paid or settled | (18,235 | ) | (4,122 | ) | ||||
Change in foreign exchange | 376 | — | ||||||
Balance at March 31, 2014 | $ | 6,217 | $ | — | ||||
Note 5: Impairment Charges
During fiscal years 2014, 2013 and 2012, the Company incurred impairment charges totaling $4.5 million, $7.6 million, and $15.8 million, respectively. The impairment charges are recorded on the Consolidated Statements of Operations line item “Write down of long-lived assets” in fiscal years 2014, 2013 and 2012.
The Company's restructuring of its Evora, Portugal manufacturing operations, is expected to be substantially complete by June 30, 2014. As a part of the ongoing restructuring activities, the Company has relocated certain Solid Capacitor manufacturing operations from the Evora, Portugal facility to a manufacturing facility in Mexico and the remaining Solid Capacitor equipment in Portugal will be disposed. During fiscal year 2013, using an income approach to estimate the fair value of assets to be disposed, the Company incurred impairment charges totaling $3.1 million ($0.07 per basic and diluted share) related to the Solid Capacitors restructuring activities. In fiscal year 2014 Solid Capacitors incurred $3.9 million ($0.09 per
78
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 5: Impairment Charges (Continued)
basic and diluted share) in additional impairment charges due to a decrease in forecasted revenues. In addition, during fiscal year 2014, the Company incurred impairment charges totaling $0.6 million ($0.01 per basic and diluted share) related to Film and Electrolytic manufacturing equipment in Italy.
Also in fiscal year 2013, in connection with the consolidation of two manufacturing facilities within Italy, the Company incurred impairment charges totaling $4.2 million ($0.09 per basic and diluted share) related to the Film and Electrolytic Business Group ("Film and Electrolytic"). The Company obtained appraisals for each of these facilities indicating there was a decrease in the market price of the manufacturing facilities, and therefore, the carrying amounts for these manufacturing facilities were reviewed for recoverability. It was determined that the carrying amounts of the manufacturing facilities were not recoverable since they exceeded the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset (asset group). The impairment was measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeded its fair value. The Company utilized the market approach to estimate fair value of the long-lived asset group.
In addition, in fiscal year 2013 the Company incurred a $0.3 million ($0.01 per basic and diluted share) charge related to the write-off of a trademark which is no longer utilized.
During fiscal year 2012, the Company incurred impairment charges totaling $15.8 million ($0.36 per basic share and $0.30 per diluted share) related to Solid Capacitors. Certain Solid Capacitors equipment was disposed of since the equipment could not meet customer demands for lower Equivalent Series Resistance capacitors. The impairment amount of $15.8 million was the carrying amount of the equipment, less the scrap value net of disposal costs.
Note 6: Acquisitions
Cornell Dubilier Foil, LLC
On June 13, 2011, the Company completed its acquisition of Cornell Dubilier Foil, LLC (whose name was subsequently changed to KEMET Foil Manufacturing, LLC ("KEMET Foil")), a Tennessee based manufacturer of etched foils utilized as a core component in the manufacture of aluminum electrolytic capacitors. The undiscounted purchase price was $15.0 million plus a $0.5 million working capital adjustment, of which $11.6 million (net of cash received) was paid at closing and $1.0 million was paid on the first and second anniversary of the closing date and $1.0 million is due on June 13, 2014. The Company recorded goodwill of $1.1 million and amortizable intangibles of $1.7 million. The allocation of the purchase price to specific assets and liabilities was based on the relative fair value of all assets and liabilities. Factors contributing to the purchase price which resulted in the goodwill (which is tax deductible) included the trained workforce. Pro forma results are not presented because the acquisition was not material to the consolidated financial statements. KEMET Foil is included within Film and Electrolytic.
The total discounted purchase price for KEMET Foil was $15.3 million and is comprised of (amounts in thousands):
Cash at closing | $ | 12,000 | ||
Deferred payments (discounted) | 2,815 | |||
Working capital adjustment | 526 | |||
$ | 15,341 | |||
The purchase price was determined through arms-length negotiations between representatives of the Company and Cornell Dubilier Marketing, Inc.
79
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 6: Acquisitions (Continued)
The following table presents the final allocations of the aggregate purchase price based on the assets and liabilities estimated fair values (amounts in thousands):
Fair Value | ||||
Cash | $ | 416 | ||
Accounts receivable | 2,577 | |||
Inventories | 3,382 | |||
Other current assets | 84 | |||
Property, plant and equipment | 9,534 | |||
Goodwill | 1,092 | |||
Intangible assets | 1,660 | |||
Current liabilities | (3,404 | ) | ||
Total net assets acquired | $ | 15,341 | ||
As discussed in Note 7, "Goodwill and Intangible Assets," the goodwill recorded for KEMET Foil was fully impaired in fiscal year 2013.
Niotan Incorporated
On February 21, 2012, KEMET acquired all of the outstanding shares of Niotan Incorporated, whose name was subsequently changed to KEMET Blue Powder Corporation ("Blue Powder"), a manufacturer of tantalum powders, from an affiliate of Denham Capital Management LP. Blue Powder has its headquarters and principal operating location in Carson City, Nevada. KEMET paid an initial purchase price of $30.5 million (net of cash received) at the closing of the transaction. Additional deferred payments of $45 million are payable over a thirty-month period after the closing and a working capital adjustment of $0.4 million which was paid in April 2012. In fiscal years 2014 and 2013 KEMET has made installment payments totaling $20.0 million and $15.0 million, respectively. KEMET will also be required to make quarterly royalty payments for tantalum powder produced by Blue Powder, in an aggregate amount equal to $10.0 million by December 31, 2014, and KEMET made payments of $1.5 million through March 31, 2014. As of March 31, 2014 deferred payment of $18.6 million remain due to the seller in fiscal year 2015. The Company determined that the royalty payments should be treated as part of the consideration for Blue Powder instead of a separate transaction because (i) it is paid to the selling shareholder who is not continuing with Blue Powder, (ii) it was based solely on the negotiation process and (iii) KEMET now owns the technology. The Company recorded goodwill of $35.6 million and amortizable intangibles of $22.4 million. The allocation of the purchase price to specific assets and liabilities was based on the relative fair value of all assets and liabilities. Factors contributing to the purchase price which resulted in the goodwill (which is not tax deductible) include market recognition of the world class quality of Blue Powder's tantalum powder, the Company's cost savings due to vertical integration and Blue Powder's ability to provide a constant and reliable supply of tantalum powder. Pro forma results are not presented because the acquisition was not material to the consolidated financial statements. Blue Powder is included within Solid Capacitors.
The total discounted purchase price for Blue Powder was $82.0 million which includes (amounts in thousands):
Cash at closing | $ | 30,656 | ||
Deferred payments (discounted) | 41,938 | |||
Royalty payments (discounted) | 8,975 | |||
Working capital adjustment | 403 | |||
$ | 81,972 | |||
The purchase price was determined through arms-length negotiations between representatives of the Company and Denham Capital Management LP.
80
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 6: Acquisitions (Continued)
The following table presents the final allocations of the aggregate purchase price based on the assets and liabilities estimated fair values (amounts in thousands):
Fair Value | ||||
Cash | $ | 153 | ||
Accounts receivable | 479 | |||
Inventories | 7,305 | |||
Prepaid expenses | 186 | |||
Property, plant and equipment | 15,122 | |||
Goodwill | 35,584 | |||
Intangible assets | 22,420 | |||
Deferred income taxes | 311 | |||
Other noncurrent assets | 1,303 | |||
Current liabilities | (873 | ) | ||
Long-term liabilities | (18 | ) | ||
Total net assets acquired | $ | 81,972 | ||
The following table presents the amounts assigned to intangible assets (amounts in thousands except useful life data):
Fair Value | Useful Life (years) | |||||
Developed technology | $ | 22,300 | 18 | |||
Software | 120 | 4 | ||||
$ | 22,420 | |||||
The useful life for developed technology of 18 years is based on the history of the underlying chemical processes and an estimate of the future economic benefit. The Company also considered that the technology was developed approximately 4 years ago and considered functional obsolescence. The useful life for software is based upon its implementation in 2011 and taking into consideration functional obsolescence.
Note 7: Goodwill and Intangible Assets
The following table highlights the Company's intangible assets (amounts in thousands):
March 31, 2014 | March 31, 2013 | |||||||||||||||
Carrying Amount | Accumulated Amortization | Carrying Amount | Accumulated Amortization | |||||||||||||
Indefinite Lived Intangible Assets: | ||||||||||||||||
Trademarks | $ | 7,207 | $ | — | $ | 7,207 | $ | — | ||||||||
Amortizing Intangibles: | ||||||||||||||||
Purchased technology, customer relationships and patents (3 - 18 years) | 44,428 | 14,451 | 43,227 | 11,788 | ||||||||||||
$ | 51,635 | $ | 14,451 | $ | 50,434 | $ | 11,788 | |||||||||
For fiscal years ended March 31, 2014, 2013 and 2012 amortization related to intangibles was $2.1 million, $2.3 million and $2.0 million, respectively. The weighted average useful life of amortized intangibles was 16 years in the fiscal years ended March 31, 2014 and 2013. Estimated amortization of intangible assets for the each of the next five fiscal years is $2.1 million and, thereafter, amortization will total $19.4 million.
81
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 7: Goodwill and Intangible Assets (Continued)
For fiscal year 2014, the Company completed its impairment test on goodwill and intangible assets with indefinite useful lives as of January 1, 2014 and concluded that goodwill and indefinite-lived assets were not impaired.
In fiscal year 2013, the Company's annual goodwill and other indefinite-lived intangible asset impairment test resulted in a $1.1 million goodwill impairment charge, which represented all of the goodwill related to the KEMET Foil Manufacturing, LLC ("KEMET Foil") reporting unit due to reduced earnings and cash flows caused by macro-economic factors and excess capacity in our industry.
The changes in the carrying amount of goodwill for the years ended March 31, 2014 and 2013 are as follows (amounts in thousands):
Fiscal Year 2014 | Fiscal Year 2013 | |||||||
Gross balance at beginning of fiscal year | ||||||||
Goodwill | $ | 36,676 | $ | 36,676 | ||||
Accumulated impairment losses | (1,092 | ) | — | |||||
Net balance at the end of the year | $ | 35,584 | $ | 36,676 | ||||
Impairment charges | $ | — | $ | (1,092 | ) | |||
Balance at the end of the year | ||||||||
Goodwill | $ | 36,676 | $ | 36,676 | ||||
Accumulated impairment losses | (1,092 | ) | (1,092 | ) | ||||
Balance at the end of the year, net | $ | 35,584 | $ | 35,584 | ||||
Note 8: Investment in NEC TOKIN
On March 12, 2012, KEMET Electronics Corporation ("KEC"), a wholly owned subsidiary of the Company, entered into a Stock Purchase Agreement (the "Stock Purchase Agreement") with NEC TOKIN Corporation ("NEC TOKIN"), a manufacturer of tantalum capacitors, electro-magnetic, electro-mechanical and access devices, to acquire 51% of the commmon stock of NEC TOKIN (which represents a 34% economic interest, as calculated based on the number of common shares held by KEC, directly and indirectly, in proportion to the aggregate number of common and preferred shares of NEC TOKIN as of such date) (the "Initial Purchase") from NEC Corporation ("NEC") of Japan. The transaction closed on February 1, 2013, at which time KEC paid a purchase price of $50.0 million for new shares of common stock of NEC TOKIN (the "Initial Closing"). The Company accounts for its investment in NEC TOKIN using the equity method for a non-consolidated variable interest entity since KEC does not have the power to direct significant activities of NEC TOKIN. The Company believes that the NEC TOKIN preferred stock represents in-substance common stock of NEC TOKIN and, as a result, its method of calculating KEC’s economic basis in NEC TOKIN is the appropriate basis on which to recognize its share of the earnings or loss of NEC TOKIN.
In connection with KEC's execution of the Stock Purchase Agreement, KEC entered into a Stockholders' Agreement (the "Stockholders' Agreement") with NEC TOKIN and NEC, which provides for restrictions on transfers of NEC TOKIN's capital stock, certain tag-along and first refusal rights on transfer, restrictions on NEC's ability to convert the preferred stock of NEC TOKIN held by it, certain management services to be provided to NEC TOKIN by KEC (or an affiliate of KEC) and certain board representation rights. KEC holds four of seven NEC TOKIN director positions. However, NEC has significant board rights.
Concurrent with execution of the Stock Purchase Agreement and the Stockholders' Agreement, KEC entered into an Option Agreement (the "Option Agreement") with NEC whereby KEC may purchase additional shares of NEC TOKIN common stock from NEC TOKIN for a purchase price of $50.0 million resulting in an economic interest of approximately 49% while maintaining ownership of 51% of NEC TOKIN's common stock (the "First Call Option") by providing notice of the First Call Option between the Initial Closing and August 31, 2014. Upon providing such notice, but not before August 1, 2014, KEC may also exercise an option to purchase all outstanding capital stock of NEC TOKIN from its stockholders, primarily NEC, for a purchase price based on the greater of six times LTM EBITDA (as defined in the Option Agreement) less the previous payments and certain other adjustments, or the outstanding amount of NEC TOKIN's debt obligation to NEC (the "Second Call Option") by providing notice of the Second Call Option by May 31, 2018. From August 1, 2014 through May 31, 2018, NEC
82
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 8: Investment in NEC TOKIN (Continued)
may require KEC to purchase all outstanding capital stock of NEC TOKIN from its stockholders, primarily NEC. However, NEC may only exercise this right (the "Put Option") from August 1, 2014 through April 1, 2016 if NEC TOKIN achieves certain financial performance measures. The purchase price for the Put Option will be based on the greater of six times LTM EBITDA less previous payments and certain other adjustments, or the outstanding amount of NEC TOKIN's debt obligation to NEC as of the date the Put Option is exercised. The purchase price for the Put Option is reduced by the amount of NEC TOKIN's debt obligation to NEC which KEC will assume. The determination of the purchase price will be modified in the event there is an unresolved agreement between NEC and us under the Stockholders' Agreement. In the event the Put Option is exercised, NEC will be required to maintain in place the outstanding debt obligation owed by NEC TOKIN to NEC. The Company valued these options as a net call derivative of $0.5 million which is included in line item "Other Assets" on the Consolidated Balance Sheets. The Company has marked these options to fair value and in the fiscal year ended March 31, 2014 recognized a $3.1 million gain which was included on the line item “Other expense, net” in the Consolidated Statement of Operations. The value included for the options in the line item “Other assets” on the Consolidated Balance Sheets as of March 31, 2014, is $3.6 million.
KEC's total investment in NEC TOKIN including the net call derivative described above on February 1, 2013 was $54.5 million which includes $50.0 million cash consideration plus approximately $4.5 million in transaction expenses (fees for legal, accounting, due diligence, investment banking and other various services necessary to complete the transactions). The Company has made an allocation of the aggregate purchase price, which were based upon estimates that the Company believes are reasonable.
Summarized financial information for NEC TOKIN follows (in thousands):
March 31, 2014 | March 31, 2013 | |||||
Current assets | $ | 245,709 | $ | 220,652 | ||
Noncurrent assets | 302,161 | 422,246 | ||||
Current liabilities | 120,929 | 121,238 | ||||
Noncurrent liabilities | 360,908 | 411,789 | ||||
Fiscal Year March 31, 2014 | Two Months Ended March 31, 2013 | |||||
Net sales | $ | 512,073 | $ | 82,772 | ||
Gross profit | 90,325 | 9,147 | ||||
Net loss | (42,937 | ) | (2,216 | ) | ||
83
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 8: Investment in NEC TOKIN (Continued)
A reconciliation between NEC TOKIN's net loss and KEMET's equity investment loss follows (in thousands):
Fiscal year Ended March 31, 2014 | Two Months Ended March 31, 2013 | |||||
NEC TOKIN net Loss | $ | (42,937 | ) | $ | (2,216 | ) |
KEMET's equity ownership % | 34 | % | 34 | % | ||
Equity loss from NEC TOKIN before Adjustments | $ | (14,599 | ) | $ | (753 | ) |
Adjustments: | ||||||
Amortization and depreciation | (1,390 | ) | (247 | ) | ||
Gain on sale of long-lived assets adjustment | (5,998 | ) | — | |||
Loss on impairment of long-lived assets adjustment | 14,643 | — | ||||
Inventory valuation adjustment | 254 | (254 | ) | |||
Equity Loss from NEC TOKIN | $ | (7,090 | ) | $ | (1,254 | ) |
A reconciliation between NEC TOKIN's net assets and KEMET's equity investment balance follows (in thousands):
March 31, 2014 | March 31, 2013 | |||||
Investment in NEC TOKIN | $ | 46,419 | $ | 52,738 | ||
Purchase price accounting basis adjustment: | ||||||
Property, plant and equipment | 7,325 | 21,593 | ||||
Technology | (16,261 | ) | (18,000 | ) | ||
Long-term debt | (4,754 | ) | (5,824 | ) | ||
Goodwill | (9,326 | ) | (9,326 | ) | ||
Other | (952 | ) | (3,825 | ) | ||
KEMET's 34% interest of NEC TOKIN's equity | $ | 22,451 | $ | 37,356 | ||
The above basis differences (except Goodwill) are being amortized over the respective estimated life of the assets. As of March 31, 2014, KEC's maximum loss exposure as a result of its investments in NEC TOKIN is limited to the aggregate of the carrying value of the investment and any accounts receivable balance. For the fiscal year ended March 31, 2014, KEMET recorded sales of $6.0 million to NEC TOKIN. As of March 31, 2014, KEMET’s accounts receivable and accounts payable balances with NEC TOKIN were $2.0 million and $0.1 million respectively. In accordance with the Stockholders’ Agreement, KEC entered into a management services agreement to provide services for which KEC would be reimbursed. As of March 31, 2014, KEMET’s receivable balance under this agreement is $0.7 million.
In March and April, 2014, NEC TOKIN and certain of its subsidiaries received inquiries, requests for information and other communications from government authorities in China, the United States, the European Commission, Japan and South Korea concerning alleged anti-competitive activities within the capacitor industry. According to NEC TOKIN, the investigations are at an early stage. As of this date, NEC TOKIN has not recorded an accrual as a result of the investigations.
Note 9: Segment and Geographic Information
The Company is organized into two business groups: Solid Capacitors and Film and Electrolytic based primarily on product lines. Each business group is responsible for their respective manufacturing operations and research and development efforts. Beginning in fiscal year 2013, the Company did not allocate indirect Selling, general and administrative ("SG&A") and Research and Development ("R&D") expenses to the business groups to be consistent with its internal management reporting.
84
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 9: Segment and Geographic Information (Continued)
Prior period information has been reclassified to conform to this convention. Substantially all research and development expenses are direct costs to the respective business group.
Solid Capacitors
Operating in nine manufacturing sites in the United States, Mexico, China and Portugal, Solid Capacitors primarily produces tantalum, aluminum, polymer and ceramic capacitors which are sold globally. Solid Capacitors also produces tantalum powder used in the production of tantalum capacitors and has a product innovation center in the United States.
Film and Electrolytic
Film and Electrolytic operates twelve manufacturing sites throughout Europe, Asia, Mexico and the United States and produces film, paper, and electrolytic capacitors which are sold globally. In addition, the business group has product innovation centers in the United Kingdom, Italy, Germany and Sweden.
The following tables summarize information about each segment's net sales, operating income (loss), depreciation and amortization, capitalized expenditures and total assets (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Net sales: | ||||||||||||
Solid Capacitors | $ | 626,494 | $ | 622,305 | $ | 630,762 | ||||||
Film and Electrolytic | 207,172 | 201,598 | 293,290 | |||||||||
$ | 833,666 | $ | 823,903 | $ | 924,052 | |||||||
Operating income (loss)(1)(2)(3): | ||||||||||||
Solid Capacitors | $ | 91,848 | $ | 94,986 | $ | 111,769 | ||||||
Film and Electrolytic | (17,587 | ) | (31,109 | ) | 12,347 | |||||||
Corporate | (92,472 | ) | (98,957 | ) | (96,033 | ) | ||||||
Consolidated operating income (loss) | $ | (18,211 | ) | $ | (35,080 | ) | $ | 28,083 | ||||
Depreciation and amortization: | ||||||||||||
Solid Capacitors | $ | 28,081 | $ | 27,407 | $ | 27,939 | ||||||
Film and Electrolytic | 14,557 | 13,360 | 11,398 | |||||||||
Corporate | 6,889 | 4,391 | 4,064 | |||||||||
$ | 49,527 | $ | 45,158 | $ | 43,401 | |||||||
Capital expenditures: | ||||||||||||
Solid Capacitors | $ | 10,498 | $ | 16,838 | $ | 19,039 | ||||||
Film and Electrolytic | 14,494 | 23,970 | 21,539 | |||||||||
Corporate | 7,155 | 5,366 | 8,736 | |||||||||
$ | 32,147 | $ | 46,174 | $ | 49,314 | |||||||
_______________________________________________________________________________
85
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 9: Segment and Geographic Information (Continued)
(1) | Restructuring charges included in Operating income (loss) were as follows (amounts in thousands): |
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Total restructuring: | ||||||||||||
Solid Capacitors | $ | 8,108 | $ | 7,335 | $ | 1,161 | ||||||
Film and Electrolytic. | 5,657 | 9,621 | 13,093 | |||||||||
Restructuring charges | 357 | 1,763 | — | |||||||||
$ | 14,122 | $ | 18,719 | $ | 14,254 | |||||||
(2) | Impairment charges and write downs included in Operating income (loss) were as follows (amounts in thousands): |
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Impairment and write down of long-lived assets: | ||||||||||||
Solid Capacitors | $ | 3,920 | $ | 3,348 | $ | 15,786 | ||||||
Film and Electrolytic | 556 | 5,326 | — | |||||||||
$ | 4,476 | $ | 8,674 | $ | 15,786 | |||||||
(3) (Gain) loss on sales and disposals of assets included in Operating income (loss) were as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
(Gain) loss on sales and disposals of assets: | ||||||||||||
Solid Capacitors | $ | (705 | ) | $ | (161 | ) | $ | 338 | ||||
Film and Electrolytic | 767 | 179 | (20 | ) | ||||||||
Corporate | (30 | ) | — | — | ||||||||
$ | 32 | $ | 18 | $ | 318 | |||||||
_______________________________________________________________________________
March 31, | ||||||||
2014 | 2013 | |||||||
Total assets: | ||||||||
Solid Capacitors | $ | 479,377 | $ | 525,270 | ||||
Film and Electrolytic. | 287,861 | 300,501 | ||||||
Corporate | 76,429 | 85,820 | ||||||
$ | 843,667 | $ | 911,591 | |||||
86
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 9: Segment and Geographic Information (Continued)
The following highlights net sales by geographic location (amounts in thousands):
Fiscal Years Ended March 31,(1) | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
United States | $ | 245,032 | $ | 228,975 | $ | 219,785 | ||||||
Hong Kong | 135,570 | 148,014 | 147,054 | |||||||||
Germany | 105,261 | 105,818 | 138,700 | |||||||||
Europe (2)(3) | 70,895 | 82,021 | 133,378 | |||||||||
China | 67,460 | 70,696 | 79,681 | |||||||||
Asia Pacific (2)(3) | 51,467 | 50,735 | 43,433 | |||||||||
United Kingdom | 36,085 | 34,188 | 39,512 | |||||||||
Netherlands | 33,581 | 24,568 | 19,447 | |||||||||
Singapore | 27,777 | 25,060 | 33,586 | |||||||||
Italy | 20,249 | 21,203 | 31,064 | |||||||||
Hungary | 18,332 | 13,554 | 16,206 | |||||||||
Mexico | 17,886 | 15,923 | 16,944 | |||||||||
Other Countries (2) | 4,071 | 3,148 | 5,262 | |||||||||
$ | 833,666 | $ | 823,903 | $ | 924,052 | |||||||
_______________________________________________________________________________
(1) | Revenues are attributed to countries or regions based on the location of the customer. Nets Sales to one customer exceeded 10% of total net sales as follows: $128.4 million, $127.7 million and $125.3 million in fiscal years 2014, 2013 and 2012, respectively. Solid Capacitor sales to one customer over 10% were $115.5 million, $119.0 million and $112.3 million in fiscal years 2014, 2013 and 2012, respectively. Film and Electrolytic sales to one customer over 10% were $12.9 million, $8.7 million and $13.0 million in fiscal years 2014, 2013 and 2012, respectively. |
(2) | Excluding the specific countries listed in this table, no country included in this caption exceeded 2% of consolidated net sales for fiscal years 2014, 2013 and 2012. |
_______________________________________________________________________________
The following geographic information includes Property, plant and equipment, net, based on physical location (amounts in thousands):
March 31, | ||||||||
2014 | 2013 | |||||||
United States | $ | 64,754 | $ | 71,447 | ||||
Mexico | 67,154 | 69,870 | ||||||
Italy | 61,726 | 51,800 | ||||||
China | 31,405 | 33,873 | ||||||
Portugal | 23,817 | 28,716 | ||||||
Macedonia | 21,044 | 18,724 | ||||||
Indonesia | 6,026 | 7,243 | ||||||
Finland | 2,280 | 2,435 | ||||||
United Kingdom | 492 | 5,246 | ||||||
Other | 13,950 | 14,328 | ||||||
$ | 292,648 | $ | 303,682 | |||||
87
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 10: Pension and Other Post-retirement Benefit Plans
The Company sponsors defined benefit pension plans which include six in Europe, one in Singapore and two in Mexico. The Company funds the pension liabilities in accordance with laws and regulations applicable to those plans.
In July 2012, Film and Electrolytic paid out retirement benefits which represented more than 20% of a plan's pension obligation. As a result, the Company recognized a settlement gain of $1.7 million. In the second half of fiscal year 2013, the Company recognized a curtailment loss of $2.0 million as a result of headcount reductions within a sales office, this curtailment was allocated equally to each business group.
The Company has two post-retirement benefit plans: health care and life insurance benefits for certain retired United States employees who reached retirement age while working for the Company. The health care plan is contributory, with participants' contributions adjusted annually. The life insurance plan is non-contributory. A summary of the changes in benefit obligations and plan assets is as follows (amounts in thousands):
Pension | Other Benefits | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Change in Benefit Obligation | ||||||||||||||||
Benefit obligation at beginning of the year | $ | 39,096 | $ | 47,892 | $ | 799 | $ | 1,057 | ||||||||
Service cost | 1,308 | 1,583 | — | — | ||||||||||||
Interest cost | 1,734 | 1,903 | 23 | 27 | ||||||||||||
Plan participants' contributions | — | 73 | 555 | 503 | ||||||||||||
Plan amendments | 285 | — | — | — | ||||||||||||
Actuarial (gain) loss | (377 | ) | 4,108 | 94 | (145 | ) | ||||||||||
Foreign currency exchange rate change | 2,009 | (1,391 | ) | — | — | |||||||||||
Gross benefits paid | (1,302 | ) | (1,300 | ) | (686 | ) | (643 | ) | ||||||||
Curtailments and settlements | (38 | ) | (13,772 | ) | — | — | ||||||||||
Benefit obligation at end of year | $ | 42,715 | $ | 39,096 | $ | 785 | $ | 799 | ||||||||
Change in Plan Assets | ||||||||||||||||
Fair value of plan assets at beginning of year | $ | 8,806 | $ | 17,156 | $ | — | $ | — | ||||||||
Actual return on plan assets | 260 | 1,097 | — | — | ||||||||||||
Foreign currency exchange rate changes | 874 | (799 | ) | — | — | |||||||||||
Employer contributions | 1,346 | 2,490 | 131 | 140 | ||||||||||||
Settlements | (38 | ) | (9,911 | ) | — | — | ||||||||||
Plan participants' contributions | — | 73 | 555 | 503 | ||||||||||||
Gross benefits paid | (1,302 | ) | (1,300 | ) | (686 | ) | (643 | ) | ||||||||
Fair value of plan assets at end of year | $ | 9,946 | $ | 8,806 | $ | — | $ | — | ||||||||
Funded status at end of year | ||||||||||||||||
Fair value of plan assets | $ | 9,946 | $ | 8,806 | $ | — | $ | — | ||||||||
Benefit obligations | (42,715 | ) | (39,096 | ) | (785 | ) | (799 | ) | ||||||||
Amount recognized at end of year | $ | (32,769 | ) | $ | (30,290 | ) | $ | (785 | ) | $ | (799 | ) | ||||
The Company expects to contribute $1.6 million to the pension plans in fiscal year 2015, which includes direct contributions to be made for funded plans and benefit payments to be made for unfunded plans.
88
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 10: Pension and Other Post-retirement Benefit Plans (Continued)
The Company does not prefund its post-retirement health care and life insurance benefit plans. As a result, the Company is responsible annually for the payment of benefits as incurred by the plans. The Company anticipates making payments of $88 thousand during fiscal year 2015. Amounts recognized in the Consolidated Balance Sheets consist of the following (amounts in thousands):
Pension | Other Benefits | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Current liability | $ | (615 | ) | $ | (644 | ) | $ | (88 | ) | $ | (90 | ) | ||||
Noncurrent liability | (32,154 | ) | (29,646 | ) | (697 | ) | (709 | ) | ||||||||
Amount recognized, end of year | $ | (32,769 | ) | $ | (30,290 | ) | $ | (785 | ) | $ | (799 | ) | ||||
Amounts recognized in Accumulated other comprehensive income (loss) consist of the following (amounts in thousands):
Pension | Other Benefits | |||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||
Net actuarial loss (gain) | $ | 9,269 | $ | 9,742 | $ | (1,464 | ) | $ | (1,818 | ) | ||||||
Prior service cost | 310 | 32 | — | — | ||||||||||||
Accumulated other comprehensive income | $ | 9,579 | $ | 9,774 | $ | (1,464 | ) | $ | (1,818 | ) | ||||||
The tax effect on the above balances was $2.2 million and $2.1 million as of March 31, 2014 and 2013, respectively.
Components of benefit costs (credit) consist of the following (amounts in thousands):
Pension | Other Benefits | |||||||||||||||||||||||
2014 | 2013 | 2012 | 2014 | 2013 | 2012 | |||||||||||||||||||
Net service cost | $ | 1,308 | $ | 1,583 | $ | 1,310 | $ | — | $ | — | $ | — | ||||||||||||
Interest cost | 1,734 | 1,903 | 2,111 | 23 | 27 | 44 | ||||||||||||||||||
Expected return on plan assets | (454 | ) | (656 | ) | (712 | ) | — | — | — | |||||||||||||||
Amortization: | ||||||||||||||||||||||||
Actuarial (gain) loss | 318 | 544 | 392 | (259 | ) | (322 | ) | (323 | ) | |||||||||||||||
Prior service cost | 4 | 20 | 25 | — | — | — | ||||||||||||||||||
Recurring activity | 2,910 | 3,394 | 3,126 | (236 | ) | (295 | ) | (279 | ) | |||||||||||||||
Curtailment expense | (32 | ) | 266 | — | — | — | — | |||||||||||||||||
Net periodic benefit cost (credit) | $ | 2,878 | $ | 3,660 | $ | 3,126 | $ | (236 | ) | $ | (295 | ) | $ | (279 | ) | |||||||||
The estimated amounts that will be amortized from accumulated other comprehensive income into net periodic benefit costs in fiscal year 2015 are actuarial losses of $88 thousand, and prior service costs of $18 thousand.
89
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 10: Pension and Other Post-retirement Benefit Plans (Continued)
The asset allocation for the Company's defined benefit pension plans at March 31, 2014 and the target allocation for 2014, by asset category, are as follows:
Asset Category | Target Allocation (%) | Plan Assets at March 31, 2014 (%) | ||
Insurance(1) | 10 | 7 | ||
International equities | 30 | 35 | ||
International bonds | 50 | 57 | ||
Other | 10 | 1 | ||
Total | 100 | 100 | ||
_______________________________________________________________________________
(1) | Comprised of assets held by the defined benefit pension plan in Germany. |
The Company's investment strategy for its defined benefit pension plans is to maximize long-term rate of return on plan assets within an acceptable level of risk in order to minimize the cost of providing pension benefits. The investment policy establishes a target allocation range for each asset class and the fund is managed within those ranges. The plans use a number of investment approaches including insurance products, equity and fixed income funds in which the underlying securities are marketable in order to achieve this target allocation. Certain plans invest solely in insurance products. The Company continuously monitors the performance of the overall pension asset portfolio, asset allocation policies, and the performance of individual pension asset managers and makes adjustments and changes, as required. The Company does not manage any assets internally, does not have any passive investments in index funds, and does not directly utilize futures, options, or other derivative instruments or hedging strategies with regard to the pension plans; however, the investment mandate of some pension asset managers allows the use of the foregoing as components of their portfolio management strategies.
The expected rate of return was determined by modeling the expected long-term rates of return for broad categories of investments held by the plan against a number of various potential economic scenarios.
Other changes in plan assets and benefit obligations recognized in Accumulated other comprehensive income (loss) are as follows (amounts in thousands):
Pension | Other Benefits | |||||||||||||||||||||||
2014 | 2013 | 2012 | 2014 | 2013 | 2012 | |||||||||||||||||||
Current year actuarial (gain) loss | $ | (190 | ) | $ | 3,669 | $ | 2,845 | $ | 95 | $ | (145 | ) | $ | (206 | ) | |||||||||
Foreign currency exchange rate changes | — | (238 | ) | (218 | ) | 259 | 322 | 323 | ||||||||||||||||
Amortization of actuarial gain (loss) | (286 | ) | (4,582 | ) | (392 | ) | — | — | — | |||||||||||||||
Current year prior service cost | 285 | — | — | — | — | — | ||||||||||||||||||
Amortization of prior service cost | (4 | ) | (101 | ) | (25 | ) | — | — | — | |||||||||||||||
Total recognized in other comprehensive income | $ | (195 | ) | $ | (1,252 | ) | $ | 2,210 | $ | 354 | $ | 177 | $ | 117 | ||||||||||
Total recognized in net periodic benefit cost and other comprehensive income (loss) | $ | 2,683 | $ | 2,408 | $ | 5,336 | $ | 118 | $ | (118 | ) | $ | (162 | ) | ||||||||||
Each of these changes has been factored into the following benefit payments schedule for the next ten fiscal years. The Company expects to have benefit payments in the future as follows (amounts in thousands):
Expected benefit payments | ||||||||||||||||||||||||
2015 | 2016 | 2017 | 2018 | 2019 | 2020 - 2024 | |||||||||||||||||||
Pension benefits | $ | 1,476 | $ | 1,575 | $ | 1,680 | $ | 1,615 | $ | 1,959 | $ | 10,765 | ||||||||||||
Other benefits | 89 | 87 | 83 | 79 | 75 | 297 | ||||||||||||||||||
Total | $ | 1,565 | $ | 1,662 | $ | 1,763 | $ | 1,694 | $ | 2,034 | $ | 11,062 | ||||||||||||
90
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 10: Pension and Other Post-retirement Benefit Plans (Continued)
The following weighted-average assumptions were used to determine the projected benefit obligation at the measurement date and the net periodic cost for the pension and post-retirement plan (amounts in thousands except percentages):
Pension | Other Benefits | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||
Projected benefit obligation: | ||||||||||||||
Discount rate | 4.5 | % | 4.5 | % | 3.4 | % | 2.8 | % | ||||||
Rate of compensation increase | 3.4 | % | 3.5 | % | — | — | ||||||||
Health care cost trend on covered charges | — | — | 7.0% decreasing to ultimate trend of 5% in 2018 | 7.0% decreasing to ultimate trend of 5% in 2017 | ||||||||||
Net periodic benefit cost: | ||||||||||||||
Discount rate | 4.5 | % | 4.2 | % | 2.8 | % | 3.5 | % | ||||||
Rate of compensation increase | 3.5 | % | 2.9 | % | — | — | ||||||||
Expected return on plan assets | 4.9 | % | 4.0 | % | — | — | ||||||||
Health care cost trend on covered charges | — | — | 7.0% decreasing to ultimate trend of 5% in 2017 | 7.5% decreasing to ultimate trend of 5% in 2017 | ||||||||||
Sensitivity of retiree welfare results | ||||||||||||||
Effect of a one percentage point increase in assumed health care cost trend: | ||||||||||||||
—On total service and interest costs components | $ | — | $ | — | ||||||||||
—On post-retirement benefits obligation | 15 | 11 | ||||||||||||
Effect of a one percentage point decrease in assumed health care cost trend: | ||||||||||||||
—On total service and interest costs components | — | — | ||||||||||||
—On post-retirement benefits obligation | (13 | ) | (10 | ) | ||||||||||
The measurement date used to determine pension and post-retirement benefits is March 31.
The Company evaluated input from its third-party actuary to determine the appropriate discount rate. The determination of the discount rate is based on various factors such as the rate on bonds, term of the expected payouts, and long-term inflation factors.
91
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 10: Pension and Other Post-retirement Benefit Plans (Continued)
The following table sets forth by level, within the fair value hierarchy as described in Note 1, the pension plan's assets, required to be carried at fair value on a recurring basis as of March 31, 2014 and March 31, 2013 (amounts in thousands):
Fair Value March 31, 2014 | Fair Value Measurement Using | Fair Value March 31, 2013 | Fair Value Measurement Using | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||
Cash and cash equivalents | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||
Equity securities: | ||||||||||||||||||||||||||||||||
International equities | 3,512 | 3,512 | — | — | 2,884 | 2,884 | — | — | ||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||||||||||
International bonds | 5,636 | 5,636 | — | — | 5,098 | 5,098 | — | — | ||||||||||||||||||||||||
Insurance contracts | 706 | — | — | 706 | 636 | — | — | 636 | ||||||||||||||||||||||||
Other | 92 | 92 | — | — | 188 | 188 | — | — | ||||||||||||||||||||||||
$ | 9,946 | $ | 9,240 | $ | — | $ | 706 | $ | 8,806 | $ | 8,170 | $ | — | $ | 636 | |||||||||||||||||
The table below sets forth a summary of changes in the fair value of the defined benefit pension plan's Level 3 assets for the fiscal year ended March 31, 2014 (amounts in thousands):
Balance at March 31, 2013 | $ | 636 | |
Actual return on plan assets | 29 | ||
Employer contributions | 247 | ||
Settlements | — | ||
Benefits paid | (255 | ) | |
Foreign currency exchange rate change | 49 | ||
Balance at March 31, 2014 | $ | 706 | |
The Company also sponsors a deferred compensation plan for highly compensated employees. The plan is non-qualified and allows certain employees to contribute to the plan. Gains net of the Company matches related to the deferred compensation plan were $189 thousand in fiscal year 2014, $141 thousand in fiscal year 2013, and $26 thousand in fiscal year 2012. Total benefits accrued under this plan were $1.6 million and $1.9 million at March 31, 2014 and March 31, 2013, respectively.
In addition, the Company has a defined contribution retirement plan (the "Savings Plan") in which all United States employees who meet certain eligibility requirements may participate. A participant may direct the Company to contribute amounts, based on a percentage of the participant's compensation, to the Savings Plan through the execution of salary reduction agreements. In addition, the participants may elect to make after-tax contributions. The Company matches contributions to the Savings Plan up to 6% of the employee's salary. The Company made matching contributions of $2.2 million, $2.5 million and $2.2 million in fiscal years 2014, 2013, and 2012, respectively.
Note 11: Stock-Based Compensation
The Company's stock-based compensation plans are broad-based, long-term retention programs intended to attract and retain talented employees and align stockholder and employee interests.
92
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 11: Stock-Based Compensation (Continued)
The major components of stock-based compensation expense are as follows (amounts in thousands):
Fiscal Year Ended March 31, 2014 | Fiscal Year Ended March 31, 2013 | Fiscal Year Ended March 31, 2012 | ||||||||||||||||||||||||||||||||||
Stock Options | Restricted Stock | LTIPs | Stock Options | Restricted Stock | LTIPs | Stock Options | Restricted Stock | LTIPs | ||||||||||||||||||||||||||||
Cost of sales | $ | 421 | $ | 62 | $ | 523 | $ | 710 | $ | 445 | $ | 356 | $ | 542 | $ | 81 | $ | 176 | ||||||||||||||||||
Selling, general and administrative expenses | 413 | 580 | 712 | 872 | 1,303 | 725 | 788 | 688 | 800 | |||||||||||||||||||||||||||
Research and development | 5 | — | 193 | 58 | — | 130 | — | — | — | |||||||||||||||||||||||||||
$ | 839 | $ | 642 | $ | 1,428 | $ | 1,640 | $ | 1,748 | $ | 1,211 | $ | 1,330 | $ | 769 | $ | 976 | |||||||||||||||||||
Employee Stock Options
At March 31, 2014, the Company had four stock option plans that reserved shares of common stock for issuance to executives and key employees: the 1992 Key Employee Stock Option Plan, the 1995 Executive Stock Option Plan, the 2004 Long-Term Equity Incentive Plan (collectively, the "Prior Plans") and the 2011 Omnibus Equity Incentive Plan (the "2011 Incentive Plan"). All of these plans were approved by the Company's stockholders. The 2011 Incentive Plan authorized the grant of up to 4.8 million shares of the Company's common stock, which is comprised of 4.0 million shares under the new plan and 0.8 million shares which remained under the Prior Plans. The 2011 Incentive Plan authorizes the Company to provide equity-based compensation in the form of (1) stock options, including incentive stock options, entitling the optionee to favorable tax treatment under Section 422 of the Code; (2) stock appreciation rights; (3) restricted stock and restricted stock units; (4) other share-based awards; and (5) performance awards. Options issued under these plans vest within one to three years and expire ten years from the grant date. Stock options granted to the Company's Chief Executive Officer on January 27, 2010 vest 50% on June 30, 2014 and 50% on June 30, 2015. If available, the Company issues shares of Common Stock from treasury stock upon exercise of stock options and vesting of restricted stock units. The Company has no plans to purchase additional shares in conjunction with its employee stock option program in the near future.
Employee stock option activity for fiscal year 2014 is as follows (amounts in thousands, except exercise price, fair value and contractual life):
Options | Weighted- Average Exercise Price | ||||||
Outstanding at March 31, 2013 | 1,817 | $ | 11.64 | ||||
Granted | 312 | 5.89 | |||||
Exercised | (89 | ) | 2.82 | ||||
Forfeited | (280 | ) | 12.34 | ||||
Expired | (109 | ) | 38.43 | ||||
Outstanding at March 31, 2014 | 1,651 | 9.15 | |||||
Exercisable at March 31, 2014 | 1,000 | $ | 11.30 | ||||
Remaining weighted average contractual life of options exercisable (years) | 5.4 | ||||||
Remaining weighted average contractual life of options outstanding (years) | 6.6 | ||||||
At March 31, 2014 and 2013, the weighted average grant-date fair value of non-vested shares was $3.13 and $4.09, respectively. The weighted average grant-date fair value of shares granted, vested, and forfeited during fiscal year 2014 was $2.71, $4.55 and $5.47, respectively. The total estimated fair value of shares vested during fiscal years 2014, 2013 and 2012 was $1.1 million, $1.7 million and $0.6 million, respectively. The intrinsic value of stock options exercised in fiscal years 2014, 2013, and 2012 was $0.2 million, $0.2 million and $1.0 million, respectively.
As of March 31, 2014, the intrinsic value related to options outstanding was $1.0 million. The intrinsic value of options currently exercisable was $0.7 million. Total unrecognized compensation cost, net of estimated forfeitures, related to non-vested options was $0.9 million as of March 31, 2014. This cost is expected to be recognized over a weighted-average period of
93
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 11: Stock-Based Compensation (Continued)
1.2 years. At March 31, 2014 and 2013, respectively, the weighted average exercise price of stock options expected to vest was $5.84 and$6.81, respectively. The Company measures the fair value of each employee stock option grant at the date of grant using a Black-Scholes option pricing model. This model requires the input of assumptions regarding a number of complex and subjective variables that will usually have a significant impact on the fair value estimate. The following table summarizes the weighted average assumptions used in the Black-Scholes valuation model to value stock option grants:
Fiscal Years Ended March 31, | |||||||||
2014 | 2013 | 2012 | |||||||
Assumptions: | |||||||||
Expected volatility | 59.8 | % | 70.9 | % | 83.2 | % | |||
Risk-free interest rate | 1.0 | % | 0.5 | % | 0.7 | % | |||
Expected option lives in years | 4.0 | 4.0 | 4.1 | ||||||
Dividend yield | — | — | — | ||||||
The expected volatility is based on a historical volatility calculation of the Company's stock price. The risk-free rate is based on the U.S. Treasury yield with a maturity commensurate with the expected term. The expected term is based on the Company's historical option term which considers the weighted-average vesting, contractual term and vesting schedule. In addition, stock-based compensation expense is calculated based on the number of awards that are ultimately expected to vest, and therefore has been reduced for estimated forfeitures. The Company's estimate of expected forfeitures is based on the Company's actual historical annual forfeiture rate of 2.0%. The estimated forfeiture rate, which is evaluated each balance sheet date throughout the life of the award, provides a time-based adjustment of forfeited shares. The estimated forfeiture rate is reassessed at each balance sheet date and may change based on new facts and circumstances. The dividend yield is based on a set dividend rate of 0.0% as the Company has not paid and does not anticipate paying dividends.
All options plans provide that options to purchase shares be supported by the Company's authorized but unissued common stock or treasury stock. All restricted stock and performance awards are also supported by the Company's authorized but unissued common stock or treasury stock. The prices of the options granted pursuant to these plans are not less than 100% of the value of the shares on the date of the grant.
Performance Vesting Stock Options
During fiscal year 2006, the Company issued 166,667 performance awards with a weighted-average exercise price of $24.15 to the Chief Executive Officer which will entitle him to receive shares of common stock if and when the stock price maintains certain thresholds. These awards are open ended until they vest and will have a ten-year life after vesting or will expire on the third year following retirement, whichever comes first. Effective March 4, 2010, 83,333 of these awards were voluntarily relinquished and no concurrent grant, replacement award or other valuable consideration was provided.
Restricted Stock
Restricted stock activity for fiscal year 2014 is as follows (amounts in thousands except fair value):
Shares | Weighted- average Fair Value on Grant Date | ||||||
Non-vested restricted stock at March 31, 2013 | 441 | $ | 7.15 | ||||
Granted | 47 | 4.24 | |||||
Vested | (100 | ) | 6.71 | ||||
Forfeited | (80 | ) | 8.05 | ||||
Non-vested restricted stock at March 31, 2014 | 308 | 6.62 | |||||
The Company grants shares of restricted stock to members of the Board of Directors, the Chief Executive Officer and a limited group of executives. In fiscal year 2014, restricted stock granted to the Board of Directors vests in one year, and restricted
94
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 11: Stock-Based Compensation (Continued)
stock granted to certain executives vests 50% in two years and 50% in 3 years. In fiscal year 2013, restricted stock granted to the Board of Directors vests in nine months, restricted stock granted to the Chief Executive Officer vests on June 30, 2017 and restricted stock granted to certain executives vests 25% per year over four years. The contractual term on restricted stock is indefinite. Once vested, restricted shares cannot be sold until 90 days after the Chief Executive Officer, the executive or the member of the Board of Directors, as applicable, resigns from his or her position, or until the individual achieves the targeted ownership under the Company's stock ownership guidelines, and only to the extent that such ownership exceeds the target. As of March 31, 2014 and 2013, unrecognized compensation costs related to the unvested restricted stock share based compensation arrangements granted was $0.8 million and $1.8 million, respectively. The expense is being recognized over the respective vesting periods.
Long-term Incentive Plans ("LTIP")
Historically the Board of Directors of the Company has approved annual Long Term Incentive Plans which cover two year periods. The LTIPs are primarily based upon the achievement of an Adjusted EBITDA target for the two-year period. At the time of the award, the individual plans entitle the participants to receive cash or restricted shares of the Company's common stock, or a combination of both. The 2013/2014 LTIP and 2014/2015 LTIP also awarded restricted stock shares which vest over the course of three years from the anniversary of the establishment of the plan and are not subject to a performance metric. The Company assesses the likelihood of meeting the Adjusted EBITDA financial metric on a quarterly basis and adjusts compensation expense to match expectations. Any related liability is reflected in the line item "Accrued expenses" on the Consolidated Balance Sheets and any restricted stock commitment is reflected in the line item "Additional paid-in capital" on the Consolidated Balance Sheets. The Company issued 224 thousand restricted shares subject to a performance metric under the 2011/2012 LTIP. The Company granted 444 thousand and 501 thousand shares subject only to a time-based vesting schedule under the 2013/2014 LTIP and 2014/2015 LTIP, respectively.
In the Operating activities section of the Consolidated Statements of Cash Flows, stock-based compensation expense was treated as an adjustment to net income (loss) for fiscal years 2014, 2013 and 2012.
Note 12: Income Taxes
The components of Income (loss) from continuing operations before income taxes and equity loss from NEC TOKIN consists of (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Domestic (U.S.) | $ | (89,529 | ) | $ | (88,939 | ) | $ | (4,591 | ) | |||
Foreign (Outside U.S.) | 33,232 | 14,962 | 3,317 | |||||||||
Total | $ | (56,297 | ) | $ | (73,977 | ) | $ | (1,274 | ) | |||
95
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 12: Income Taxes (Continued)
The provision (benefit) for Income tax expense is as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Current: | ||||||||||||
Federal | $ | — | $ | — | $ | (938 | ) | |||||
State and local | 35 | 37 | 49 | |||||||||
Foreign | 7,816 | 3,561 | 6,519 | |||||||||
Total current income tax expense from continuing operations | 7,851 | 3,598 | 5,630 | |||||||||
Deferred: | ||||||||||||
Federal | (1,694 | ) | (65 | ) | 11 | |||||||
State and local | 406 | 700 | (394 | ) | ||||||||
Foreign | (5,081 | ) | (952 | ) | (4,171 | ) | ||||||
Deferred tax benefit from continuing operations | (6,369 | ) | (317 | ) | (4,554 | ) | ||||||
Income tax expense | $ | 1,482 | $ | 3,281 | $ | 1,076 | ||||||
A reconciliation of the statutory federal income tax rate to the effective income tax rate is as follows:
Fiscal Years Ended March 31, | |||||||||
2014 | 2013 | 2012 | |||||||
Statutory U.S. federal income tax rate | 35.0 | % | 35.0 | % | 35.0 | % | |||
Change in U.S. valuation allowance | (37.3 | )% | (36.6 | )% | (33.7 | )% | |||
Taxable foreign source income | (6.0 | )% | (4.9 | )% | (30.8 | )% | |||
State income taxes, net of federal taxes | (0.8 | )% | (1.0 | )% | (32.2 | )% | |||
Other non-deductible expenses | (0.3 | )% | (0.5 | )% | (23.1 | )% | |||
Income tax settlements | — | % | — | % | 93.5 | % | |||
Change in foreign operations valuation allowance | 3.2 | % | 6.2 | % | 744.0 | % | |||
Other effect of foreign operations | 3.6 | % | (2.6 | )% | (837.2 | )% | |||
Effective income tax rate | (2.6 | )% | (4.4 | )% | (84.5 | )% | |||
96
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 12: Income Taxes (Continued)
The components of deferred tax assets and liabilities are as follows (amounts in thousands):
March 31, | ||||||||
2014 | 2013 | |||||||
Deferred tax assets: | ||||||||
Net operating loss carry forwards | $ | 173,377 | $ | 154,841 | ||||
Sales allowances and inventory reserves | 19,447 | 14,683 | ||||||
Tax credits | 10,838 | 11,664 | ||||||
Medical and employee benefits | 10,035 | 7,868 | ||||||
Stock options | 4,439 | 3,416 | ||||||
Other | 4,338 | 4,615 | ||||||
Total deferred tax assets before valuation allowance | 222,474 | 197,087 | ||||||
Less valuation allowance | (189,276 | ) | (169,270 | ) | ||||
Total deferred tax assets | 33,198 | 27,817 | ||||||
Deferred tax liabilities: | ||||||||
Depreciation and differences in basis | (13,299 | ) | (14,629 | ) | ||||
Amortization of intangibles and debt discounts | (7,420 | ) | (6,978 | ) | ||||
Non-amortized intangibles | (2,549 | ) | (2,542 | ) | ||||
Other | (1,682 | ) | (72 | ) | ||||
Total deferred tax liabilities | (24,950 | ) | (24,221 | ) | ||||
Net deferred tax asset | $ | 8,248 | $ | 3,596 | ||||
The following table presents the annual activities included in the deferred tax valuation allowance:
Valuation Allowance for Deferred Tax Assets | |||
Balance at March 31, 2011 | $ | 143,216 | |
Charge to costs and expenses | 10,206 | ||
Deductions | (4,116 | ) | |
Balance at March 31, 2012 | 149,306 | ||
Charge to costs and expenses | 23,977 | ||
Deductions | (4,013 | ) | |
Balance at March 31, 2013 | 169,270 | ||
Charge to costs and expenses | 21,515 | ||
Deductions | (1,509 | ) | |
Balance at March 31, 2014 | $ | 189,276 | |
In fiscal year 2014, the valuation allowance increased $20.0 million primarily as a result of the increase in federal net operating loss carryforwards. In fiscal year 2013, the valuation allowance increased $20.0 million primarily as a result of the increase in federal net operating loss carryforwards offset by a decrease in net operating loss carryforwards in certain foreign jurisdictions. In fiscal year 2012, the valuation allowance decreased $6.1 million primarily as a result of the increase in federal net operating loss carryforwards offset by a decrease in net operating loss carryforwards in certain foreign jurisdictions. Deductions in fiscal years 2014, 2013 and 2012 resulted from expiring net operating loss carryforwards and expiring tax credits in certain U.S. state and foreign jurisdictions.
97
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 12: Income Taxes (Continued)
The change in net deferred income tax asset (liability) for the current year is presented below (amounts in thousands):
Balance at March 31, 2013 | $ | 3,596 | |
Deferred income taxes related to continuing operations (1) | 6,369 | ||
Deferred income taxes related to other comprehensive income | (1,758 | ) | |
Foreign currency translation | 41 | ||
Balance at March 31, 2014 | $ | 8,248 | |
(1) Fiscal year ended March 31, 2014 includes a federal tax expense of $1.7 million allocated to other comprehensive income.
As of March 31, 2014 and 2013, the Company's gross deferred tax assets are reduced by a valuation allowance of $189.3 million and $169.3 million, respectively. A full valuation allowance on U.S. deferred tax assets was determined to be necessary based on the existence of significant negative evidence such as a cumulative three-year loss of the U.S. consolidated group.
In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will realize the benefits of these deductible differences, net of the existing valuation allowances as of March 31, 2014. However, the amount of deferred tax assets considered realizable could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced.
As of March 31, 2014, the Company had U.S. federal net operating loss carryforwards of $404.8 million. These U.S. federal net operating losses were incurred from 2004 through 2014 and are available to offset future federal taxable income, if any, through 2034. The Company had state net operating losses of $449.8 million, of which $3.4 million will expire in one year if unused. These state net operating losses are available to offset future state taxable income, if any, through 2034. Foreign subsidiaries, primarily in Finland, Italy, Portugal and Sweden had net operating loss carryforwards totaling $78.3 million of which $3.6 million will expire in one year if unused. The net operating losses in Portugal and Finland are available to offset future taxable income through 2018 and 2019, respectively. The net operating losses in Italy and Sweden are available indefinitely to offset future taxable income. For the U.S. there is a greater likelihood of not realizing the future tax benefits of these deferred tax assets; and accordingly, the Company has recorded valuation allowances related to the net deferred tax assets in these jurisdictions. For the foreign jurisdictions with net operating loss carryforwards, a valuation allowance has been recorded where the Company does not expect to fully realize the deferred tax assets in the future.
Utilization of the Company's net operating loss carryforwards may be subject to substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended (the "Code") and similar state provisions. Such an annual limitation could result in the expiration of the net operating loss and tax credit carryforwards before utilization. The issuance of the Platinum Warrant may have given rise to an "ownership change" for purposes of Section 382 of the Code. If such an ownership change were deemed to have occurred, the amount of our taxable income that could be offset by the Company's net operating loss carryovers in taxable years after the ownership change would be severely limited. While the Company believes that the issuance of the Platinum Warrant did not result in an ownership change for purposes of Section 382 of the Code, there is no assurance that the Company's view will be unchallenged. Moreover, a future exercise of part or all of the Platinum Warrant may give rise to an ownership change in the future. Blue Powder was acquired which has substantial federal net operating losses that will now be limited due to the ownership change which occurred.
98
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 12: Income Taxes (Continued)
At March 31, 2014, the U.S. consolidated group of companies had the following tax credit carryforwards available (amounts in thousands):
Tax Credits ($) | Fiscal Year of Expiration | ||||
U.S. foreign tax credits | 6,908 | 2017 | |||
U.S. research credits | 533 | 2023 | |||
Texas franchise tax credits | 3,396 | 2026 | |||
At March 31, 2014, unremitted earnings of the subsidiaries outside the United States were deemed to be permanently invested. The Company has $80.8 million of unremitted foreign earnings. There are no current plans to repatriate foreign earnings and no deferred tax liability was recognized with regard to such earnings. It is not practicable to estimate the income tax liability that might be incurred if such earnings were remitted to the United States.
At March 31, 2014, the Company had $5.7 million of unrecognized tax benefits. A reconciliation of gross unrecognized tax benefits (excluding interest and penalties) is as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Beginning of fiscal year | $ | 5,395 | $ | 6,321 | $ | 5,156 | ||||||
Additions for tax positions of the current year | 639 | 35 | 433 | |||||||||
Additions for tax positions of prior years | 19 | 37 | 820 | |||||||||
Reductions for tax positions of prior years | (28 | ) | (640 | ) | (39 | ) | ||||||
Lapse in statute of limitations | — | (358 | ) | — | ||||||||
Settlements | (334 | ) | — | (49 | ) | |||||||
End of fiscal year | $ | 5,691 | $ | 5,395 | $ | 6,321 | ||||||
At March 31, 2014, $0.9 million of the $5.7 million of unrecognized income tax benefits would affect the Company's effective income tax rate, if recognized. It is reasonably possible that the total unrecognized tax benefit could decrease by $0.4 million in fiscal year 2015 related to uncertain tax positions in certain foreign jurisdictions which may settle or close.
The Company files income tax returns in the U.S. and multiple foreign jurisdictions, including various state and local jurisdictions. The U.S. Internal Revenue Service concluded its examinations of the Company's U.S. federal tax returns for all tax years through 2003. Because of net operating losses, the Company's U.S. federal returns for 2003 and later years will remain subject to examination until the losses are utilized. For our more significant foreign locations, we are subject to income tax examinations for the years 2008 and forward in Mexico and Portugal; and 2010 and forward in China, and Italy. The Company recognizes potential accrued interest and penalties related to unrecognized income tax benefits within its global operations in income tax expense. The Company had $0.4 million and $0.3 million of accrued interest and penalties respectively at March 31, 2014 and March 31, 2013, which is included as a component of income tax expense. To the extent interest and penalties are not assessed with respect to uncertain tax positions, amounts accrued will be reduced and reflected as a reduction of the overall income tax provision.
99
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 13: Supplemental Balance Sheets and Statements of Operations Detail (amounts in thousands)
March 31, | ||||||||
2014 | 2013 | |||||||
Accounts receivable: | ||||||||
Trade | $ | 123,607 | $ | 112,292 | ||||
Allowance for doubtful accounts | (1,401 | ) | (1,255 | ) | ||||
Ship-from-stock and debit | (18,041 | ) | (14,116 | ) | ||||
Returns | (2,993 | ) | (1,421 | ) | ||||
Rebates | (1,035 | ) | (1,071 | ) | ||||
Price protection | (125 | ) | (376 | ) | ||||
Other | (1,065 | ) | (279 | ) | ||||
$ | 98,947 | $ | 93,774 | |||||
The Company has agreements with distributors and certain other customers that, under certain conditions, allow for returns of overstocked inventory, provide protection against price reductions initiated by the Company and grant other sales allowances. Allowances for these commitments are included in the Consolidated Balance Sheets as reductions in trade accounts receivable. The Company adjusts sales based on historical experience. The following table presents the annual activities included in the allowance for these commitments:
Balance at March 31, 2011 | $ | 17,335 | |
Charged to operations | 71,462 | ||
Write-offs | (71,237 | ) | |
Other | (97 | ) | |
Balance at March 31, 2012 | 17,463 | ||
Charged to operations | 82,738 | ||
Write-offs | (81,621 | ) | |
Other | (62 | ) | |
Balance at March 31, 2013 | 18,518 | ||
Charged to operations | 89,909 | ||
Write-offs | (83,911 | ) | |
Other | 144 | ||
Balance at March 31, 2014 | $ | 24,660 | |
March 31, | ||||||||
2014 | 2013 | |||||||
Inventories: | ||||||||
Raw materials and supplies | $ | 90,968 | $ | 84,149 | ||||
Work in process | 61,310 | 64,498 | ||||||
Finished goods | 62,522 | 68,705 | ||||||
214,800 | 217,352 | |||||||
Inventory reserves | (26,826 | ) | (18,464 | ) | ||||
$ | 187,974 | $ | 198,888 | |||||
100
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 13: Supplemental Balance Sheets and Statements of Operations Detail (amounts in thousands) (Continued)
The following table presents the annual activities included in the inventory reserves:
Balance at March 31, 2011 | $ | 15,464 | |
Costs charged to expense | 9,941 | ||
Write-offs | (8,253 | ) | |
Other | (8 | ) | |
Balance at March 31, 2012 | 17,144 | ||
Costs charged to expense | 3,145 | ||
Write-offs | (1,488 | ) | |
Other | (337 | ) | |
Balance at March 31, 2013 | 18,464 | ||
Costs charged to expense | 10,638 | ||
Write-offs | (2,672 | ) | |
Other | 396 | ||
Balance at March 31, 2014 | $ | 26,826 | |
Useful life (years) | March 31, | |||||||||
2014 | 2013 | |||||||||
Property, plant and equipment: | ||||||||||
Land and land improvements | 20 | $ | 25,965 | $ | 25,824 | |||||
Buildings | 20 - 40 | 163,062 | 145,977 | |||||||
Machinery and equipment | 10 | 824,878 | 809,885 | |||||||
Furniture and fixtures | 4 - 10 | 69,676 | 62,071 | |||||||
Construction in progress | 14,754 | 31,323 | ||||||||
Total property and equipment | 1,098,335 | 1,075,080 | ||||||||
Accumulated depreciation | (805,687 | ) | (771,398 | ) | ||||||
$ | 292,648 | $ | 303,682 | |||||||
March 31, | ||||||||
2014 | 2013 | |||||||
Accrued expenses: | ||||||||
Salaries, wages, and related employee costs | $ | 23,596 | $ | 20,971 | ||||
Deferred acquisition payments | 19,153 | 22,135 | ||||||
Vacation | 10,570 | 12,582 | ||||||
Interest | 15,735 | 15,628 | ||||||
Restructuring | 6,217 | 13,871 | ||||||
Other | 1,197 | 7,991 | ||||||
$ | 76,468 | $ | 93,178 | |||||
101
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 13: Supplemental Balance Sheets and Statements of Operations Detail (amounts in thousands) (Continued)
March 31, | ||||||||
2014 | 2013 | |||||||
Other non-current obligations: | ||||||||
Deferred acquisition payments | $ | — | $ | 17,585 | ||||
Pension plans | 32,852 | 30,355 | ||||||
Employee separation liability | 15,419 | 14,322 | ||||||
Deferred construction costs | — | 2,476 | ||||||
Restructuring | — | 205 | ||||||
Other | 7,593 | 4,079 | ||||||
$ | 55,864 | $ | 69,022 | |||||
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Other (income) expense, net: | ||||||||||||
Net foreign exchange (gains) losses | $ | (304 | ) | $ | (28 | ) | $ | 919 | ||||
Miscellaneous non-product income | — | (465 | ) | — | ||||||||
Other | (2,377 | ) | (1,802 | ) | 46 | |||||||
$ | (2,681 | ) | $ | (2,295 | ) | $ | 965 | |||||
Note 14: Income/Loss Per Share
Basic earnings per share calculation is based on the weighted-average number of common shares outstanding. Diluted earnings per share calculation is based on the weighted-average number of common shares outstanding adjusted by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued. Potentially dilutive shares of common stock include stock options and Platinum Warrant.
102
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 14: Income/Loss Per Share (Continued)
The following table presents the basic and diluted weighted-average number of shares of common stock (amounts in thousands, except per share data):
Fiscal Years Ended March 31, | ||||||||||||
2014 | 2013 | 2012 | ||||||||||
Numerator | ||||||||||||
Loss from continuing operations | $ | (64,869 | ) | $ | (78,512 | ) | $ | (2,350 | ) | |||
Income (loss) from discontinued operations | (3,634 | ) | (3,670 | ) | 9,042 | |||||||
Net income (loss) | $ | (68,503 | ) | $ | (82,182 | ) | $ | 6,692 | ||||
Denominator: | ||||||||||||
Weighted-average common shares outstanding: | ||||||||||||
Basic | 45,102 | 44,897 | 43,285 | |||||||||
Assumed conversion of employee stock options | — | — | 281 | |||||||||
Assumed conversion of Platinum Warrant | — | — | 8,754 | |||||||||
Weighted-average shares outstanding (diluted) | 45,102 | 44,897 | 52,320 | |||||||||
Net income (loss) per basic share: | ||||||||||||
Loss from continuing operations | $ | (1.44 | ) | $ | (1.75 | ) | $ | (0.05 | ) | |||
Income (loss) from discontinued operations | $ | (0.08 | ) | $ | (0.08 | ) | $ | 0.21 | ||||
Net income (loss) | $ | (1.52 | ) | $ | (1.83 | ) | $ | 0.16 | ||||
Net income (loss) per diluted share: | ||||||||||||
Loss from continuing operations | $ | (1.44 | ) | $ | (1.75 | ) | $ | (0.04 | ) | |||
Income (loss) from discontinued operations | $ | (0.08 | ) | $ | (0.08 | ) | $ | 0.17 | ||||
Net income (loss) | $ | (1.52 | ) | $ | (1.83 | ) | $ | 0.13 | ||||
Common stock equivalents that could potentially dilute net income per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been antidilutive, were as follows (amounts in thousands):
Fiscal Years Ended March 31, | |||||||||
2014 | 2013 | 2012 | |||||||
Assumed conversion of employee stock options | 1,761 | 1,996 | 860 | ||||||
Assumed conversion of Platinum Warrant | 6,704 | 6,836 | — | ||||||
Note 15: Commitments and Contingencies
The Company's leases are primarily for distribution facilities or sales offices that expire principally between 2014 and 2023. A number of leases require the Company to pay certain executory costs (taxes, insurance, and maintenance) and contain certain renewal and purchase options. Annual rental expenses for operating leases were included in results of operations and were $9.9 million, $10.1 million and $9.8 million in fiscal years 2014, 2013, and 2012, respectively.
103
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 15: Commitments and Contingencies (Continued)
Future minimum lease payments over the next five fiscal years and thereafter under non-cancellable operating leases at March 31, 2014, are as follows (amounts in thousands):
Fiscal Years Ended March 31, | ||||||||||||||||||||||||
2015 | 2016 | 2017 | 2018 | 2019 | Thereafter | |||||||||||||||||||
Minimum lease payments | $ | 8,734 | $ | 5,379 | $ | 2,805 | $ | 2,248 | $ | 1,347 | $ | 1,863 | ||||||||||||
Sublease rental income | (252 | ) | (21 | ) | — | — | — | — | ||||||||||||||||
Net minimum lease payments | $ | 8,482 | $ | 5,358 | $ | 2,805 | $ | 2,248 | $ | 1,347 | $ | 1,863 | ||||||||||||
The Company or its subsidiaries are at any one time parties to a number of lawsuits arising out of their respective operations, including workers' compensation or work place safety cases, some of which involve claims of substantial damages. Although there can be no assurance, based upon information known to the Company, the Company does not believe that any liability which might result from an adverse determination of such lawsuits would have a material adverse effect on the Company's financial condition or results of operations.
Note 16: Quarterly Results of Operations (Unaudited)
The following table sets forth certain quarterly information for fiscal years 2014 and 2013. This information, in the opinion of the Company's management, reflects all adjustments (consisting only of normal recurring adjustments) necessary to present fairly this information when read in conjunction with the consolidated financial statements and notes thereto included elsewhere herein (amounts in thousands except per share data):
Fiscal Year 2014 Quarters Ended | ||||||||||||||||
Jun-30 | Sep-30 | Dec-31 | Mar-31 | |||||||||||||
Net sales | $ | 202,057 | $ | 208,449 | $ | 207,339 | $ | 215,821 | ||||||||
Operating income (loss)(1) | (18,212 | ) | 1,585 | 3,623 | (5,207 | ) | ||||||||||
Loss from continuing operations | (33,630 | ) | (11,945 | ) | (4,744 | ) | (14,550 | ) | ||||||||
Income (loss) from discontinued operations | (1,510 | ) | (1,151 | ) | (1,076 | ) | 103 | |||||||||
Net loss | (35,140 | ) | (13,096 | ) | (5,820 | ) | (14,447 | ) | ||||||||
Net loss per basic share: | ||||||||||||||||
Loss from continuing operations | $ | (0.75 | ) | $ | (0.26 | ) | $ | (0.11 | ) | $ | (0.32 | ) | ||||
Loss from discontinued operations | $ | (0.03 | ) | $ | (0.03 | ) | $ | (0.02 | ) | $ | — | |||||
Net loss | $ | (0.78 | ) | $ | (0.29 | ) | $ | (0.13 | ) | $ | (0.32 | ) | ||||
Net loss per diluted share: | ||||||||||||||||
Loss from continuing operations | $ | (0.75 | ) | $ | (0.26 | ) | $ | (0.11 | ) | $ | (0.32 | ) | ||||
Loss from discontinued operations | $ | (0.03 | ) | $ | (0.03 | ) | $ | (0.02 | ) | $ | — | |||||
Net loss | $ | (0.78 | ) | $ | (0.29 | ) | $ | (0.13 | ) | $ | (0.32 | ) | ||||
104
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 16: Quarterly Results of Operations (Unaudited)
Fiscal Year 2013 Quarters Ended | ||||||||||||||||
Jun-30 | Sep-30 | Dec-31 | Mar-31 | |||||||||||||
Net sales | $ | 215,500 | $ | 211,165 | $ | 197,697 | $ | 199,539 | ||||||||
Operating loss(1) | (4,323 | ) | (12,872 | ) | (3,437 | ) | (14,448 | ) | ||||||||
Loss from continuing operations | (17,997 | ) | (23,642 | ) | (13,169 | ) | (23,704 | ) | ||||||||
Income (loss) from discontinued operations | 243 | (1,278 | ) | (1,088 | ) | (1,547 | ) | |||||||||
Net loss | (17,754 | ) | (24,920 | ) | (14,257 | ) | (25,251 | ) | ||||||||
Net income (loss) per basic share: | ||||||||||||||||
Loss from continuing operations | $ | (0.40 | ) | $ | (0.53 | ) | $ | (0.29 | ) | $ | (0.53 | ) | ||||
Income (loss) from discontinued operations | $ | — | $ | (0.03 | ) | $ | (0.03 | ) | $ | (0.03 | ) | |||||
Net loss | $ | (0.40 | ) | $ | (0.56 | ) | $ | (0.32 | ) | $ | (0.56 | ) | ||||
Net loss per diluted share: | ||||||||||||||||
Loss from continuing operations | $ | (0.40 | ) | $ | (0.53 | ) | $ | (0.29 | ) | $ | (0.53 | ) | ||||
Loss from discontinued operations | $ | — | $ | (0.03 | ) | $ | (0.03 | ) | $ | (0.03 | ) | |||||
Net loss | $ | (0.40 | ) | $ | (0.56 | ) | $ | (0.32 | ) | $ | (0.56 | ) | ||||
_______________________________________________________________________________
(1) | Operating income (loss) as a percentage of net sales fluctuates from quarter to quarter due to a number of factors, including net sales fluctuations, restructuring charges, product mix, the timing and expense of moving product lines to lower-cost locations, the write-down of long lived assets, the net gain/loss on sales and disposals of assets and the relative mix of sales among distributors, original equipment manufacturers, and electronic manufacturing service providers. |
Note 17: Condensed Consolidating Financial Statements
As discussed in Note 2, "Debt", the Company's 10.5% Senior Notes are fully and unconditionally guaranteed, jointly and severally, on a senior basis by certain of the Company's 100% owned domestic subsidiaries ("Guarantor Subsidiaries") and secured by a first priority lien on 51% of the capital stock of certain of the Company's foreign restricted subsidiaries ("Non-Guarantor Subsidiaries"). The Company's Guarantor Subsidiaries are not consistent with the Company's business groups or geographic operations; accordingly this basis of presentation is not intended to present the Company's financial condition, results of operations or cash flows for any purpose other than to comply with the specific requirements for subsidiary guarantor reporting. We are required to present condensed consolidating financial information in order for the subsidiary guarantors of the Company's public debt to be exempt from reporting under the Securities Exchange Act of 1934, as amended.
Condensed consolidating financial statements for the Company's Guarantor Subsidiaries and Non-Guarantor Subsidiaries are presented in the following tables (amounts in thousands):
105
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 17: Condensed Consolidating Financial Statements (Continued)
Condensed Consolidating Balance Sheet
March 31, 2014
Parent | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Reclassifications and Eliminations | Consolidated | ||||||||||||||||
ASSETS | ||||||||||||||||||||
Current assets: | ||||||||||||||||||||
Cash and cash equivalents | $ | 616 | $ | 22,200 | $ | 35,113 | $ | — | $ | 57,929 | ||||||||||
Accounts receivable, net | — | 49,462 | 49,485 | — | 98,947 | |||||||||||||||
Intercompany receivable | 318,582 | 329,211 | 203,018 | (850,811 | ) | — | ||||||||||||||
Inventories, net | — | 119,340 | 68,634 | — | 187,974 | |||||||||||||||
Prepaid expenses and other | 3,146 | 15,286 | 21,380 | (2,941 | ) | 36,871 | ||||||||||||||
Deferred income taxes | — | 1,022 | 5,673 | — | 6,695 | |||||||||||||||
Current assets of discontinued operations | — | — | 12,160 | — | 12,160 | |||||||||||||||
Total current assets | 322,344 | 536,521 | 395,463 | (853,752 | ) | 400,576 | ||||||||||||||
Property and equipment, net | 329 | 104,874 | 187,445 | — | 292,648 | |||||||||||||||
Investments in NEC TOKIN | — | 46,419 | — | — | 46,419 | |||||||||||||||
Investments in subsidiaries | 402,090 | 424,386 | 30,285 | (856,761 | ) | — | ||||||||||||||
Goodwill | — | 35,584 | — | — | 35,584 | |||||||||||||||
Intangible assets, net | — | 28,380 | 8,804 | — | 37,184 | |||||||||||||||
Restricted cash | — | 13,512 | — | — | 13,512 | |||||||||||||||
Deferred income taxes | — | 1,010 | 5,768 | — | 6,778 | |||||||||||||||
Other assets | 5,415 | 3,895 | 820 | — | 10,130 | |||||||||||||||
Noncurrent assets of discontinued operations | — | — | 836 | — | 836 | |||||||||||||||
Long-term intercompany receivable | 81,746 | 60,663 | 2,801 | (145,210 | ) | — | ||||||||||||||
Total assets | $ | 811,924 | $ | 1,255,244 | $ | 632,222 | $ | (1,855,723 | ) | $ | 843,667 | |||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Current liabilities: | ||||||||||||||||||||
Current portion of long-term debt | $ | 5,988 | $ | — | $ | 1,309 | $ | — | $ | 7,297 | ||||||||||
Accounts payable, trade | 84 | 36,579 | 38,155 | — | 74,818 | |||||||||||||||
Intercompany payable | 176,624 | 570,535 | 103,652 | (850,811 | ) | — | ||||||||||||||
Accrued expenses | 34,236 | 13,698 | 28,534 | — | 76,468 | |||||||||||||||
Income taxes payable | — | 2,909 | 1,012 | (2,941 | ) | 980 | ||||||||||||||
Current liabilities of discontinued operations | — | — | 7,269 | — | 7,269 | |||||||||||||||
Total current liabilities | 216,932 | 623,721 | 179,931 | (853,752 | ) | 166,832 | ||||||||||||||
Long-term debt, less current portion | 372,251 | 6,449 | 12,592 | — | 391,292 | |||||||||||||||
Other non-current obligations | 857 | 3,311 | 51,696 | — | 55,864 | |||||||||||||||
Deferred income taxes | — | 3,258 | 1,945 | — | 5,203 | |||||||||||||||
Noncurrent liabilities of discontinued operations | — | — | 2,592 | — | 2,592 | |||||||||||||||
Long-term intercompany payable | — | 81,747 | 63,463 | (145,210 | ) | — | ||||||||||||||
Stockholders' equity | 221,884 | 536,758 | 320,003 | (856,761 | ) | 221,884 | ||||||||||||||
Total liabilities and stockholders' equity | $ | 811,924 | $ | 1,255,244 | $ | 632,222 | $ | (1,855,723 | ) | $ | 843,667 | |||||||||
106
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 17: Condensed Consolidating Financial Statements (Continued)
Condensed Consolidating Balance Sheet
March 31, 2013
Parent | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Reclassifications and Eliminations | Consolidated | ||||||||||||||||
ASSETS | ||||||||||||||||||||
Current assets: | ||||||||||||||||||||
Cash and cash equivalents | $ | 17,202 | $ | 52,056 | $ | 26,720 | $ | — | $ | 95,978 | ||||||||||
Accounts receivable, net | — | 42,051 | 51,723 | — | 93,774 | |||||||||||||||
Intercompany receivable | 287,513 | 251,524 | 150,376 | (689,413 | ) | — | ||||||||||||||
Inventories, net | — | 126,286 | 72,602 | — | 198,888 | |||||||||||||||
Prepaid expenses and other | 3,186 | 13,564 | 27,303 | (2,952 | ) | 41,101 | ||||||||||||||
Deferred income taxes | — | 578 | 3,589 | — | 4,167 | |||||||||||||||
Current assets of discontinued operations | — | — | 9,517 | — | 9,517 | |||||||||||||||
Total current assets | 307,901 | 486,059 | 341,830 | (692,365 | ) | 443,425 | ||||||||||||||
Property and equipment, net | 361 | 111,584 | 191,737 | — | 303,682 | |||||||||||||||
Investments in NEC TOKIN | — | 52,738 | — | — | 52,738 | |||||||||||||||
Investment in subsidiaries | 423,695 | 424,386 | 10,750 | (858,831 | ) | — | ||||||||||||||
Goodwill | — | 35,584 | — | — | 35,584 | |||||||||||||||
Intangible assets, net | — | 29,763 | 8,883 | — | 38,646 | |||||||||||||||
Restricted cash | — | 17,397 | — | — | 17,397 | |||||||||||||||
Deferred income taxes | — | 1,500 | 6,494 | — | 7,994 | |||||||||||||||
Other assets | 6,741 | 3,173 | 235 | — | 10,149 | |||||||||||||||
Noncurrent assets of discontinued operations | — | — | 1,976 | — | 1,976 | |||||||||||||||
Long-term intercompany receivable | 75,919 | 56,338 | 2,800 | (135,057 | ) | — | ||||||||||||||
Total assets | $ | 814,617 | $ | 1,218,522 | $ | 564,705 | $ | (1,686,253 | ) | $ | 911,591 | |||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Current liabilities: | ||||||||||||||||||||
Current portion of long-term debt | $ | 9,561 | $ | 16 | $ | 1,216 | $ | — | $ | 10,793 | ||||||||||
Accounts payable, trade | 61 | 37,444 | 33,269 | — | 70,774 | |||||||||||||||
Intercompany payable | 100,947 | 481,707 | 106,759 | (689,413 | ) | — | ||||||||||||||
Accrued expenses | 37,490 | 19,615 | 36,073 | — | 93,178 | |||||||||||||||
Income taxes payable | — | 3,046 | 980 | (2,952 | ) | 1,074 | ||||||||||||||
Current liabilities of discontinued operations | — | — | 5,661 | — | 5,661 | |||||||||||||||
Total current liabilities | 148,059 | 541,828 | 183,958 | (692,365 | ) | 181,480 | ||||||||||||||
Long-term debt, less current portion | 372,157 | — | 550 | — | 372,707 | |||||||||||||||
Other non-current obligations | 17,485 | 3,899 | 47,638 | — | 69,022 | |||||||||||||||
Deferred income taxes | — | 2,808 | 5,734 | — | 8,542 | |||||||||||||||
Noncurrent liabilities of discontinued operations | — | — | 2,924 | — | 2,924 | |||||||||||||||
Long-term intercompany payable | — | 75,919 | 59,138 | (135,057 | ) | — | ||||||||||||||
Stockholders' equity | 276,916 | 594,068 | 264,763 | (858,831 | ) | 276,916 | ||||||||||||||
Total liabilities and stockholders' equity | $ | 814,617 | $ | 1,218,522 | $ | 564,705 | $ | (1,686,253 | ) | $ | 911,591 | |||||||||
107
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 17: Condensed Consolidating Financial Statements (Continued)
Condensed Consolidating Statements of Operations
Fiscal Year Ended March 31, 2014
Parent | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Reclassifications and Eliminations | Consolidated | ||||||||||||||||
Net sales | $ | 218 | $ | 966,369 | $ | 817,945 | $ | (950,866 | ) | $ | 833,666 | |||||||||
Operating costs and expenses: | ||||||||||||||||||||
Cost of sales | 1,336 | 878,308 | 729,105 | (895,824 | ) | 712,925 | ||||||||||||||
Selling, general and administrative expenses | 41,359 | 61,896 | 47,643 | (55,042 | ) | 95,856 | ||||||||||||||
Research and development | 229 | 16,849 | 7,388 | — | 24,466 | |||||||||||||||
Restructuring charges | — | 2,858 | 11,264 | — | 14,122 | |||||||||||||||
Write down of long-lived assets | — | 1,118 | 3,358 | — | 4,476 | |||||||||||||||
Net (gain) loss on sales and disposals of assets | — | (625 | ) | 657 | — | 32 | ||||||||||||||
Net (gain) loss on intercompany asset transfer | — | 14,564 | (14,564 | ) | — | — | ||||||||||||||
Total operating costs and expenses | 42,924 | 974,968 | 784,851 | (950,866 | ) | 851,877 | ||||||||||||||
Operating income (loss) | (42,706 | ) | (8,599 | ) | 33,094 | — | (18,211 | ) | ||||||||||||
Interest income | (12 | ) | (4 | ) | (179 | ) | — | (195 | ) | |||||||||||
Interest expense | 40,069 | 1,130 | (237 | ) | — | 40,962 | ||||||||||||||
Other (income) expense, net | (40,642 | ) | 36,741 | 1,220 | — | (2,681 | ) | |||||||||||||
Equity in earnings of subsidiaries | 26,332 | — | — | (26,332 | ) | — | ||||||||||||||
Income (loss) from continuing operations before income taxes and equity income from NEC TOKIN | (68,453 | ) | (46,466 | ) | 32,290 | 26,332 | (56,297 | ) | ||||||||||||
Income tax expense (benefit) | — | (1,302 | ) | 2,784 | — | 1,482 | ||||||||||||||
Income (loss) from continuing operations before equity income from NEC TOKIN | (68,453 | ) | (45,164 | ) | 29,506 | 26,332 | (57,779 | ) | ||||||||||||
Equity loss from NEC TOKIN | — | (7,090 | ) | — | — | (7,090 | ) | |||||||||||||
Income (loss) from continuing operations | (68,453 | ) | (52,254 | ) | 29,506 | 26,332 | (64,869 | ) | ||||||||||||
Loss from discontinued operations | (50 | ) | (1,195 | ) | (2,389 | ) | — | (3,634 | ) | |||||||||||
Net income (loss) | $ | (68,503 | ) | $ | (53,449 | ) | $ | 27,117 | $ | 26,332 | $ | (68,503 | ) | |||||||
Condensed Consolidating Statements of Comprehensive Income (Loss)
Fiscal Year Ended March 31, 2014
Comprehensive income (loss) | $ | (62,676 | ) | $ | (57,309 | ) | $ | 35,640 | $ | 26,332 | $ | (58,013 | ) | |||||||
108
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 17: Condensed Consolidating Financial Statements (Continued)
Condensed Consolidating Statements of Operations
Fiscal Year Ended March 31, 2013
Parent | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Reclassifications and Eliminations | Consolidated | ||||||||||||||||
Net sales | $ | — | $ | 905,755 | $ | 843,938 | $ | (925,790 | ) | $ | 823,903 | |||||||||
Operating costs and expenses: | ||||||||||||||||||||
Cost of sales | 2,003 | 823,170 | 754,783 | (882,880 | ) | 697,076 | ||||||||||||||
Selling, general and administrative expenses | 30,838 | 68,711 | 50,981 | (42,910 | ) | 107,620 | ||||||||||||||
Research and development | 190 | 20,028 | 6,658 | — | 26,876 | |||||||||||||||
Restructuring charges | — | 7,266 | 11,453 | — | 18,719 | |||||||||||||||
Write down of long-lived assets | — | 438 | 7,144 | — | 7,582 | |||||||||||||||
Goodwill impairment | — | 1,092 | — | — | 1,092 | |||||||||||||||
Net (gain) loss on sales and disposals of assets | 3 | 98 | (83 | ) | — | 18 | ||||||||||||||
Total operating costs and expenses | 33,034 | 920,803 | 830,936 | (925,790 | ) | 858,983 | ||||||||||||||
Operating income (loss) | (33,034 | ) | (15,048 | ) | 13,002 | — | (35,080 | ) | ||||||||||||
Interest income | (24 | ) | (43 | ) | (72 | ) | — | (139 | ) | |||||||||||
Interest expense | 40,651 | 972 | (292 | ) | — | 41,331 | ||||||||||||||
Other (income) expense, net | (27,233 | ) | 27,623 | (2,685 | ) | — | (2,295 | ) | ||||||||||||
Equity in earnings of subsidiaries | 35,754 | — | — | (35,754 | ) | — | ||||||||||||||
Income (loss) from continuing operations before income taxes and equity income from NEC TOKIN | (82,182 | ) | (43,600 | ) | 16,051 | 35,754 | (73,977 | ) | ||||||||||||
Income tax expense | — | 636 | 2,645 | — | 3,281 | |||||||||||||||
Income (loss) from continuing operations before equity income from NEC TOKIN | (82,182 | ) | (44,236 | ) | 13,406 | 35,754 | (77,258 | ) | ||||||||||||
Equity loss from NEC TOKIN | — | (1,254 | ) | — | — | (1,254 | ) | |||||||||||||
Income (loss) from continuing operations | (82,182 | ) | (45,490 | ) | 13,406 | 35,754 | (78,512 | ) | ||||||||||||
Loss from discontinued operations | — | — | (3,670 | ) | — | (3,670 | ) | |||||||||||||
Net income (loss) | $ | (82,182 | ) | $ | (45,490 | ) | $ | 9,736 | $ | 35,754 | $ | (82,182 | ) | |||||||
Condensed Consolidating Statements of Comprehensive Loss
Fiscal Year Ended March 31, 2013
Comprehensive income (loss) | $ | (85,449 | ) | $ | (43,519 | ) | $ | 6,706 | $ | 35,754 | $ | (86,508 | ) | |||||||
109
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 17: Condensed Consolidating Financial Statements (Continued)
Condensed Consolidating Statements of Operations
Fiscal Year Ended March 31, 2012
Parent | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Reclassifications and Eliminations | Consolidated | ||||||||||||||||
Net sales | $ | — | $ | 938,525 | $ | 883,385 | $ | (897,858 | ) | $ | 924,052 | |||||||||
Operating costs and expenses: | ||||||||||||||||||||
Cost of sales | 799 | 799,659 | 804,464 | (873,610 | ) | 731,312 | ||||||||||||||
Selling, general and administrative expenses | 30,741 | 60,872 | 39,783 | (24,862 | ) | 106,534 | ||||||||||||||
Research and development | — | 21,283 | 6,482 | — | 27,765 | |||||||||||||||
Restructuring charges | — | 2,255 | 11,999 | — | 14,254 | |||||||||||||||
Write down of long-lived assets | — | — | 15,786 | — | 15,786 | |||||||||||||||
Net (gain) loss on sales and disposals of assets | — | 384 | (66 | ) | — | 318 | ||||||||||||||
Total operating costs and expenses | 31,540 | 884,453 | 878,448 | (898,472 | ) | 895,969 | ||||||||||||||
Operating income (loss) | (31,540 | ) | 54,072 | 4,937 | 614 | 28,083 | ||||||||||||||
Interest income | (12 | ) | (58 | ) | (105 | ) | — | (175 | ) | |||||||||||
Interest expense | 27,375 | 459 | 733 | — | 28,567 | |||||||||||||||
Other (income) expense, net | (29,947 | ) | 32,127 | (986 | ) | (229 | ) | 965 | ||||||||||||
Equity in earnings of subsidiaries | (34,456 | ) | — | — | 34,456 | — | ||||||||||||||
Income (loss) from continuing operations before income taxes | 5,500 | 21,544 | 5,295 | (33,613 | ) | (1,274 | ) | |||||||||||||
Income tax expense (benefit) | (1,192 | ) | (80 | ) | 2,348 | — | 1,076 | |||||||||||||
Income (loss) from continuing operations | 6,692 | 21,624 | 2,947 | (33,613 | ) | (2,350 | ) | |||||||||||||
Income from discontinued operations | — | — | 9,042 | — | 9,042 | |||||||||||||||
Net income | $ | 6,692 | $ | 21,624 | $ | 11,989 | $ | (33,613 | ) | $ | 6,692 | |||||||||
Condensed Consolidating Statements of Comprehensive Income (Loss)
Fiscal Year Ended March 31, 2012
Comprehensive income (loss) | $ | 1,646 | $ | 20,641 | $ | 7,483 | $ | (33,613 | ) | $ | (3,843 | ) | ||||||||
110
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 17: Condensed Consolidating Financial Statements (Continued)
Condensed Consolidating Statements of Cash Flows
Fiscal Year Ended March 31, 2014
Parent | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Reclassifications and Eliminations | Consolidated | ||||||||||||||||
Sources (uses) of cash and cash equivalents | ||||||||||||||||||||
Net cash provided by (used in) operating activities | $ | 7,724 | $ | (26,984 | ) | $ | 12,514 | $ | — | $ | (6,746 | ) | ||||||||
Investing activities: | ||||||||||||||||||||
Capital expenditures | — | (13,348 | ) | (18,799 | ) | — | (32,147 | ) | ||||||||||||
Change in restricted cash | — | 4,047 | — | — | 4,047 | |||||||||||||||
Proceeds from sale of assets | — | 996 | 1,851 | — | 2,847 | |||||||||||||||
Net cash used in investing activities | — | (8,305 | ) | (16,948 | ) | — | (25,253 | ) | ||||||||||||
Financing activities: | ||||||||||||||||||||
Proceeds from revolving line of credit | — | 9,000 | 12,000 | — | 21,000 | |||||||||||||||
Payments of revolving line of credit | — | (2,551 | ) | — | — | (2,551 | ) | |||||||||||||
Deferred acquisition payments | (20,977 | ) | (1,000 | ) | — | — | (21,977 | ) | ||||||||||||
Payments of long-term debt | (3,583 | ) | (16 | ) | — | — | (3,599 | ) | ||||||||||||
Proceeds from exercise of stock options | 250 | — | — | — | 250 | |||||||||||||||
Net cash provided by (used in) financing activities | (24,310 | ) | 5,433 | 12,000 | — | (6,877 | ) | |||||||||||||
Net increase (decrease) in cash and cash equivalents | (16,586 | ) | (29,856 | ) | 7,566 | — | (38,876 | ) | ||||||||||||
Effect of foreign currency fluctuations on cash | — | — | 827 | — | 827 | |||||||||||||||
Cash and cash equivalents at beginning of fiscal year | 17,202 | 52,056 | 26,720 | — | 95,978 | |||||||||||||||
Cash and cash equivalents at end of fiscal year | $ | 616 | $ | 22,200 | $ | 35,113 | $ | — | $ | 57,929 | ||||||||||
111
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 17: Condensed Consolidating Financial Statements (Continued)
Condensed Consolidating Statements of Cash Flows
Fiscal Year Ended March 31, 2013
Parent | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Reclassifications and Eliminations | Consolidated | ||||||||||||||||
Sources (uses) of cash and cash equivalents | ||||||||||||||||||||
Net cash provided by (used in) operating activities | $ | (14,492 | ) | $ | (43,099 | ) | $ | 34,764 | $ | — | $ | (22,827 | ) | |||||||
Investing activities: | ||||||||||||||||||||
Capital expenditures | — | (15,841 | ) | (30,333 | ) | — | (46,174 | ) | ||||||||||||
Investment in NEC TOKIN (excludes non cash investment) | — | (50,917 | ) | — | — | (50,917 | ) | |||||||||||||
Change in restricted cash | — | (15,284 | ) | — | — | (15,284 | ) | |||||||||||||
Proceeds from sale of assets | — | — | 398 | — | 398 | |||||||||||||||
Net cash used in investing activities | — | (82,042 | ) | (29,935 | ) | — | (111,977 | ) | ||||||||||||
Financing activities: | ||||||||||||||||||||
Proceeds from issuance of debt | 39,825 | — | — | — | 39,825 | |||||||||||||||
Deferred acquisition payments | (15,900 | ) | (1,000 | ) | — | — | (16,900 | ) | ||||||||||||
Payment of long-term debt | — | (8 | ) | (1,901 | ) | — | (1,909 | ) | ||||||||||||
Debt issuance costs | (275 | ) | — | — | — | (275 | ) | |||||||||||||
Proceeds from exercise of stock options | 111 | — | — | — | 111 | |||||||||||||||
Net cash provided by (used in) financing activities | 23,761 | (1,008 | ) | (1,901 | ) | — | 20,852 | |||||||||||||
Net increase (decrease) in cash and cash equivalents | 9,269 | (126,149 | ) | 2,928 | — | (113,952 | ) | |||||||||||||
Effect of foreign currency fluctuations on cash | — | — | (591 | ) | — | (591 | ) | |||||||||||||
Cash and cash equivalents at beginning of fiscal year | 7,933 | 178,205 | 24,383 | — | 210,521 | |||||||||||||||
Cash and cash equivalents at end of fiscal year | $ | 17,202 | $ | 52,056 | $ | 26,720 | $ | — | $ | 95,978 | ||||||||||
112
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 17: Condensed Consolidating Financial Statements (Continued)
Condensed Consolidating Statements of Cash Flows
Fiscal Year Ended March 31, 2012
Parent | Guarantor Subsidiaries | Non-Guarantor Subsidiaries | Reclassifications and Eliminations | Consolidated | ||||||||||||||||
Sources (uses) of cash and cash equivalents | ||||||||||||||||||||
Net cash provided by (used in) operating activities | $ | (71,930 | ) | $ | 124,591 | $ | 28,069 | $ | — | $ | 80,730 | |||||||||
Investing activities: | ||||||||||||||||||||
Capital expenditures | — | (23,099 | ) | (26,215 | ) | — | (49,314 | ) | ||||||||||||
Acquisitions net of cash received | — | (42,613 | ) | — | — | (42,613 | ) | |||||||||||||
Proceeds from sale of assets | — | — | 74 | — | 74 | |||||||||||||||
Net cash used in investing activities | — | (65,712 | ) | (26,141 | ) | — | (91,853 | ) | ||||||||||||
Financing activities: | ||||||||||||||||||||
Proceeds from issuance of debt | 116,050 | — | — | — | 116,050 | |||||||||||||||
Payments of long-term debt | (40,581 | ) | — | — | — | (40,581 | ) | |||||||||||||
Net (payments) borrowings under other credit facilities | — | — | (3,154 | ) | — | (3,154 | ) | |||||||||||||
Debt issuance costs | (2,313 | ) | — | — | — | (2,313 | ) | |||||||||||||
Proceeds from exercise of stock options | 290 | — | — | — | 290 | |||||||||||||||
Net cash provided by (used in) financing activities | 73,446 | — | (3,154 | ) | — | 70,292 | ||||||||||||||
Net increase (decrease) in cash and cash equivalents | 1,516 | 58,879 | (1,226 | ) | — | 59,169 | ||||||||||||||
Effect of foreign currency fluctuations on cash | — | — | (699 | ) | — | (699 | ) | |||||||||||||
Cash and cash equivalents at beginning of fiscal year | 6,417 | 119,326 | 26,308 | — | 152,051 | |||||||||||||||
Cash and cash equivalents at end of fiscal year | $ | 7,933 | $ | 178,205 | $ | 24,383 | $ | — | $ | 210,521 | ||||||||||
Note 18: Subsequent Events
On April 30, 2014, KEMET Electronics Corporation (“KEC”) and its subsidiaries KEMET Foil Manufacturing, LLC (“KEMET Foil”), Blue Powder as “U.S. Borrowers,” and KEMET Electronics Marketing (S) PTE LTD. (“KEMET Singapore”), and, together with U.S. Borrowers, collectively, “Existing Borrowers,” entered into Amendment No. 5 to Loan and Security Agreement and Joinder (“Amendment“) with Bank of America, N.A., as agent for the Lenders, which amends the Loan and Security Agreement dated as of September 30, 2010 (as amended by the Consolidated Amendment to Loan and Security Agreement dated July 8, 2013, the principal terms of which were disclosed in the Registrant's Form 10-Q for the quarterly period ended June 30, 2013) (the “Loan Agreement”). In connection with and as part of the Amendment, Existing Borrowers also entered into a Second Amended and Restated Revolver Note. The Loan Agreement provides a $50 million revolving line of credit, which is bifurcated into a U.S. facility (for which KEC, KEMET Foil, and KEMET Blue are the borrowers) and a Singapore facility (for which KEMET Singapore is the borrower). The principal features of the Amendment are included in the description of the revolving line of credit within Note 2 "Debt".
On April 30, 2014, KEMET completed the sale of its machinery division which had historically been included within Film and Electrolytic.
113
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
KEMET CORPORATION (Registrant) | ||
Date: May 30, 2014 | /s/ WILLIAM M. LOWE, JR. | |
William M. Lowe, Jr. Executive Vice President and Chief Financial Officer | ||
________________________________________________________________________________________________________________________
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Date: May 30, 2014 | /s/ PER-OLOF LÖÖF | |
Per-Olof Lööf Chief Executive Officer and Director (Principal Executive Officer) | ||
Date: May 30, 2014 | /s/ WILLIAM M. LOWE, JR. | |
William M. Lowe, Jr. Executive Vice President and Chief Financial Officer (Principal Accounting and Financial Officer) | ||
Date: May 30, 2014 | /s/ FRANK G. BRANDENBERG | |
Frank G. Brandenberg Chairman and Director | ||
Date: May 30, 2014 | /s/ DR. WILFRIED BACKES | |
Dr. Wilfried Backes Director | ||
Date: May 30, 2014 | /s/ GURMINDER S. BEDI | |
Gurminder S. Bedi Director | ||
Date: May 30, 2014 | /s/ JOSEPH V. BORRUSO | |
Joseph V. Borruso Director | ||
Date: May 30, 2014 | /s/ JACOB KOZUBEI | |
Jacob Kozubei Director | ||
Date: May 30, 2014 | /s/ E. ERWIN MADDREY, II | |
E. Erwin Maddrey, II Director | ||
Date: May 30, 2014 | /s/ ROBERT G. PAUL | |
Robert G. Paul Director | ||
114